# EDGAR Filing Document

**Accession Number:** 0000887340
**File Stem:** 0000887340-25-000004
**Filing Date:** 2025-9
**Character Count:** 315125
**Document Hash:** 0b989a6e80f6e4341c43421d7f3be932
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000887340-25-000004.hdr.sgml**: 20250919

**ACCESSION NUMBER**: 0000887340-25-000004

**CONFORMED SUBMISSION TYPE**: POS EX

**PUBLIC DOCUMENT COUNT**: 39

**FILED AS OF DATE**: 20250919

**DATE AS OF CHANGE**: 20250919

**EFFECTIVENESS DATE**: 20250919

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** NEW YORK LIFE INVESTMENTS VP FUNDS TRUST
- **CENTRAL INDEX KEY:** 0000887340

**ORGANIZATION NAME:**
- **EIN:** 133186036
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** POS EX
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 002-86082
- **FILM NUMBER:** 251327350

**BUSINESS ADDRESS:**
- **STREET 1:** 51 MADISON AVE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10010
- **BUSINESS PHONE:** 2125767000

**MAIL ADDRESS:**
- **STREET 1:** 51 MADISON AVE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10010

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MAINSTAY VP FUNDS TRUST
- **DATE OF NAME CHANGE:** 20110429

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MAINSTAY VP SERIES FUND INC
- **DATE OF NAME CHANGE:** 20010518

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** NEW YORK LIFE MFA SERIES FUND INC
- **DATE OF NAME CHANGE:** 19920929

AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON SEPTEMBER 19, 2025

FILE NO. 002-86082

FILE NO. 811-03833-01

<br> UNITED STATES<br>SECURITIES AND EXCHANGE COMMISSION <br>WASHINGTON, D.C. 20549

<br> FORM N-1AREGISTRATION STATEMENTUNDERTHE SECURITIES ACT OF 1933Post-Effective Amendment No. 159ANDREGISTRATION STATEMENTUNDERTHE INVESTMENT COMPANY ACT OF 1940Amendment No. 159

**NEW YORK LIFE INVESTMENTS VP FUNDS TRUST**<br>**(exact name of registrant as specified in charter)**<br>

<br> <u>51 MADISON AVENUE<br>NEW YORK, NEW YORK 10010<br>(address of principal executive office) <br>REGISTRANT'S TELEPHONE NUMBER: (212) 576-7000</u>

Copy to:

<br> <u>J. Kevin Gao, Esq. <br>New York Life Investments VP Funds Trust<br>51 Madison Avenue<br>New York, NY 10010</u> <u>Thomas C. Bogle, Esq. <br>Corey F. Rose, Esq.<br>Dechert LLP 1900 K Street, NW<br>Washington, DC 20006</u>

(NAME AND ADDRESS OF AGENT FOR SERVICE)

It is proposed that this filing will become effective immediately upon filing pursuant to Rule 462(d) under the Securities Act of 1933, as amended.

EXPLANATORY NOTE:

This Post-Effective Amendment No.159 to the Registration Statement on Form N-1A (File No. 002-86082) is being filed pursuant to Rule 462(d) under the Securities Act of 1933, as amended (the "Securities Act"), solely for the purpose of adding exhibits to such Registration Statement. Accordingly, this Post-Effective Amendment No. 159 consists only of a facing page, this explanatory note, and Part C of the Registration Statement on Form N-1A. This Post-Effective Amendment No. 159 does not change the form of any prospectus or Statement of Additional Information included in post-effective amendments previously filed with the Securities and Exchange Commission (the "SEC"). As permitted by Rule 462(d), this Post-Effective Amendment No. 159 shall become effective upon filing with the SEC.

------

PART C. OTHER INFORMATION

ITEM 28. EXHIBITS

a. Declaration of Trust

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. [Amended and Restated Declaration of Trust, dated as of August 12, 2024 – Previously filed with Post-Effective Amendment No. 155 as Exhibit (a)(1) on December 17, 2024](http://www.sec.gov/Archives/edgar/data/887340/000174177324004633/ex99acharter-1.htm)<u>\*</u>

b. By-Laws

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. [Amended and Restated By-Laws dated as of August 12, 2024 – Previously filed with Post-Effective Amendment No. 155 as Exhibit (b)(1) on December 17, 2024](http://www.sec.gov/Archives/edgar/data/887340/000174177324004633/ex99bbylaws-1.htm)<u>\*</u>

c. Instruments Defining Rights of Security Holders

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. See the Declaration of Trust and the By-Laws (see above)

d. Investment Advisory Contracts

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. [Amended and Restated Management Agreement dated May 1, 2015 between the Registrant and New York Life Investment Management LLC – Previously filed with Post-Effective Amendment No. 80 as Exhibit (d)(1) on May 1, 2015\*](http://www.sec.gov/Archives/edgar/data/887340/000114420415027045/v409061_ex-d1.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. [Amendment dated January 15, 2016 – Previously filed with Post-Effective Amendment No. 88 as Exhibit (d)(1)(a) on May 2, 2016\*](http://www.sec.gov/Archives/edgar/data/887340/000114420416098026/v438147_ex99-d1a.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. [Amendment dated May 1, 2016 – Previously filed with Post-Effective Amendment No. 88 as Exhibit (d)(1)(b) on May 2, 2016\*](http://www.sec.gov/Archives/edgar/data/887340/000114420416098026/v438147_ex99-d1b.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. [Amendment dated July 29, 2016 – Previously filed with Post-Effective Amendment No. 96 as Exhibit (d)(1)(c) on August 10, 2017\*](http://www.sec.gov/Archives/edgar/data/887340/000114420417042012/v472627_ex99-d1c.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. [Amendment dated March 13, 2017 – Previously filed with Post-Effective Amendment No. 96 as Exhibit (d)(1)(d) on August 10, 2017\*](http://www.sec.gov/Archives/edgar/data/887340/000114420417042012/v472627_ex99-d1d.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. [Amendment dated August 4, 2017 – Previously filed with Post-Effective Amendment No. 96 as Exhibit (d)(1)(e) on August 10, 2017\*](http://www.sec.gov/Archives/edgar/data/887340/000114420417042012/v472627_ex99-d1e.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f. [Amendment dated May 1, 2018 – Previously filed with Post-Effective Amendment No. 101 as Exhibit (d)(1)(f) on September 10, 2018\*](http://www.sec.gov/Archives/edgar/data/887340/000114420418048618/tv501627_ex99-d1f.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;g. [Amendment dated September 10, 2018 – Previously filed with Post-Effective Amendment No. 101 as Exhibit (d)(1)(g) on September 10, 2018\*](http://www.sec.gov/Archives/edgar/data/887340/000114420418048618/tv501627_ex99-d1g.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;h. [Amendment dated October 1, 2018 – Previously filed with Post-Effective Amendment No. 103 as Exhibit (d)(1)(h) on November 30, 2018\*](http://www.sec.gov/Archives/edgar/data/887340/000114420418062447/tv508074_ex99-d1h.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. [Amendment dated November 30, 2018 – Previously filed with Post-Effective Amendment No. 103 as Exhibit (d)(1)(i) on November 30, 2018\*](http://www.sec.gov/Archives/edgar/data/887340/000114420418062447/tv508074_ex99-d1i.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;j. [Amendment dated May 1, 2019 - Previously filed with Post-Effective Amendment No. 110 as Exhibit (d)(1)(j) on September 4, 2019\*](http://www.sec.gov/Archives/edgar/data/887340/000114420419043170/tv528602_ex99-d1j.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;k. [Amendment dated February 28, 2020 – Previously filed with Post-Effective Amendment No. 111 as Exhibit (d)(1)(k) on February 19, 2020\*](http://www.sec.gov/Archives/edgar/data/887340/000110465920022677/tm209215d1_exd1k.htm)

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;l. [Amendment dated May 1, 2020 – Previously filed with Post-Effective Amendment No. 113 as Exhibit (d)(1) on April 16, 2020\*](http://www.sec.gov/Archives/edgar/data/887340/000110465920047623/tm2015911-1_ex99d1l.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;m. [Amendment dated May 1, 2021 – Previously filed with Post-Effective Amendment No. 127 as Exhibit (d)(1)(m) on April 23, 2021\*](http://www.sec.gov/Archives/edgar/data/887340/000174177321000834/ex99dadvsrcontr-1.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;n. [Amendment dated May 1, 2022 – Previously filed with Post-Effective Amendment No. 145 as Exhibit (d)(1)(n) on April 18, 2022\*](http://www.sec.gov/Archives/edgar/data/887340/000174177322001139/ex99dadvsrcontr-1.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;o. [Amendment dated May 1, 2023 – Previously filed with Post-Effective Amendment No. 150 as Exhibit (d)(1)(o) on April 14, 2023\*](http://www.sec.gov/Archives/edgar/data/887340/000174177323001013/ex99dadvsrcontr-1o.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;p. [Amendment dated August 28, 2023 – Previously filed with Post-Effective Amendment No. 151 as Exhibit (d)(1)(p) on October 25, 2023\*](http://www.sec.gov/Archives/edgar/data/887340/000174177323003548/ex99dadvsrcontr-1.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;q. [Amendment dated May 1, 2024 – Previously filed with Post-Effective Amendment No. 153 as Exhibit (d)(1)(q) on April 19, 2024\*](http://www.sec.gov/Archives/edgar/data/887340/000174177324001451/ex99dadvsrcontr-1.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;r. [Amendment dated August 12, 2024 – Previously filed with Post-Effective Amendment No. 155 as Exhibit (d)(1)(r) on December 17, 2024\*](http://www.sec.gov/Archives/edgar/data/887340/000174177324004633/ex99dadvsrcontr-1.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;s. [Amendment dated October 14, 2024 – Previously filed with Post-Effective Amendment No. 155 as Exhibit (d)(1)(s) on December 17, 2024\*](http://www.sec.gov/Archives/edgar/data/887340/000174177324004633/ex99dadvsrcontr-2.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;t. [Amendment dated December 18, 2024 – Previously filed with Post-Effective Amendment No. 155 as Exhibit (d)(1)(t) on December 17, 2024\*](http://www.sec.gov/Archives/edgar/data/887340/000174177324004633/ex99dadvsrcontr-3.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. [Subadvisory Agreement between New York Life Investment Management LLC and Epoch Investment Partners, Inc. dated March 31, 2017 – Previously filed as Exhibit (d)(2) to MainStay Funds Trust's Post-Effective Amendment No. 115 on August 10, 2017\*](http://www.sec.gov/Archives/edgar/data/1469192/000114420417041950/v472398_ex99-d2.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. [Amendment dated May 8, 2017 – Previously filed as Exhibit (d)(2) to MainStay Funds Trust's Post-Effective Amendment No. 115 on August 10, 2017\*](http://www.sec.gov/Archives/edgar/data/1469192/000114420417041950/v472398_ex99-d2a.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. [Amendment dated February 28, 2019 – Previously filed with Post-Effective Amendment 107 as Exhibit (d)(2)(b) on April 18, 2019\*](http://www.sec.gov/Archives/edgar/data/887340/000114420419020208/tv518974_ex99-d2b.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. [Amendment dated April 1, 2019 – Previously filed with Post-Effective Amendment No. 107 as Exhibit (d)(2)(c) on April 18, 2019\*](http://www.sec.gov/Archives/edgar/data/887340/000114420419020208/tv518974_ex99-d2c.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. [Amendment dated May 1, 2019 - Previously filed with Post-Effective Amendment No. 110 as Exhibit (d)(2)(d) on September 4, 2019\*](http://www.sec.gov/Archives/edgar/data/887340/000114420419043170/tv528602_ex99-d2d.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. [Amendment dated April 26, 2021 – Previously filed with Post-Effective Amendment No. 127 as Exhibit (d)(2)(e) on April 23, 2021\*](http://www.sec.gov/Archives/edgar/data/887340/000174177321000834/ex99dadvsrcontr-2.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. [Subadvisory Agreement dated January 1, 2018 between New York Life Investment Management LLC and MacKay Shields LLC –Previously filed with Post-Effective Amendment No. 97 as Exhibit (d)(3) on April 13, 2018\*](http://www.sec.gov/Archives/edgar/data/887340/000114420418020502/tv491017_ex99-d3.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. [Amendment dated February 28, 2018 – Previously filed with Post-Effective Amendment No. 97 as Exhibit (d)(3)(a) on April 13, 2018\*](http://www.sec.gov/Archives/edgar/data/887340/000114420418020502/tv491017_ex99-d3a.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. [Amendment dated May 1, 2018 – Previously filed with Post-Effective Amendment No. 101 as Exhibit (d)(3)(b) on September 10, 2018\*](http://www.sec.gov/Archives/edgar/data/887340/000114420418048618/tv501627_ex99-d3b.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. [Amendment dated May 22, 2018 – Previously filed with Post-Effective Amendment No. 101 as Exhibit (d)(3)(c) on September 10, 2018\*](http://www.sec.gov/Archives/edgar/data/887340/000114420418048618/tv501627_ex99-d3c.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. [Amendment dated November 30, 2018 – Previously filed with Post-Effective Amendment No. 103 as Exhibit (d)(3)(d) on November 30, 2018\*](http://www.sec.gov/Archives/edgar/data/887340/000114420418062447/tv508074_ex99-d3d.htm)

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. [Amendment dated February 28, 2019 – Previously filed with Post-Effective Amendment No. 107 as Exhibit (d)(3)(e) on April 18, 2019\*](http://www.sec.gov/Archives/edgar/data/887340/000114420419020208/tv518974_ex99-d3e.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f. [Amendment dated April 1, 2019 – Previously filed with Post-Effective Amendment No. 107 as Exhibit (d)(3)(f) on April 18, 2019\*](http://www.sec.gov/Archives/edgar/data/887340/000114420419020208/tv518974_ex99-d3f.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;g. [Amendment dated May 1, 2019 – Previously filed with Post-Effective Amendment No. 110 as Exhibit (d)(3)(g) on September 4, 2019\*](http://www.sec.gov/Archives/edgar/data/887340/000114420419043170/tv528602_ex99-d3g.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;h. [Amendment dated June 21, 2019 - Previously filed with Post-Effective Amendment No. 110 as Exhibit (d)(3)(h) on September 4, 2019\*](http://www.sec.gov/Archives/edgar/data/887340/000114420419043170/tv528602_ex99-d3h.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. [Amendment dated June 28, 2019 - Previously filed with Post-Effective Amendment No. 110 as Exhibit (d)(3)(i) on September 4, 2019\*](http://www.sec.gov/Archives/edgar/data/887340/000114420419043170/tv528602_ex99-d3i.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;j. [Amendment dated February 26, 2020 – Previously filed with Post-Effective Amendment No. 113 as Exhibit (d)(3)(j) on April 16, 2020\*](http://www.sec.gov/Archives/edgar/data/887340/000110465920047623/tm2015911-1_ex99d3j.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;k. [Amendment dated February 28, 2020 – Previously filed with Post-Effective Amendment No. 113 as Exhibit (d)(3)(k) on April 16, 2020\*](http://www.sec.gov/Archives/edgar/data/887340/000110465920047623/tm2015911-1_ex99d3k.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;l. [Amendment dated August 31, 2020 – Previously filed with Post-Effective Amendment No. 127 as Exhibit (d)(3)(l) on April 23, 2021\*](http://www.sec.gov/Archives/edgar/data/887340/000174177321000834/ex99dadvsrcontr-3.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;m. [Amendment dated February 28, 2021 – Previously filed with Post-Effective Amendment No. 127 as Exhibit (d)(3)(m) on April 23, 2021\*](http://www.sec.gov/Archives/edgar/data/887340/000174177321000834/ex99dadvsrcontr-4.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;n. [Amendment dated March 5, 2021 – Previously filed with Post-Effective Amendment No. 127 as Exhibit (d)(3)(n) on April 23, 2021\*](http://www.sec.gov/Archives/edgar/data/887340/000174177321000834/ex99dadvsrcontr-5.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;o. [Amendment dated April 26, 2021 – Previously filed with Post-Effective Amendment No. 127 as Exhibit (d)(3)(o) on April 23, 2021\*](http://www.sec.gov/Archives/edgar/data/887340/000174177321000834/ex99dadvsrcontr-6.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;p. [Amendment dated May 1, 2021 – Previously filed with Post-Effective Amendment No. 127 as Exhibit (d)(3)(p) on April 23, 2021\*](http://www.sec.gov/Archives/edgar/data/887340/000174177321000834/ex99dadvsrcontr-7.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;q. [Amendment dated August 28, 2021 – Previously filed with Post-Effective Amendment No. 135 as Exhibit (d)(3)(q) on November 4, 2021\*](http://www.sec.gov/Archives/edgar/data/887340/000174177321003680/ex99dadvsrcontr-1.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;r. [Amendment dated November 30, 2021 – Previously filed with Post-Effective Amendment No. 155 as Exhibit (d)(3)(r) on December 17, 2024\*](http://www.sec.gov/Archives/edgar/data/887340/000174177324004633/ex99dadvsrcontr-4.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;s. [Amendment dated February 28, 2022 – Previously filed with Post-Effective Amendment No. 155 as Exhibit (d)(3)(s) on December 17, 2024\*](http://www.sec.gov/Archives/edgar/data/887340/000174177324004633/ex99dadvsrcontr-5.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;t. [Amendment dated May 1, 2022 – Previously filed with Post-Effective Amendment No. 145 as Exhibit (d)(3)(r) on April 18, 2022\*](http://www.sec.gov/Archives/edgar/data/887340/000174177322001139/ex99dadvsrcontr-2.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;u. [Amendment dated August 28, 2023 – Previously filed with Post-Effective Amendment No. 151 as Exhibit (d)(3)(s) on October 25, 2023\*](http://www.sec.gov/Archives/edgar/data/887340/000174177323003548/ex99dadvsrcontr-2.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;v. [Amendment dated September 8, 2023 – Previously filed with Post-Effective Amendment No. 151 as Exhibit (d)(3)(t) on October 25, 2023\*](http://www.sec.gov/Archives/edgar/data/887340/000174177323003548/ex99dadvsrcontr-3.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;w. [Amendment dated February 28, 2024 – Previously filed with Post-Effective Amendment No. 153 as Exhibit (d)(3)(u) on April 19, 2024\*](http://www.sec.gov/Archives/edgar/data/887340/000174177324001451/ex99dadvsrcontr-2.htm)

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;x. [Amendment dated May 1, 2024 – Previously filed with Post-Effective Amendment No. 153 as Exhibit (d)(3)(v) on April 19, 2024\*](http://www.sec.gov/Archives/edgar/data/887340/000174177324001451/ex99dadvsrcontr-3.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;y. [Amendment dated May 27, 2024 – Previously filed with Post-Effective Amendment No. 155 as Exhibit (d)(3)(y) on December 17, 2024\*](http://www.sec.gov/Archives/edgar/data/887340/000174177324004633/ex99dadvsrcontr-6.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;z. [Amendment dated February 28, 2025 – Previously filed with Post-Effective Amendment No. 158 as Exhibit (d)(3)(z) on April 16, 2025](http://www.sec.gov/Archives/edgar/data/887340/000174177325001495/ex99dadvsrcontr-1.htm)

aa. [Amendment dated February 28, 2025 – Previously filed with Post-Effective Amendment No. 158 as Exhibit (d)(3)(aa) on April 16, 2025](http://www.sec.gov/Archives/edgar/data/887340/000174177325001495/ex99dadvsrcontr-2.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. [Subadvisory Agreement dated October 1, 2014 between New York Life Investment Management LLC and Winslow Capital Management LLC – Previously filed with Post-Effective Amendment No. 96 as Exhibit (d)(6) on August 10, 2017\*](http://www.sec.gov/Archives/edgar/data/887340/000114420417042012/v472627_ex99-d6.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. [Amendment dated February 28, 2016 – Previously filed with Post-Effective Amendment No. 88 as Exhibit (d)(6)(b) on May 2, 2016\*](http://www.sec.gov/Archives/edgar/data/887340/000114420416098026/v438147_ex99-d6b.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. [Amendment dated May 1, 2020 – Previously filed with Post-Effective Amendment No. 127 as Exhibit (d)(4)(b) on April 23, 2021\*](http://www.sec.gov/Archives/edgar/data/887340/000174177321000834/ex99dadvsrcontr-8.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. [Subadvisory Agreement dated May 30, 2017 between New York Life Investment Management LLC and Janus Capital Management LLC – Previously filed with Post-Effective Amendment No. 96 as Exhibit (d)(8) on August 10, 2017\*](http://www.sec.gov/Archives/edgar/data/887340/000114420417042012/v472627_ex99-d8.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. [Amended and Restated Subadvisory Agreement between New York Life Investment Management LLC and Newton Investment Management North America, LLC dated March 1, 2023– Previously filed with Post-Effective Amendment No. 151 as Exhibit (d)(6) on October 25, 2023\*](http://www.sec.gov/Archives/edgar/data/887340/000174177323003548/ex99dadvsrcontr-4.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. [Amendment dated December 18, 2024 – Previously filed with Post-Effective Amendment No. 155 as Exhibit (d)(6)(a) on December 17, 2024\*](http://www.sec.gov/Archives/edgar/data/887340/000174177324004633/ex99dadvsrcontr-7.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. [Subadvisory Agreement dated February 3, 2012 between New York Life Investment Management LLC and Pacific Investment Management Company LLC – Previously filed with Post-Effective Amendment No. 66 as Exhibit (d)(12) on April 11, 2012\*](http://www.sec.gov/Archives/edgar/data/887340/000114420412021102/v309045_exd12.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. [Subadvisory Agreement dated November 30, 2018 between New York Life Investment Management LLC and FIAM LLC – Previously filed with Post-Effective Amendment No. 103 as Exhibit (d)(10) on November 30, 2018\*](http://www.sec.gov/Archives/edgar/data/887340/000114420418062447/tv508074_ex99-d10.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. [Amended and Restated Subadvisory Agreement between New York Life Investment Management LLC and Candriam dated July 1, 2022 – Previously filed with Post-Effective Amendment No. 151 as Exhibit (d)(9) on October 25, 2023\*](http://www.sec.gov/Archives/edgar/data/887340/000174177323003548/ex99dadvsrcontr-5.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10. [Subadvisory Agreement dated May 1, 2014 between New York Life Investment Management LLC and NYL Investors LLC –Previously filed with Post-Effective Amendment No. 80 as Exhibit (d)(17) on May 1, 2015\*](http://www.sec.gov/Archives/edgar/data/887340/000114420415027045/v409061_ex-d17.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. [Amendment dated May 1, 2015 – Previously filed with Post-Effective Amendment No. 89 as Exhibit (d)(16)(a) on September 12, 2016\*](http://www.sec.gov/Archives/edgar/data/887340/000114420416123575/v444423_ex99-d16a.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. [Amendment dated May 1, 2017 – Previously filed with Post-Effective Amendment No. 96 as Exhibit (d)(16)(b) on August 10, 2017\*](http://www.sec.gov/Archives/edgar/data/887340/000114420417042012/v472627_ex99-d16b.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. [Amendment dated May 1, 2021 – Previously filed with Post-Effective Amendment No. 135 as Exhibit (d)(11)(c) on November 4, 2021\*](http://www.sec.gov/Archives/edgar/data/887340/000174177321003680/ex99dadvsrcontr-2.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. [Amendment dated October 14, 2024 – Previously filed with Post-Effective Amendment No. 155 as Exhibit (d)(10)(d) on December 17, 2024\*](http://www.sec.gov/Archives/edgar/data/887340/000174177324004633/ex99dadvsrcontr-8.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11. [Subadvisory Agreement dated February 28, 2020 between New York Life Investment Management LLC and CBRE Clarion Securities LLC - Previously filed with Post-Effective Amendment No. 111 as Exhibit (d)(15) on February 19, 2020\*](http://www.sec.gov/Archives/edgar/data/887340/000110465920022677/tm209215d1_exd15.htm)

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. [Amendment dated May 1, 2023 – Previously filed with Post-Effective Amendment No. 150 as Exhibit (d)(12)(a) on April 14, 2023\*](http://www.sec.gov/Archives/edgar/data/887340/000174177323001013/ex99dadvsrcontr-12a.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12. [Subadvisory Agreement dated May 1, 2020 between New York Life Investment Management LLC and Brown Advisory LLC – Previously filed with Post-Effective Amendment No. 127 as Exhibit (d)(14) on April 23, 2021\*](http://www.sec.gov/Archives/edgar/data/887340/000174177321000834/ex99dadvsrcontr-12.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13. [Subadvisory Agreement dated March 5, 2021 between New York Life Investment Management LLC and Wellington Management Company LLP - Previously filed with Post-Effective Amendment No. 127 as Exhibit (d)(16) on April 23, 2021\*](http://www.sec.gov/Archives/edgar/data/887340/000174177321000834/ex99dadvsrcontr-14.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. [Amendment dated May 1, 2023 – Previously filed with Post-Effective Amendment No. 150 as Exhibit (d)(14)(a) on April 14, 2023\*](http://www.sec.gov/Archives/edgar/data/887340/000174177323001013/ex99dadvsrcontr-14a.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. [Amendment dated August 12, 2024 – Previously filed with Post-Effective Amendment No. 155 as Exhibit (d)(13)(b) on December 17, 2024\*](http://www.sec.gov/Archives/edgar/data/887340/000174177324004633/ex99dadvsrcontr-9.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14. [Subadvisory Agreement dated April 30, 2021 between New York Life Investment Management LLC and Segall Bryant & Hamill LLC – Previously filed with Post-Effective Amendment No. 145 as Exhibit (d)(15) on April 18, 2022\*](http://www.sec.gov/Archives/edgar/data/887340/000174177322001139/ex99dadvsrcontr-3.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15. [Subadvisory Agreement dated May 1, 2022 between New York Life Investment Management LLC and American Century Investment Management, Inc. – Previously filed with Post-Effective Amendment No. 145 as Exhibit (d)(16) on April 18, 2022\*](http://www.sec.gov/Archives/edgar/data/887340/000174177322001139/ex99dadvsrcontr-4.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16. [Subadvisory Agreement between New York Life Investment Management LLC and PineStone Asset Management Inc. dated July 24, 2023 – Previously filed with Post-Effective Amendment No. 151 as Exhibit (d)(18) on October 25, 2023\*](http://www.sec.gov/Archives/edgar/data/887340/000174177323003548/ex99dadvsrcontr-7.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17. [Subadvisory Agreement between New York Life Investment Management LLC and Dimensional Fund Advisors LP dated August 12, 2024 – Previously filed with Post-Effective Amendment No. 155 as Exhibit (d)(17) on December 17, 2024\*](http://www.sec.gov/Archives/edgar/data/887340/000174177324004633/ex99dadvsrcontr-10.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18. [Subadvisory Agreement between New York Life Investment Management LLC and Schroder Investment Management North America Inc. dated August 12, 2024 – Previously filed with Post-Effective Amendment No. 155 as Exhibit (d)(18) on December 17, 2024\*](http://www.sec.gov/Archives/edgar/data/887340/000174177324004633/ex99dadvsrcontr-11.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19. [Subadvisory Agreement between New York Life Investment Management LLC and Massachusetts Financial Services Company dated December 18, 2024 – Previously filed with Post-Effective Amendment No. 155 as Exhibit (d)(19) on December 17, 2024\*](http://www.sec.gov/Archives/edgar/data/887340/000174177324004633/ex99dadvsrcontr-12.htm)

e. Underwriting Contracts

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. [Amended and Restated Distribution and Service Agreement dated May 1, 2016 (Service and Service 2) – Previously filed with Post-Effective Amendment No. 88 as Exhibit (e)(1) on May 2, 2016\*](http://www.sec.gov/Archives/edgar/data/887340/000114420416098026/v438147_ex99-e1.htm)

f. Not Applicable

g. Custodian Agreements

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. [Global Custody Agreement with JPMorgan Chase Bank, National Association dated June 22, 2020 – Previously filed with Post-Effective Amendment No. 127 as Exhibit (g)(1) on April 23, 2021\*](http://www.sec.gov/Archives/edgar/data/887340/000174177321000834/ex99gcustagreemt-1.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. [Amendment dated May 1, 2021 – Previously filed with Post-Effective Amendment No. 135 as Exhibit (g)(1)(a) on November 4, 2021\*](http://www.sec.gov/Archives/edgar/data/887340/000174177321003680/ex99gcustagreemt-1.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. [Amendment dated September 9, 2021 – Previously filed with Post-Effective Amendment No. 135 as Exhibit (g)(1)(b) on November 4, 2021\*](http://www.sec.gov/Archives/edgar/data/887340/000174177321003680/ex99gcustagreemt-2.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. [Amendment dated March 30, 2023 – Previously filed with Post-Effective Amendment No. 151 as Exhibit (g)(1)(c) on October 25, 2023\*](http://www.sec.gov/Archives/edgar/data/887340/000174177323003548/ex99gcustagreemt-1.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. [Amendment dated May 16, 2023 – Previously filed with Post-Effective Amendment No. 151 as Exhibit (g)(1)(d) on October 25, 2023\*](http://www.sec.gov/Archives/edgar/data/887340/000174177323003548/ex99gcustagreemt-2.htm)

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. [Amendment dated January 3, 2024 – Previously filed with Post-Effective Amendment No. 153 as Exhibit (g)(1)(e) on April 19, 2024\*](http://www.sec.gov/Archives/edgar/data/887340/000174177324001451/ex99gcustagreemt-1.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f. [Amendment dated April 9, 2024 – Previously filed with Post-Effective Amendment No. 155 as Exhibit (g)(1)(f) on December 17, 2024\*](http://www.sec.gov/Archives/edgar/data/887340/000174177324004633/ex99gcustagreemt-1.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;g. [Amendment dated July 5, 2024 – Previously filed with Post-Effective Amendment No. 155 as Exhibit (g)(1)(g) on December 17, 2024\*](http://www.sec.gov/Archives/edgar/data/887340/000174177324004633/ex99gcustagreemt-2.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;h. [Amendment dated September 5, 2024 – Previously filed with Post-Effective Amendment No. 155 as Exhibit (g)(1)(h) on December 17, 2024](http://www.sec.gov/Archives/edgar/data/887340/000174177324004633/ex99gcustagreemt-3.htm)\*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. [Amendment dated December 18, 2024 – Previously filed with Post-Effective Amendment No. 156 as Exhibit (g)(1)(i) on January 17, 2025\*](http://www.sec.gov/Archives/edgar/data/887340/000119312525008112/d829999dex99g1i.htm)

h. Other Material Contracts

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. [Amended and Restated Fund Participation Agreement between and among New York Life Insurance and Annuity Corporation, MainStay VP Series Fund, Inc. and New York Life Investment Management LLC dated June 30, 2010 – Previously filed with Post-Effective Amendment No. 56 as Exhibit (h)(1) on April 29, 2011\*](http://www.sec.gov/Archives/edgar/data/887340/000114420411024781/v219826_exh1.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. [Assignment and Amendment dated April 29, 2011 – Previously filed with Post-Effective Amendment No. 56 as Exhibit (h)(1)(a) on April 29, 2011\*](http://www.sec.gov/Archives/edgar/data/887340/000114420411024781/v219826_exh1a.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. [Addendum dated February 17, 2012 – Previously filed with Post-Effective Amendment No. 66 as Exhibit (h)(1)(b) on April 11, 2012\*](http://www.sec.gov/Archives/edgar/data/887340/000114420412021102/v309045_exh1b.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. [Amendment dated January 15, 2016 – Previously filed with Post-Effective Amendment No. 89 as Exhibit (h)(1)(c) on September 12, 2016\*](http://www.sec.gov/Archives/edgar/data/887340/000114420416123575/v444423_ex99-h1c.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. [Amendment dated May 1, 2016 – Previously filed with Post-Effective Amendment No. 89 as Exhibit (h)(1)(d) on September 12, 2016\*](http://www.sec.gov/Archives/edgar/data/887340/000114420416123575/v444423_ex99-h1d.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. [Form of Stock License Agreement relating to the use of the New York Life name and service marks – Previously filed as Exhibit (h) (2) to Post-Effective Amendment No. 28 as Exhibit (h)(2) filed on April 14, 2000\*](http://www.sec.gov/Archives/edgar/data/887340/000095012300003691/0000950123-00-003691.txt)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. [Master Administration Agreement between MainStay VP Series Fund, Inc. and New York Life Insurance and Annuity Corporation – Previously filed with Post-Effective Amendment No. 30 as Exhibit (h)(3) filed on April 13, 2001\*](http://www.sec.gov/Archives/edgar/data/887340/000095012301500751/y47883ex99-h_3.txt)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. [Form of Substitution Agreement substituting NYLIM for NYLIAC – Previously filed with Post-Effective Amendment No. 30 as Exhibit (h)(3)(a) filed on April 13, 2001\*](http://www.sec.gov/Archives/edgar/data/887340/000095012301500751/y47883ex99-h_3a.txt)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. [Administration Agreement Supplements – Previously filed with Post-Effective Amendment No. 41 as Exhibit (h)(4) filed on April 5, 2005\*](http://www.sec.gov/Archives/edgar/data/887340/000095012305004100/y69467xtexv99whw4.txt)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. [Amended and Restated Expense Limitation Agreement dated May 1, 2025 – Previously filed with Post-Effective Amendment No. 158 on April 16, 2025](http://www.sec.gov/Archives/edgar/data/887340/000174177325001495/ex99hothmatcont-1.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. [Notice of Contractual Fee Waiver dated May 1, 2015 (Janus and Eagle) – Previously filed with Post-Effective Amendment No. 80 as Exhibit (h)(5) on May 1, 2015\*](http://www.sec.gov/Archives/edgar/data/887340/000114420415027045/v409061_ex-h5.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. [Notice of Contractual Fee Waiver dated May 1, 2020 (Large Cap Growth) – Previously filed with Post-Effective Amendment No. 150 as Exhibit (h)(6) filed on April 14, 2023\*](http://www.sec.gov/Archives/edgar/data/887340/000174177323001013/ex99hothmatcont-6.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. [Amended and Restated Transfer Agency and Service Agreement with NYLIM Service Company LLC dated October 1, 2008 –Previously filed as Exhibit (h)(1)(a) with Pre-Effective Amendment No. 2 to MainStay Funds Trust's Registration Statement on October 30, 2009.\*](http://www.sec.gov/Archives/edgar/data/1469192/000114420409055707/v163642_ex99-h1a.htm)

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. [Amendment dated April 11, 2016 to the Amended and Restated Transfer Agency Agreement dated October 1, 2008 –Previously filed with Post-Effective Amendment No. 88 as Exhibit (h)(7)(a) on May 2, 2016\*](http://www.sec.gov/Archives/edgar/data/887340/000114420416098026/v438147_ex99-h7a.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. [Amendment dated June 30, 2016 – Previously filed as Exhibit (h)(1)(a)(xi) to Post-Effective Amendment No. 100 to MainStay Funds Trust's Registration Statement on September 12, 2016\*](http://www.sec.gov/Archives/edgar/data/1469192/000114420416123566/v444209_ex99-h1axi.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. [Amendment dated March 13, 2017 – Previously filed as Exhibit (h)(1)(a)(xii) to MainStay Funds Trust's Post-Effective Amendment No. 115 on August 10, 2017\*](http://www.sec.gov/Archives/edgar/data/1469192/000114420417041950/v472398_ex99-h1axii.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. [Amendment dated April 11, 2017 – Previously filed as Exhibit (h)(1)(a)(xiii) to MainStay Funds Trust's Post-Effective Amendment No. 115 on August 10, 2017\*](http://www.sec.gov/Archives/edgar/data/1469192/000114420417041950/v472398_ex99-h1axiii.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. [Amendment dated May 8, 2017 – Previously filed as Exhibit (h)(1)(a)(xiv) to MainStay Funds Trust's Post-Effective Amendment No. 115 on August 10, 2017\*](http://www.sec.gov/Archives/edgar/data/1469192/000114420417041950/v472398_ex99-h1axiv.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f. [Amendment dated November 15, 2017 – Previously filed with Post-Effective Amendment No. 101 as Exhibit (h)(7)(f) on September 10, 2018\*](http://www.sec.gov/Archives/edgar/data/887340/000114420418048618/tv501627_ex99-h7f.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;g. [Amendment dated February 28, 2018 – Previously filed with Post-Effective Amendment No. 101 as Exhibit (h)(7)(g) on September 10, 2018\*](http://www.sec.gov/Archives/edgar/data/887340/000114420418048618/tv501627_ex99-h7g.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;h. [Amendment dated May 22, 2018 – Previously filed with Post-Effective Amendment No. 101 as Exhibit (h)(7)(h) on September 10, 2018\*](http://www.sec.gov/Archives/edgar/data/887340/000114420418048618/tv501627_ex99-h7h.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. [Amendment dated July 2, 2018 – Previously filed with Post-Effective Amendment No. 101 as Exhibit (h)(7)(i) on September 10, 2018\*](http://www.sec.gov/Archives/edgar/data/887340/000114420418048618/tv501627_ex99-h7i.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;j. [Amendment dated November 30, 2018 – Previously filed with Post-Effective Amendment No. 103 as Exhibit (h)(7)(j) on November 30, 2018\*](http://www.sec.gov/Archives/edgar/data/887340/000114420418062447/tv508074_ex99-h7j.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;k. [Amendment dated February 28, 2019 – Previously filed with Post-Effective Amendment No. 107 as exhibit (h)(7)(k) on April 18, 2019\*](http://www.sec.gov/Archives/edgar/data/887340/000114420419020208/tv518974_ex99-h7k.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;l. [Amendment dated April 1, 2019 – Previously filed with Post-Effective Amendment No. 107 as Exhibit (h)(7)(l) on April 18, 2019\*](http://www.sec.gov/Archives/edgar/data/887340/000114420419020208/tv518974_ex99-h7l.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;m. [Amendment dated June 14, 2019 – Previously filed with Post-Effective Amendment No. 110 as Exhibit (h)(7)(m) on September 4, 2019\*](http://www.sec.gov/Archives/edgar/data/887340/000114420419043170/tv528602_ex99-h7m.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;n. [Amendment dated November 1, 2019 - Previously filed with Post-Effective Amendment No. 111 as Exhibit (h)(7)(n) on February 19, 2020\*](http://www.sec.gov/Archives/edgar/data/887340/000110465920022677/tm209215d1_exh7n.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;o. [Amendment dated February 26, 2020 – Previously filed with Post-Effective Amendment No. 113 as Exhibit (h)(7)(o) on April 16, 2020\*](http://www.sec.gov/Archives/edgar/data/887340/000110465920047623/tm2015911-1_ex99h7o.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;p. [Amendment dated May 1, 2020 – Previously filed with Post-Effective Amendment No. 113 as Exhibit (h)(7)(p) on April 16, 2020\*](http://www.sec.gov/Archives/edgar/data/887340/000110465920047623/tm2015911-1_ex99h7p.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;q. [Amendment dated June 30, 2020 – Previously filed with Post-Effective Amendment No. 135 as Exhibit (h)(7)(q) on November 4, 2021\*](http://www.sec.gov/Archives/edgar/data/887340/000174177321003680/ex99hothmatcont-1.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;r. [Amendment dated September 30, 2020 – Previously filed with Post-Effective Amendment No. 135 as Exhibit (h)(7)(r) on November 4, 2021\*](http://www.sec.gov/Archives/edgar/data/887340/000174177321003680/ex99hothmatcont-2.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;s. [Amendment dated February 28, 2021 – Previously filed with Post-Effective Amendment No. 135 as Exhibit (h)(7)(s) on November 4, 2021\*](http://www.sec.gov/Archives/edgar/data/887340/000174177321003680/ex99hothmatcont-3.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;t. [Amendment dated September 30, 2021 – Previously filed with Post-Effective Amendment No. 135 as Exhibit (h)(7)(t) on November 4, 2021\*](http://www.sec.gov/Archives/edgar/data/887340/000174177321003680/ex99hothmatcont-4.htm)

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;u. [Amendment dated October 26, 2021 – Previously filed with Post-Effective Amendment No. 135 as Exhibit (h)(7)(u) on November 4, 2021\*](http://www.sec.gov/Archives/edgar/data/887340/000174177321003680/ex99hothmatcont-5.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;v. [Amendment dated February 28, 2022 – Previously filed with Post-Effective Amendment No. 151 as Exhibit (h)(7)(v) on October 25, 2023\*](http://www.sec.gov/Archives/edgar/data/887340/000174177323003548/ex99hothmatcont-1.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;w. [Amendment dated January 1, 2023 – Previously filed with Post-Effective Amendment No. 151 as Exhibit (h)(7)(w) on October 25, 2023\*](http://www.sec.gov/Archives/edgar/data/887340/000174177323003548/ex99hothmatcont-2.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;x. [Amendment dated July 24, 2023 – Previously filed with Post-Effective Amendment No. 151 as Exhibit (h)(7)(x) on October 25, 2023\*](http://www.sec.gov/Archives/edgar/data/887340/000174177323003548/ex99hothmatcont-3.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;y. [Amendment dated August 28, 2023 – Previously filed with Post-Effective Amendment No. 151 as Exhibit (h)(7)(y) on October 25, 2023\*](http://www.sec.gov/Archives/edgar/data/887340/000174177323003548/ex99hothmatcont-4.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;z. [Amendment dated February 28, 2024 – Previously filed with Post-Effective Amendment No. 153 as Exhibit (h)(7)(z) on April 19, 2024\*](http://www.sec.gov/Archives/edgar/data/887340/000174177324001451/ex99hothmatcont-2.htm)

aa. [Amendment dated July 1, 2024 – Previously filed with Post-Effective Amendment No. 155 as Exhibit (h)(7)(aa) on December 17, 2024\*](http://www.sec.gov/Archives/edgar/data/887340/000174177324004633/ex99hothmatcont-2.htm)

bb. [Amendment dated July 22, 2024 – Previously filed with Post-Effective Amendment No. 155 as Exhibit (h)(7)(bb) on December 17, 2024\*](http://www.sec.gov/Archives/edgar/data/887340/000174177324004633/ex99hothmatcont-3.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;cc. [Amendment dated July 1, 2025 – Filed herwith](ex99hothmatcont-1.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. [Fund Participation Agreement dated May 1, 2016 with Nationwide – Previously filed with Post-Effective Amendment No. 88 as Exhibit (h)(8) on May 2, 2016\*](http://www.sec.gov/Archives/edgar/data/887340/000114420416098026/v438147_ex99-h8.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. [Shareholder Services Plan for Service 2 Class adopted June 4, 2024 – Previously filed with Post-Effective Amendment No. 155 as Exhibit (h)(9) on December 17, 2024\*](http://www.sec.gov/Archives/edgar/data/887340/000174177324004633/ex99hothmatcont-4.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10. [Appointment of Agent for Service (VP Cayman Sub) – Previously filed with Post-Effective Amendment No. 89 as Exhibit (h)(10) on September 12, 2016\*](http://www.sec.gov/Archives/edgar/data/887340/000114420416123575/v444423_ex99-h10.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11. [Fund Participation Agreement dated May 1, 2017 with Jefferson National – Previously filed with Post-Effective Amendment No. 96 as Exhibit (h)(11) on August 10, 2017\*](http://www.sec.gov/Archives/edgar/data/887340/000114420417042012/v472627_ex99-h11.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12. [Form of MainStay Funds 12d1-4 Agreement (Acquiring Funds) – Previously filed with Post-Effective 147 as Exhibit (h)(12) on May 20, 2022\*](http://www.sec.gov/Archives/edgar/data/887340/000174177322001770/ex99hothmatcont-2.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13. [Form of MainStay Funds 12d1-4 Agreement (Acquired Funds) –Previously filed with Post-Effective 147 as Exhibit (h)(13) on May 20, 2022\*](http://www.sec.gov/Archives/edgar/data/887340/000174177322001770/ex99hothmatcont-3.htm)

i. Opinion of Counsel

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Legal Opinion of Dechert LLP – Not applicable

j. Other Opinions

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Consent of Independent Registered Public Accounting Firm – Not applicable

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. [Powers of Attorney – Previously filed with Post-Effective Amendment No. 55 as Exhibit "Other" filed on April 14, 2011\*](http://www.sec.gov/Archives/edgar/data/887340/000114420411021827/v218350_ex99-other.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. [Powers of Attorney – Previously filed with Post-Effective Amendment No. 85 as Exhibit "Other" filed on February 12, 2016\*](http://www.sec.gov/Archives/edgar/data/887340/000119312516462236/d136682dex992.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. [Powers of Attorney (Blunt, Chow & Perold) – Previously filed with Post-Effective Amendment No. 86 as Exhibit "Other" filed on March 1, 2016\*](http://www.sec.gov/Archives/edgar/data/887340/000119312516487648/d138554dex992.htm)

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. [Power of Attorney (Hung) – Previously filed with Post-Effective Amendment No. 90 as Exhibit "Other" filed on January 30, 2017\*](http://www.sec.gov/Archives/edgar/data/887340/000114420417004672/v457871_ex99-other.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. [Power of Attorney (Hammond) – Previously filed with Post-Effective Amendment No. 138 as Exhibit (j)(6) on January 12, 2022\*](http://www.sec.gov/Archives/edgar/data/887340/000174177322000062/ex99jotheropinin-1.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. [Power of Attorney (Abou-Jaoudé) – Previously filed with Post-Effective Amendment No. 151 as Exhibit (j)(7) on October 25, 2023\*](http://www.sec.gov/Archives/edgar/data/887340/000174177323003548/ex99jotheropinin-1.htm)

k. Not applicable

l. Not applicable

m. Rule 12b-1 Plan

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. [12b-1 Distribution and Service Plan for Service Class dated January 15, 2016 – Previously filed with Post-Effective Amendment No. 88 as Exhibit (m)(1) on May 2, 2016\*](http://www.sec.gov/Archives/edgar/data/887340/000114420416098026/v438147_ex99-m1.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. [12b-1 Distribution and Service Plan for Service 2 Class dated May 1, 2016 – Previously filed with Post-Effective Amendment No. 88 as Exhibit (m)(2) on May 2, 2016\*](http://www.sec.gov/Archives/edgar/data/887340/000114420416098026/v438147_ex99-m2.htm)

n. Rule 18f-3 Plan

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. [Amended 18f-3 Plan dated May 1, 2016 – Previously filed with Post-Effective Amendment No. 88 as Exhibit (n)(1) on May 2,](http://www.sec.gov/Archives/edgar/data/887340/000114420416098026/v438147_ex99-n1.htm)

2016\*

o. Reserved

p. Codes of Ethics

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. [Code of Ethics of New York Life Investments dated December 2024 – Filed herewith](ex99pcodeeth-1.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. [Nuveen Investments Inc.'s (Winslow) Code of Ethics dated February 2023 – Previously filed with Post-Effective Amendment No. 153 as Exhibit (p)(3) on April 19, 2024\*](http://www.sec.gov/Archives/edgar/data/887340/000174177324001451/ex99pcodeeth-2.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. [Code of Ethics of Epoch Investment Partners, Inc. dated October 2024 – Filed herewith](ex99pcodeeth-2.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. [Janus Henderson Investor's Code of Ethics dated November 2022 – Previously filed with Post-Effective Amendment No. 150 as Exhibit (p)(5) on April 14, 2023\*](http://www.sec.gov/Archives/edgar/data/887340/000174177323001013/ex99pcodeeth-5.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. [BNY Mellon Code of Conduct dated March 2022 – Previously filed with Post-Effective Amendment No. 150 as Exhibit (p)(6) on April 14, 2023\*](http://www.sec.gov/Archives/edgar/data/887340/000174177323001013/ex99pcodeeth-6.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. [Pacific Investment Management Company LLC's Code of Ethics dated November 2021 – Previously filed with Post-Effective Amendment No. 147 as Exhibit (p)(7) on May 20, 2022\*](http://www.sec.gov/Archives/edgar/data/887340/000174177322001770/ex99pcodeeth-3.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. [American Century Investment Management, Inc.'s Code of Ethics dated December 2022 – Previously filed with Post-Effective Amendment No. 150 as Exhibit (p)(8) on April 14, 2023\*](http://www.sec.gov/Archives/edgar/data/887340/000174177323001013/ex99pcodeeth-8.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. [Fidelity 2024 Code of Ethics – Previously filed with Post-Effective Amendment No. 153 as Exhibit (p)(9) on April 19, 2024\*](http://www.sec.gov/Archives/edgar/data/887340/000174177324001451/ex99pcodeeth-4.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. [Code of Ethics of Candriam dated October 2024 – Filed herewith](ex99pcodeeth-3.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10. [Brown Advisory LLC Code of Ethics (January 2022) – Previously filed with Post-Effective Amendment No. 150 as Exhibit (p)(11) on April 14, 2023\*](http://www.sec.gov/Archives/edgar/data/887340/000174177323001013/ex99pcodeeth-11.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11. [Segall Bryant & Hammill Code of Ethics (March 2022) – Previously filed with Post-Effective Amendment No. 150 as Exhibit (p)(12) on April 14, 2023\*](http://www.sec.gov/Archives/edgar/data/887340/000174177323001013/ex99pcodeeth-12.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12. [Code of Ethics of CBRE Investment Management Listed Real Assets LLC dated September 2021– Previously filed with Post-Effective Amendment No. 147 as Exhibit (p)(13) on May 20, 2022\*](http://www.sec.gov/Archives/edgar/data/887340/000174177322001770/ex99pcodeeth-6.htm)

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13. [Wellington Management Company LLC Code of Ethics dated December 2023 – Previously filed with Post-Effective Amendment No. 153 as Exhibit (p)(14) on April 19, 2024\*](http://www.sec.gov/Archives/edgar/data/887340/000174177324001451/ex99pcodeeth-5.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14. [Code of Ethics of PineStone Asset Management Inc. dated July 2023 – Previously filed with Post-Effective Amendment No. 151 as Exhibit (p)(15) on October 25, 2023](http://www.sec.gov/Archives/edgar/data/887340/000174177323003548/ex99pcodeeth-1.htm)\*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15. [Code of Ethics for Schroder Investment Management North America Inc. dated September 2021– Previously filed with Post-Effective Amendment No. 155 as Exhibit (p)(16) on December 17, 2024\*](http://www.sec.gov/Archives/edgar/data/887340/000174177324004633/ex99pcodeeth-1.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16. [Code of Ethics for Massachusetts Financial Services Company dated December 2023 – Previously filed with Post-Effective Amendment No. 156 as Exhibit (p)(17) on January 17, 2025\*](http://www.sec.gov/Archives/edgar/data/887340/000119312525008112/d829999dex99p17.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17. [Code of Ethics for Dimensional Fund Advisors, LP dated December 2023 – Previously filed with Post-Effective Amendment No. 156 as Exhibit (p)(18) on January 17, 2025\*](http://www.sec.gov/Archives/edgar/data/887340/000119312525008112/d829999dex99p18.htm)

<br> \* Incorporated by reference.

ITEM 29. PERSONS CONTROLLED BY OR UNDER COMMON CONTROL WITH REGISTRANT

Shares of New York Life Investments VP Funds Trust (the "Registrant") are currently offered only to separate accounts of New York Life Insurance and Annuity Corporation ("NYLIAC"), a wholly-owned subsidiary of New York Life Insurance Company ("New York Life"), for allocation to, among others, NYLIAC Variable Annuity Separate Account-I, NYLIAC Variable Annuity Separate Account-II, NYLIAC Variable Annuity Separate Account-III , NYLIAC Variable Annuity Separate Account-IV, NYLIAC MFA Separate Account I, NYLIAC MFA Separate Account II, VLI Separate Account, NYLIAC Variable Universal Life Separate Account-I, NYLIAC Variable Universal Life Separate Account-II, Corporate Sponsored Variable Universal Life Separate Account I, Private Placement Variable Universal Life Separate Account I and Private Placement Variable Universal Life Separate Account II (the "Variable Separate Accounts"). The Variable Separate Accounts are segregated asset accounts of NYLIAC. NYLIAC has provided the initial investment in the Variable Separate Accounts; and its affiliate, New York Life Investment Management LLC serves as investment adviser to the Portfolios.

The following lists entities in which New York Life Insurance Company ("NYLIC"), directly or indirectly, (1) owns more than 50% of the voting interests in, or otherwise exercises control over, the entity (each such entity, a "subsidiary") or (2) owns between 10% and 50% of the voting securities in the entity (each such entity, an "affiliate"). Unless otherwise indicated, ownership is 100% of voting securities. Details on ownership of voting securities are noted in footnotes. Third party ownership of entities is not included. Subsidiaries of subsidiaries are indented.

This listing does not include NYLIC or subsidiary ownership in any mutual funds or separate accounts.

MSSIV NYL Investor Member LLC (Delaware) (NYLIC: 90%, NYLIAC 10%)

MSVEF II Investor LLC (Delaware)

NYL Investors LLC (Delaware)

NYL Investors (U.K.) Limited (United Kingdom)

NYL Investors REIT Manager LLC (Delaware)

MSVEF II GP LLC (Delaware)

MSVEF RT Feeder II LP (Delaware)

MSVEF II RT LLC (Delaware)

MSVEF RH Feeder II LP (Delaware)

MSVEF RH II LP (Delaware)

Madison Square Value Enhancement Fund II LP (Delaware)

NYL Investors NCVAD II GP, LLC (Delaware)

McMorgan Northern California Value Add/Development Fund II, LP (Delaware) (50%)

MNCVAD II-OFC 770 L Street CA LLC (Delaware)

MNCVAD II-MF UNION CA LLC (Delaware)

MNCVAD II- HOLLIDAY UNION JV LLC (Delaware) (90%)

MNCVAD II-OFC HARBORS CA LLC (Delaware)

MNCVAD II-SEAGATE HARBORS LLC (Delaware) (LLC: 90%)

MNCVAD II-OFC 630 K Street CA LLC (Delaware)

MNCVAD II-IND SHILOH CA LLC (Delaware)

MNCVAD II-BIG SHILOH JV LLC (Delaware) (90%)

MSSDF GP LLC (Delaware)

MSSDF II GP LLC (Delaware)

MSSDF II Member LLC (Delaware) (NYLIC: 35%, NYLIAC: 65%)

Madison Square Structured Debt Fund II LP (Delaware)

------

MSSDF REIT II LLC (Delaware)

MSSDF Member LLC (Delaware) (NYLIC: 35%, NYLIAC: 65%)

Madison Square Structured Debt Fund LP (Delaware) (40.4%)

MSSDF REIT LLC (Delaware)

MSSDF REIT Funding Sub I LLC (Delaware)

MSSDF REIT Funding Sub II LLC (Delaware)

MSSDF REIT Funding Sub III LLC (Delaware)

MSSDF REIT Funding Sub IV LLC (Delaware)

MSSDF REIT Funding Sub V LLC (Delaware)

MSSDF REIT Funding Sub VI LLC (Delaware)

MSSDF REIT Funding Sub VII LLC (Delaware)

MSSDF-OFCB Voss San Felipe LLC (Delaware)

MSSDF-OFCB Woodway LLC (Delaware)

MSSDF-OFCB Hanover LLC (Delaware)

MSSDF-OFCB El Segundo LLC (Delaware)

MSSIV GP LLC (Delaware)

Madison Square Strategic Investments Venture LP (Delaware

MSSIV REIT Manager LLC (Delaware) (51%)

Madison Square Strategic Investments Venture REIT LLC (Delaware) (51%)

MSSIV- MF Country Place MD LLC (Delaware)

MSSIV-IND Speedway SC LLC (Delaware) (NYL: 45:90%, NYLIAC: 5.1%)

NRL Speedway Venture LLC (Delaware) (39.53%, TP: 60.47%)

SC Speedway Hwy 124, LLC (Delaware)

MSSIV-IND Speedway Phase II JV SC LLC (Delaware)

MSSIV-IND Speedway Phase II Member SC LLC (Delaware)

MSVEF GP LLC (Delaware)

MCPF GP LLC (Delaware)

Madison Core Property Fund LP (Delaware) (NYL Investors is Non Member Manager 0.00%)<sup>7</sup>

MCPF Holdings Manager LLC (Delaware)

MCPF MA Holdings LLC (Delaware)

MCPF Holdings LLC (Delaware)

MADISON-IND TAMARAC FL LLC (Delaware)

MADISON-OFC BRICKELL FL LLC (Delaware)

MADISION-IND POWAY CA LLC (Delaware)

MADISON-LPC POWAY JV LLC (Delaware) (95%)

MADISON-MF GRANARY FLATS TX LLC (Delaware)

MADISON-AO GRANARY FLATS JV LLC (Delaware) (99.999%; TP: 0.001%)

MADISON-AO GRANARY FLATS OWNER LLC (Delaware)

MADISON-MF THE MEADOWS WA LLC (Delaware)

MADISON-ACG THE MEADOWS OWNER LLC (Delaware)

MADISON-ACG THE MEADOWS JV LLC (Delaware)

MADISON-MOB Lee Highway VA LLC (Delaware)

Madison-OFC 5161 CA LLC (Delaware)

MADISON-SS Kernersville QRS, Inc. (Delaware)

MADISON-LPP Kernersville JV GP LLC (Delaware) (90%, TP: 10%)

MADISON-LPP Kernersville JV LP (Delaware) (90%, TP: 10%)

MADISON-LPP Kernersville GP LLC (Delaware)

MADISON-LPP Kernersville LP (Delaware)

MADISON-IND 2080 ENTERPRISE CA LLC (Delaware)

MADISON-IND CLAWITER CA LLC (Delaware)

MADISON-REDCO CLAWITER JV LLC (Delaware) (95%)

MADISON-IND ENTERPRISE RIALTO CA LLC (Delaware)

MIREF Mill Creek, LLC (Delaware)

MIREF Gateway, LLC (Delaware)

MIREF Gateway Phases II and III, LLC (Delaware)

MIREF Delta Court, LLC (Delaware)

MIREF Fremont Distribution Center, LLC (Delaware)

MIREF Century, LLC (Delaware)

MIREF Newpoint Commons, LLC (Delaware)

MIREF Northsight, LLC (Delaware)

MIREF Riverside, LLC (Delaware)

Barton's Lodge Apartments, LLC (Delaware) (90%)

MIREF 101 East Crossroads, LLC (Delaware)

101 East Crossroads, LLC (Delaware)

MIREF Hawthorne, LLC (Delaware)

MIREF Auburn 277, LLC (Delaware)

MIREF Sumner North, LLC (Delaware)

MIREF Wellington, LLC (Delaware)

MIREF Warner Center, LLC (Delaware)

MADISON-MF Duluth GA LLC (Delaware)

MADISON-OFC Centerstone I CA LLC (Delaware)

MADISON-OFC Centerstone III CA LLC Delaware)

MADISON-MOB Centerstone IV CA LLC (Delaware)

MADISON-OFC Centerpoint Plaza CA LLC (Delaware)

------

MADISON-OFC One Main Place OR LLC (Delaware)

MADISON-MF Hoyt OR LLC (Delaware)

MADISON-RTL Clifton Heights PA LLC (Delaware)

MADISON-IND Locust CA LLC (Delaware)

MADISON-OFC Weston Pointe FL LLC (Delaware)

MADISON-MF MCCADDEN CA LLC (Delaware)

MADISON-OFC 1201 WEST IL LLC (Delaware)

MADISON-MCCAFFERY 1201 WEST IL LLC (Delaware) (92.5%)

MADISON-MF TECH RIDGE TX LLC (Delaware)

MADISON-RTL SARASOTA FL, LLC (Delaware)

MADISON-MOB CITRACADO CA LLC (Delaware)

Madison-MF Osprey QRS Inc. (Delaware)

Madison-MF Osprey NC GP LLC (Delaware)

Madison-MF Osprey NC LP (Delaware) (QRS: 99%; GP/LLC: 1%)

MADISON-IND LNDR TABOR ROAD NJ LLC (Delaware)

MADISON-SS Crozet VA LLC (Delaware)

MADISON-LPP Crozet JV LLC (Delaware)

Madison-MF Apex Newbury PA LLC (Delaware)

MSVEF Investor LLC (Delaware)

MSVEF Feeder LP (Delaware) (55.56%)

MSVEF REIT LLC (Delaware) (55.56%)

Madison Square Value Enhancement Fund LP("MSVEFLP") (Delaware) (51%) (MSVEF GP LLC is the Sole GP)

MSVEF-MF Evanston GP LLC (Delaware) (51%)

MSVEF-MF Evanston IL LP (Delaware) (51%)

MSVEF-IND Commerce 303 GP LLC (Delaware)

MSVEF-IND Commerce 303 AZ LP (Delaware)

MSVEF-SW Commerce 303 JV LP (Delaware) (95%)

MSVEF-MF Pennbrook Station GP LLC (Delaware) (51%)

MSVEF-MF Pennbrook Station PA LP (Delaware) (MSVEFLP: 51%; GPLLC: 0%)

MSVEF-MF Burrough's Mill GP LLC (Delaware) (MSVEFLP: 100%)

MSVEF-MF Burrough's Mill NJ LP (Delaware) (MSVEFLP: 50%)

MSVEF-MF Gramercy JV GP LLC (Delaware)

MSVEF-MF Gramercy OH LP (Delaware) (MSVEFLP: 100%, GPLLC 0%)

MSVEF-CR Gramercy JV LP (Delaware) (75%)

MSVEF-CR Gramercy Owner GP LLC (Delaware)

MSVEF-CR Gramercy Owner LP (Delaware) (JV: 99.9%; GP/LLC: 0.1%)

New York Life Group Insurance Company of NY ("NYLG") (New York)

Life Insurance Company of North America (Pennsylvania)

LINA Benefit Payments, Inc. (Delaware)

New York Life Benefit Payments LLC (Delaware)

NYL Real Assets LLC (Delaware)

NYL Emerging Manager LLC (Delaware)

NYL Wind Investments LLC (Delaware)

NYLIFE Insurance Company of Arizona (Arizona)

NYLIC HKP Member LLC (Delaware) (NYLIC: 67.974%; NYLIAC 32.026%)

New York Life Insurance and Annuity Corporation (Delaware)

NYLIAC RLP II, LLC (Delaware)

Development Funding Backed Pass-Through Trust Series – 2025 A (Delaware) (11.75197%)

New York Life Enterprises LLC (Delaware)

SEAF Sichuan SME Investment Fund LLC (Delaware) (39.98%)

New York Life International Holdings Limited (Mauritius) (84.38%)<sup>1</sup>

Max Estates Limited. (India) (NYLIH: 19.45%, NYLIC: 1.29%) [Max Ventures and Industries Limited merged into Max Estates Ltd as of 7.31.2023]

Max I. Limited. (India)

Max Assets Services Limited. (India)

Max Square Limited (India) (Max: 51%, NYLIC: 49%)

Pharmax Corporation Limited. (India)

Max Towers Private. Limited. (India) (Max: 51%, NYLIC: 49%)

Max Estates 128 Private. Limited. (India)

Max Estates Gurgaon Limited. (India)

Acreage Builders Private. Limited. (India) (Max: 51%, NYLIC: 49%)

Astiki Realty Private Limited (India)

Max Estates Gurgaon Two Limited (India)

NYL Cayman Holdings Ltd. (Cayman Islands)

NYL Worldwide Capital Investments LLC (Delaware)

Seguros Monterrey New York Life, S.A. de C.V. (Mexico) (99.998%)<sup>2</sup>

Administradora de Conductos SMNYL, S.A. de C.V. (Mexico) (99%)

Agencias de Distribucion SMNYL, S.A. de C.V. ("ADIS") (Mexico) (99%)

Inmobiliaria SMNYL, SA de C.V. (Mexico) (99%; ADIS: 1%)

NYLIM Jacob Ballas India Holdings IV (Mauritius)

1 NYL Cayman Holdings Ltd. owns 15.62%.

2 NYL Worldwide Capital Investment LLC owns 0.002%.

------

New York Life Investment Management Holdings LLC (Delaware)

Bow River Advisers, LLC (Delaware) (49%)

NYL Investments Europe Limited (Ireland) (new ownership effective 1.1.2025)

NYL Investments (International) Ltd. (UK) ("NYLIL") (name change effective 1.2.2025, new ownership effective 1.1.2025)

NYL Investments (Services) Ltd. (UK) "(NYLISL") (name change effective 1.2.2025, new ownership effective 1.1.2025)

NYL Investments UK LLP (UK) (NYLIL: 99%; NYLISL: 1%) (name change effective 1.2.2025, new ownership effective 1.1.2025)

New York Life Investment Management Asia Limited (Cayman Islands)

Japan Branch

MacKay Shields LLC (Delaware)

MacKay Shields Emerging Markets Debt Portfolio (Delaware)

MacKay Shields Core Plus Opportunities Fund GP LLC (Delaware)

MacKay Shields Core Plus / Opportunities Fund LP (Delaware)

MacKay Municipal Managers Opportunities GP LLC (Delaware)

MacKay Municipal Opportunities Master Fund, L.P. (Delaware)

MacKay Municipal Opportunities Fund, L.P. (Delaware)

MacKay Municipal Managers Credit Opportunities GP LLC (Delaware)

MacKay Municipal Credit Opportunities Master Fund, L.P. (Delaware)

MacKay Municipal Credit Opportunities Fund, L.P. (Delaware)

MacKay Municipal Credit Opportunities HL Fund, L.P. (Delaware)

MacKay Municipal Managers Credit Opportunities HL (Cayman) GP LLC (Cayman Is.)

MacKay Municipal Credit Opportunities HL (Cayman) Fund, LP (Cayman Is.)

MacKay Municipal Short Term Opportunities Fund GP LLC (Delaware)

MacKay Municipal Short Term Opportunities Fund LP (Delaware)

Plainview Funds plc (Ireland) (50%) (MacKay Shields Employee: 50%)

Plainview Funds plc – MacKay Shields Strategic Bond Portfolio (Ireland) (NYLIC: 0.00%; MacKay: 0.00%)

Plainview Funds plc - MacKay Shields Structured Products Opportunities Portfolio (Ireland) (NYLIC: 0.00%; MacKay: 0.00%)

Plainview Funds plc – MacKay Shields Emerging Markets Debt Portfolio (NYLIC: 99.36%, MacKay: 0.64%)

MacKay Shields High Yield Active Core Fund GP LLC (Delaware)

MacKay Shields High Yield Active Core Fund LP (Delaware)

MacKay Shields Defensive Bond Arbitrage Fund Ltd. (Bermuda) (.18%)<sup>3</sup>

MacKay Shields Core Fixed Income Fund GP LLC (Delaware)

MacKay Shields Core Fixed Income Fund LP (Delaware)

MacKay Shields Select Credit Opportunities Fund GP LLC (Delaware)

MacKay Shields Select Credit Opportunities Fund LP (Delaware)

MacKay Municipal Managers California Opportunities GP LLC (Delaware)

MacKay Municipal California Opportunities Fund, L.P. (Delaware)

MacKay Municipal New York Opportunities GP LLC (Delaware)

MacKay Municipal New York Opportunities Fund, L.P. (Delaware)

MacKay Municipal Opportunities HL Fund, L.P. (Delaware)

MacKay Municipal Capital Trading GP LLC (Delaware)

MacKay Municipal Capital Trading Master Fund, L.P. (Delaware)

MacKay Municipal Capital Trading Fund, L.P. (Delaware)

MacKay Municipal Managers Strategic Opportunities GP LLC (Delaware)

MacKay Municipal Strategic Opportunities Fund, L.P. (Delaware)

MacKay Shields Intermediate Bond Fund GP LLC (Delaware)

MacKay Shields Intermediate Bond Fund LP (Delaware)

MacKay Municipal Managers Opportunities Allocation GP LLC (Delaware)

MacKay Municipal Opportunities Allocation Master Fund LP (Delaware)

MacKay Municipal Opportunities Allocation Fund A LP (Delaware)

MacKay Municipal Opportunities Allocation Fund B LP (Delaware)

MacKay Municipal Managers U.S. Infrastructure Opportunities GP LLC (Delaware)

MacKay Municipal U.S. Infrastructure Opportunities Fund LP (Delaware)

MacKay Municipal Managers High Yield Select GP LLC (Delaware)

MacKay Municipal High Yield Select Fund LP (Delaware)

MacKay Municipal Managers High Income Opportunities GP LLC (Delaware)

MacKay Municipal High Income Opportunities Fund LP (Delaware)

MKS CLO Holdings GP LLC (Delaware)

MKS CLO Holdings, LP (Cayman Is.)

MKS CLO Advisors, LLC (Delaware)

MKS Global Sustainable Emerging Markets Equities Fund GP LLC (Delaware)

Candriam Global Sustainable Emerging Markets Equities Fund LP (Delaware) (GP: .05; NYLIAC: 99.95%)

MKS Global Emerging Markets Equities Fund GP LLC (Delaware)

Candriam Global Emerging Markets Equities Fund LP (Delaware) (GP: .00; NYLIAC: 0.00%)

MacKay Shields Series Fund Managing Member LLC (Delaware)

MacKay Shields Series Fund (Delaware)

Securitized Credit Opportunities Series (Delaware)

High Yield Corporate Bond Series (NYL: 0%)

MacKay Shields Emerging Markets Sovereign Debt Feeder Fund GP LLC (Delaware)

MacKay Shields Emerging Markets Sovereign Debt Feeder Fund LP (Delaware)

3 NYLIC owns 0.00%, NYLIAC owns 0.00%, and MacKay owns .18% for a total ownership of .18%.

------

Apogem Capital LLC fka New York Life Investments Alternatives LLC (Delaware)

Apogem SRL 2 LLC (Delaware)<sup>7</sup> (0 voting ownership)

Apogem SRL 3 LLC (Delaware)<sup>7</sup> (0 voting ownership)

Madison Capital Funding LLC (Delaware) (NYLIC: 21.90%; NYLIAC: 65.64%; LINA: 12.46%) (Apogem is a Non-Managing Member)

MCF Co-Investment GP LLC (Delaware)

MCF Co-Investment GP LP (Delaware)

Madison Capital Funding Co-Investment Fund LP (Delaware)

Madison Avenue Loan Fund GP LLC (Delaware)

Madison Avenue Loan Fund LP (Delaware)

MCF Fund I LLC (Delaware)

MCF Hanwha Fund LLC (Delaware)<sup>7</sup> (0 voting ownership)

Ironshore Investment BL I Ltd. (Bermuda)<sup>7</sup> (0 voting ownership)

MCF CLO IV LLC (Delaware)<sup>7</sup> (NYLIC: 6.7%)

MCF CLO V LLC (Delaware)<sup>7</sup> (NYLIC: 5%)

MCF CLO VI LLC (Delaware)<sup>7</sup> (0 voting ownership)

MCF CLO VII LLC (f/k/a LMF WF Portfolio III, LLC) (Delaware)<sup>7</sup> (0 voting ownership)

MCF CLO VIII Ltd. (Delaware)<sup>7</sup> (0 voting ownership)

MCF CLO VIII LLC (Delaware)

MCF CLO VIII Blocker LLC (Delaware)

MCF CLO IX Ltd. (Cayman Islands)<sup>7</sup>

MCF CLO IX LLC (Delaware)

MCF CLO 10 Ltd. (Bailiwick, Jersey)<sup>7</sup>

MCF CLO 10 LLC (Delaware) (Ltd: 100%)

MCF CLO IX Blocker LLC (Delaware)

MCF CLO 10 Blocker LLC (Delaware)

MCF KB Fund LLC (Delaware)<sup>7</sup> (0 voting ownership)

MCF KB Fund II LLC (Delaware)<sup>7</sup> (0 voting ownership)

MC KB Fund III LLC (Delaware)<sup>7</sup> (0 voting ownership)

MCF Hyundai Fund LLC (Delaware)<sup>7</sup> (0 voting ownership)

Apogem Direct Lending Hyundai Fund 2 LLC (Delaware)<sup>7</sup> (0 voting ownership)

Apogem Direct Lending Levered Fund 2023-1 LLC (Delaware)<sup>7</sup> (0 voting ownership)

Apogem Direct Lending Loan Portfolio 2023 LLC (Delaware)<sup>7</sup> (0 voting ownership)

Apogem DL Levered Fund 2023-1 LLC (Delaware)<sup>7</sup> (0 voting ownership)

Apogem DL Levered Fund SPV 2023-1 LLC (Delaware)<sup>7</sup> (0 voting ownership)

Apogem Umbrella (Cayman Islands)<sup>7</sup> (0 voting ownership)

Apogem US Direct Lending Limited I (Cayman Islands)<sup>7</sup> (0 voting ownership)

MCF Senior Debt Fund 2020 GP LLC (Delaware)<sup>7</sup> (0 voting ownership)

MCF Senior Debt Fund – 2020 LP (Cayman Islands)<sup>7</sup> (0 voting ownership)

MCF Mezzanine Carry I LLC (Delaware)<sup>7</sup>

MCF Mezzanine Fund I LLC (Delaware) (NYLIC: 66.66%; NYLIAC: 33.33%) (MCF is the manager)

MCF PD Fund GP LLC (Delaware)<sup>7</sup>

MCF PD Fund LP (Delaware)<sup>7</sup>

MCF Senior Debt Fund 2019-I GP LLC (Delaware)<sup>7</sup>

MCF Senior Debt Fund 2019-I LP (Delaware)<sup>7</sup>

Apogem Direct Lending Nighthawk Fund (Cayman Islands) (Apogem initially)

New York Life Capital Partners III GenPar GP, LLC (Delaware)

New York Life Capital Partners IV GenPar GP, LLC (Delaware)

New York Life Capital Partners IV GenPar, L.P. (Delaware)

New York Life Capital Partners IV, L.P. (Delaware)

GoldPoint Core Opportunities Fund, L.P. (Delaware Series LP)

GoldPoint Core Opportunities Fund II L.P. (Delaware Series LP)

GoldPoint Mezzanine Partners IV GenPar GP, LLC (Delaware)

GoldPoint Mezzanine Partners IV GenPar, LP (Delaware)

GoldPoint Mezzanine Partners Co-Investment Fund A, LP (Delaware)

GoldPoint Mezzanine Partners IV, LP (Delaware) ("GPPIVLP")

GPP Mezz IV A Blocker LP (Delaware)("GPPMBA")

GPP Mezz IV A Preferred Blocker LP (Delaware)

GPP Mezz IV B Blocker LP (Delaware) ("GPPMBB")

GPP Mezz IV C Blocker LP (Delaware) ("GPPMBC")

GPP Mezz IV D Blocker LP (Delaware) ("GPPMBD")

GPP Mezz IV ECI Aggregator LP name change from GPP Mezzanine Blocker E, LP (Delaware)

GPP Mezz IV F Blocker LP (Delaware)

GPP Mezz IV G Blocker LP (Delaware)

GPP Mezz IV H Blocker LP (Delaware)

GPP Mezz IV I Blocker LP (Delaware)

GoldPoint Mezzanine Partners Offshore IV, L.P. (Cayman Islands)

GoldPoint Partners Co-Investment V GenPar GP LLC (Delaware)

GoldPoint Partners Co-Investment V GenPar, LP (Delaware)

GoldPoint Partners Co-Investment Fund A, LP (Delaware)

GoldPoint Partners Co-Investment V, LP (Delaware)

GPP V – ECI Aggregator LP (Delaware)

GPP V G Blocker Holdco LP (Delaware)

GoldPoint Partners Private Debt V GenPar GP, LLC (Delaware)

GoldPoint Partners Private Debt Offshore V, LP (Cayman Island)

------

GPP Private Debt V RS LP (Delaware)

GoldPoint Partners Private Debt V GenPar, LP (Delaware)

GoldPoint Partners Private Debt V, LP (Delaware)

GPP PD V A Blocker LLC (Delaware)

GPP Private Debt V-ECI Aggregator LP (Delaware)

GPP PD V B Blocker LLC (Delaware)

GPP PD V D Blocker LLC (Delaware)

GPP LuxCo V GP Sarl (Luxembourg)

GoldPoint Partners Select Manager III GenPar GP, LLC (Delaware)

GoldPoint Partners Select Manager III GenPar, L.P. (Cayman Islands)

GoldPoint Partners Select Manager Fund III, L.P. (Cayman Islands)

GoldPoint Partners Select Manager Fund III AIV, L.P. (Delaware)

GoldPoint Partners Select Manager IV GenPar GP, LLC (Delaware)

GoldPoint Partners Select Manager IV GenPar, L.P. (Delaware)

GoldPoint Partners Select Manager Fund IV, L.P. (Delaware)

GoldPoint Partners Select Manager V GenPar GP, LLC (Delaware)

GoldPoint Partners Select Manager V GenPar, L.P. (Delaware)

GoldPoint Partners Select Manager Fund V, L.P. (Delaware)

GoldPoint Partners Canada V GenPar Inc. (New Brunswick, Canada)

GoldPoint Partners Select Manager Canada Fund V, L.P. (Ontario, Canada)

GoldPoint Partners Canada III GenPar Inc. (Canada)

GoldPoint Partners Select Manager Canada Fund III, L.P. (Canada)

GoldPoint Partners Canada IV GenPar Inc. (Canada)

GoldPoint Partners Select Manager Canada Fund IV, L.P. (Canada)

GoldPoint Partners Co-Investment VI GenPar GP LLC (Delaware)

GoldPoint Partners Co-Investment VI GenPar, LP (Delaware)

GoldPoint Partners Co-Investment VI, LP (Delaware)

GPP VI - ECI Aggregator LP (Delaware)

GPP VI Blocker A LLC (Delaware)

GPP VI Blocker B LLC (Delaware)

GPP VI Blocker C LLC (Delaware)

GPP VI Blocker D LLC (Delaware)

GPP VI Blocker E LLC (Delaware)

GPP VI Blocker F LLC (Delaware)

GPP VI Blocker G LLC (Delaware)

GPP VI Blocker H LLC (Delaware)

GPP VI Blocker I LLC (Delaware)

Apogem Co-Invest VII GenPar GP LLC,

Apogem Co-Invest VII GenPar LP

Apogem Co-Investment VII, LP

GoldPoint Private Credit GenPar GP, LLC (Delaware)

GoldPoint Private Credit Fund, LP (Delaware) (GoldPoint: 100%)

GoldPoint Partners Canada GenPar, Inc. (Canada)

NYLCAP Canada II GenPar Inc. (Canada)

NYLCAP Select Manager Canada Fund II, L.P. (Canada)

NYLIM Mezzanine Partners II GenPar GP, LLC (Delaware)

NYLIM Mezzanine Partners II GenPar, LP (Delaware)

NYLCAP Mezzanine Partners III GenPar GP, LLC (Delaware)

NYLCAP Mezzanine Partners III GenPar, LP (Delaware)

NYLCAP Mezzanine Partners III, LP (Delaware)

NYLCAP Mezzanine Offshore Partners III, L.P. (Cayman Islands)

NYLCAP Select Manager GenPar, LP (Delaware)

NYLCAP Select Manager II GenPar GP, LLC (Delaware)

NYLCAP Select Manager II GenPar, L.P. (Cayman Islands)

NYLCAP Select Manager Fund II, L.P. (Cayman Islands)

NYLCAP India Funding LLC (Delaware)

NYLIM-JB Asset Management Co. (Mauritius) LLC (Mauritius) (24.66%)<sup>4</sup>

New York Life Investment Management India Fund II, LLC (Mauritius)

New York Life Investment Management India Fund (FVCI) II, LLC (Mauritius)

NYLCAP India Funding III LLC (Delaware)

NYLIM-Jacob Ballas Asset Management Co. III, LLC (Mauritius) (24.66%)<sup>5</sup>

NYLIM Jacob Ballas India Fund III LLC (Mauritius)

NYLIM Jacob Ballas India (FVCI) III LLC (Mauritius)

NYLIM Jacob Ballas India (FII) III LLC (Mauritius)

4 NYLCAP Manager LLC owns 24.66% of the voting management shares. NYLCAP India Funding LLC owns 36% of non-voting carry shares.

5 NYLCAP Manager LLC owns 24.66% of the voting management shares. NYLCAP India Funding III LLC owns 31.36% of non-voting carry shares

------

Evolvence Asset Management, Ltd. (Cayman Islands) (Apogem: 24.5%)

EIF Managers Limited (Mauritius) (58.72%)

EIF Managers II Limited (Mauritius) (55%)

AHF V (S) GenPar LP (Delaware) (1%)

AHF V ECI Aggregator LP (Delaware) (1%)

AHF V GenPar GP LLC (Delaware) (100%)

AHF V GenPar LP (Delaware) (1%)

AHF VI (S) GenPar LP (Delaware) (1%)

AHF VI ECI Aggregator LP (Delaware) (1%)

AHF VI GenPar GP LLC (Delaware) (100%)

AHF VI GenPar LP (Delaware) (100%)

Apogem Heritage Fund V (S) LP (Delaware) (1%)

Apogem Heritage Fund V LP (Delaware) (1%)

Apogem Heritage Fund VI (S) LP (Delaware) (1%)

Apogem Heritage Fund VI LP (Delaware) (1%)

Apogem Cardinal Co-Investment GP LLC (Delaware)

Apogem Cardinal Co-Investment Fund, LP (Delaware)

ARAF IV GP, LLC (Delaware)

Apogem Real Assets Fund IV, LP (Delaware)

ASF VII GP, LLC (Delaware)

Apogem Secondary Fund VII, LP (Delaware)

Apogem Secondary Fund VII Coinvestments, LP (Delaware)

BFO GP, LLC (Delaware)

BFO Apogem Private Markets (Delaware) LP

Tetra Opportunities Partners (Delaware) (DE Series)

BMG PAPM GP, LLC (Delaware)

BMG PA Private Markets (Delaware) LP (Delaware)

BMG Private Markets (Cayman) LP (Cayman Islands)

Private Advisors Special Situations LLC (Delaware)<sup>7</sup>

PACD MM, LLC (Delaware)

PA Capital Direct, LLC (Delaware)<sup>7</sup>

ApCap Strategic Partnership I LLC (Delaware)

PA Credit Program Carry Parent, LLC (Delaware)

PA Credit Program Carry, LLC (Delaware)

PACIF GP, LLC Delaware)

Private Advisors Coinvestment Fund, LP (Delaware)

PACIF II GP, LLC Delaware)

Private Advisors Coinvestment Fund II LP (Delaware)

PACIF II Carry Parent, LLC (Delaware)

PACIF II Carry, LLC (Delaware)

PACIF III GP, LLC (Delaware)

Private Advisors Coinvestment Fund III, LP (Delaware)

PACIF III Carry Parent, LLC (Delaware)

PACIF III Carry, LLC (Delaware)

PACIF IV GP, LLC (Delaware)

Private Advisors Coinvestment Fund IV, LP (Delaware)

PACIF IV Carry Parent, LLC (Delaware)

PACIF IV Carry, LLC (Delaware)

PAMMF GP, LLC (Delaware)

PA Middle Market Fund, LP (Delaware)

PASCBF IV GP, LLC (Delaware)

Private Advisors Small Company Buyout Fund IV, LP (Delaware)

PASCBF IV Carry Parent, LLC (Delaware)

PASCBF IV Carry, LLC (Delaware)

PASCBF V GP, LLC (Delaware)

Private Advisors Small Company Buyout Fund V, LP (Delaware)

Private Advisors Small Company Buyout V–ERISA Fund, LP (Delaware)

PASCBF V Carry Parent, LLC (Delaware)

PASCBF V Carry, LLC (Delaware)

PASCPEF VI Carry Parent, LLC (Delaware)

PASCPEF VI Carry, LLC (Delaware)

PASCPEF VI GP, LLC (Delaware)

Private Advisors Small Company Private Equity Fund VI, LP (Delaware)

Private Advisors Small Company Private Equity Fund VI (Cayman), LP (Cayman Islands)

PASCPEF VII GP, LLC (Delaware)

Private Advisors Small Company Private Equity Fund VII, LP (Delaware)

Private Advisors Small Company Private Equity Fund VII (Cayman), LP (Cayman Islands)

PASCPEF VII Carry Parent, LLC (Delaware)

PASCPEF VII Carry, LLC (Delaware)

PASCPEF VIII GP, LLC (Delaware)

Private Advisors Small Company Private Equity Fund VIII, LP (Delaware)

Private Advisors Small Company Private Equity Fund VIII (Cayman), LP (Cayman Islands)

PASCPEF IX GP, LLC (Delaware)

PA Small Company Private Equity Fund IX, LP (Delaware)

------

PA Small Company Private Equity Fund IX, (Cayman), LP (Cayman Islands)

APEF X GP, LLC (Delaware)

Apogem Private Equity Fund X, LP fka [PA] Private Equity Fund X, LP (Delaware)

APEF XI GP, LLC (Delaware)

Apogem Private Equity Fund XI, LP (Delaware)

APEF XI Multi-Asset, LP (Delaware)

APEF XI Directs, LP (Delaware)

Cuyahoga Capital Partners IV Management Group LLC (Delaware)

Cuyahoga Capital Partners IV LP (Delaware)

Cuyahoga Capital Emerging Buyout Partners Management Group LLC (Delaware)

Cuyahoga Capital Emerging Buyout Partners LP (Delaware)

PA Real Assets Carry Parent, LLC (Delaware)

PA Real Assets Carry, LLC (Delaware)

PA Real Assets Carry Parent II, LLC (Delaware)

PA Real Assets Carry II, LLC (Delaware)

PA Emerging Manager Carry Parent, LLC (Delaware)

PA Emerging Manager Carry, LLC (Delaware)

PA Emerging Manager Carry Parent II, LLC (Delaware)

PA Emerging Manager Carry II, LLC (Delaware)

RIC I GP, LLC (Delaware)

Richmond Coinvestment Partners I, LP (Delaware)

RIC I Carry Parent, LLC (Delaware)

RIC I Carry, LLC (Delaware)

PASF V GP, LLC (Delaware)

Private Advisors Secondary Fund V, LP (Delaware)

ABC Burgers LLC (Delaware)

PASF V Carry, LLC (Delaware)

PASF V Carry Parent, LLC (Delaware)

PASF VI GP, LLC (Delaware)

PA Secondary Fund VI, LP (Delaware)

PA Secondary Fund VI Coinvestments, LP (Delaware) (68.14%)

PA Secondary Fund VI (Cayman), LP (Cayman Islands) (68.14%)

PARAF GP, LLC (Delaware)

Private Advisors Real Assets Fund, LP (Delaware)

PARAF Carry Parent, LLC (Delaware)

PARAF Carry, LLC (Delaware)

PASCCIF GP, LLC (Delaware)

Private Advisors Small Company Coinvestment Fund, LP (Delaware)

Private Advisors Small Company Coinvestment Fund-ERISA, LP (Delaware)

PASCCIF II GP, LLC (Delaware)

PA Small Company Coinvestment Fund II, LP (Delaware)

PA Small Company Coinvestment Fund II (Cayman), LP (Cayman Islands)

PASCCIF Carry Parent, LLC (Delaware)

PASCCIF Carry, LLC (Delaware)

PARAF II GP, LLC (Delaware)

Private Advisors Real Assets Fund II, LP (Delaware)

PA Contract Resources, LLC (Delaware)

PARAF III GP, LLC (Delaware)

PA Real Assets Fund III, LP (Delaware)

SAF GP LLC (Delaware)

Social Advancement Fund, LP (Delaware)

Washington Pike GP, LLC (Delaware)

Washington Pike, LP (Delaware)

RidgeLake Partners GP, LLC (Delaware)

RidgeLake Partners, LP ("RLPLP") (Delaware)

RidgeLake Co-Investment Partners, LP ("RLPCOLP")(Delaware)

RLP Glacier Manager Investor LLC (Delaware) (RLPLP: 72%, RLPCOLP: 28%)

RLP Glacier GP Investor LLC (Delaware) (RLPLP: 72%, RLPCOLP: 28%)

RLP Evergreen LLC (Delaware) (RLPLP: 72%, RLPCOLP: 28%)

RLP Gemini LLC (Delaware)

RLP Navigator LLC (Delaware)

RLP Sigma LLC (Delaware)

RLP Sunrise GP Investor LLC (Delaware) (RLPLP: 83.33%, RLPCOLP: 16.66%)

RLP Sunrise Manager Investor LLC (Delaware) (RLPLP: 83.33%, RLPCOLP: 16.66%)

RLP Triple GP Investor LLC (Delaware) (RLPLP: 82.01%, RLPCOLP: 17.98%)

RLP Triple Manager Investor LLC (Delaware) (RLPLP: 82.01%, RLPCOLP: 17.98%)

RLP Fund II GP LLC (Delaware);

RLP Fund II LP (Delaware)

RLP Profit Share (PA), LLC (Delaware) (NYLIC: 51%, Employees: 49%)

RLP Profit Share (OAPC), LLC (Delaware) (TP: 100%)

The Hedged Strategies Fund LLC (Delaware) (Apogem: 2%, Ex-employees: 98%non-mananging members)

NYLCAP Holdings (Mauritius) (Mauritius)

Jacob Ballas India Private Limited (Mauritius) (23.30%)

Industrial Assets Holdings Limited (Mauritius) (28.02%)

------

JB Cerestra Investment Management LLP (Mauritius)

NYLIM Service Company LLC (Delaware)

NYL Workforce GP LLC (Delaware)

New York Life Investment Management LLC (Delaware)

NYLIM Fund II GP, LLC (Delaware)

NYLIM-TND, LLC (Delaware)

WFHG GP, LLC (Delaware) (50%)

Workforce Housing Fund I-2007 LP (Delaware) (50%)

IndexIQ Holdings LLC (Delaware) ("IQ Holdings")

IndexIQ LLC (Delaware) (NYLIMH: 74.37%, IQHoldings: 25.63%)

IndexIQ Trust (Delaware) (Dormant)

IndexIQ Advisors LLC (Delaware)

New York Life Investments Active ETF Trust (Delaware)<sup>7</sup> (NYLIAC: 98.5%)

NYLI CBRE Real Assets ETF (NYLIM: 95.11%)

NYLI MacKay Muni Insured ETF (NYL: 0.00%)

NYLI MacKay Muni Intermediate ETF (NYL: 0.00%)

NYLI MacKay Core Plus Bond ETF (NYLIM: 94.54%)

NYLI MacKay California Muni Intermediate ETF (NYLIM: 40.42%)

NYLI MacKay ESG High Income ETF (NYLIM: 94.86%)

NYLI Winslow Focused Large Cap Growth ETF (NYLIM: 90.86%)

NYLI Winslow Large Cap Growth ETF (NYLIM: 90.73%)

NYLI MacKay Securitized Income ETF (NYLIM: 82.75%, NYLIAC: 16:44%)

New York Life Investments ETF Trust (Delaware) (NYLIC: 10.2%)

NYLI 500 International ETF (NYLIM: 53.62%)

NYLI Clean Oceans ETF (NYLIAC: 84.13%)

NYLI Cleaner Transport ETF (NYLIAC: 84.56%)

NYLI Engender Equality ETF (NYLIAC: 72.81%)

NYLI FTSE International Equity Currency Neutral ETF (NYLIM: 13.23%)

NYLI Global Equity R&D Leaders ETF (NYLIM: 85.22%)

NYLI Healthy Hearts ETF (NYLIM: 66.18%)

NYLI Hedge Multi-Strategy Tracker ETF (NYL: 0.00%)

NYLI Merger Arbitrage ETF (NYL: 0.00%)

NYLI CRBE NexGen Real Estate ETF (NYLIM: 56.52%)

NYLI Candriam International Equity ETF (NYLIM: 84.19%)

NYLI Candriam U.S. Mid Cap Equity ETF (NYLIM: 98.63%)

NYLI Candriam U.S. Large Cap Equity ETF (NYLIM: 69.29%)

NYLI U.S. Large Cap R&D Leaders ETF (NYLIM: 76.06%)

New York Life Investment Management Holdings International (Luxembourg)

New York Life Investment Management Holdings II International (Luxembourg)

Candriam Group ("CG") (Luxembourg)

KTA Holdco (Luxembourg) (CANLUX: 66.67%, Apogem: 33.33%)

Kartesia Management SA (Luxembourg) (33%)

Kartesia Italy Branch

Kartesia Spain Branch

Kartesia Netherlands Branch

Kartesia Germany Branch

Kartesia France (France)

Kartesia UK Ltd. (UK)

Kartesia Belgium (Belgium)

Kartesia Credit FFS (France)

Kartesia GP III (Luxembourg)

Kartesia Credit Opportunities III S.C.A., SICAV-SIF (Luxembourg)

Kartesia Securities (Luxembourg)

Kartesia III Topco S.ẚ.r.l. (Luxembourg)

Kartesia GP IV (Luxembourg)

Kartesia Credit Opportunities IV SCS SICAV-SIF (Luxembourg)

Kartesia Securities IV (Luxembourg)

Kartesia IV Topco S.ẚ.r.l. (Luxembourg)

Kartesia Master GP (Luxembourg)

Kartesia Credit Opportunities V Feeder SCS (Luxembourg)

Kartesia Senior Opportunities I SCS, SICAV-RAIF (Luxembourg)

KASS Unleveled S.ẚ.r.l. (Luxembourg)

KSO I Topco S.ẚ.r.l. (Luxembourg)

Kartesia Credit Opportunities V SCS (Luxembourg)

Kartesia Securities V S.ẚ.r.l. (Luxembourg)

Kartesia Credit Opportunities VI Feeder SCS (Luxembourg)

Kartesia Credit Opportunities VI SCS (Luxembourg)

Kartesia Securities VI SCS S.ẚ.r.l. (Luxembourg)

Kartesia VI Topco S.ẚ.r.l. (Luxembourg)

Flexam Invest Asset Management (France) (51%)

FIAM HLD SAS (France)

Flexam Invest France Management SAS (France)

Flexam Tangible Asset Income Fund II SLP (France)

Flexam Invest Lux Management S.ẚ.r.l. (Luxembourg)

------

Flexam Tangible Asset Income Fund S.C.A., SICAV-RAIF (Luxembourg)

Flexam Invest Operations S.ẚ.r.l. (Luxembourg)

Candriam Luxco S.a.r.l. (Luxembourg) ("CANLUXS")

Candriam (Luxembourg) ("CANLUX") (CG: 96%; 1 share held by CANLUXS)

Candriam Belgian Branch

Candriam France Branch

Candriam Italy Branch

Candriam UK Establishment

Candriam Germany Branch

Candriam US Branch

Candriam Spain Branch

Candriam Netherlands Branch

Candriam MENA Branch (Dubai, UAE)

Candriam Nordic Branch (Sweden)

Candriam Monétaire SICAV (France) (CANBEL: 2.24%; CANFR: 1.86%, CIG: 0.01%)

Candriam Switzerland LLC (Switzerland)

Candriam GP (Luxembourg)

Candriam Tristan Real Estate Fund (RAIF) (Luxembourg)

Candriam GP PA (Luxembourg)

Candriam Private Assets (Luxembourg)

ATA Holdco Luxembourg S.ẚ.r.l. (Luxembourg)

Belfius Fund (Luxembourg) (SICAV with Board controlled by Candriam)

Belfius Fund Target Income 2032 (0.00%)

Belfius Equities (Belgian) (0.00%)

IZNES SAS (Luxembourg) (2%)

Belfius Investment Partners (Luxembourg) (0.01%)

S.W.I.F.T. SCRL (Luxembourg) (0.02%)

Cordius (Luxembourg) (CANLUX: 14.07%, CANBEL: 4.42%)

Cordius CIG ("CIG") (CANBEL: 23.91%, CANLUX: 76.09%)

Candriam Absolute Return (Luxembourg) (CIG: .35%)

Candriam Absolute Return Equity Market Neutral (Lux) (0.00%)

Candriam Bonds (Luxembourg) (NYLIAC: 0.12%; CIG: .02%)

Candriam Bonds Capital Securities (CIG: 0.01%)

Candriam Bonds Convertible Defensive (0.00%)

Candriam Bonds Convertible Opportunities (0.00%)

Candriam Bonds Credit Alpha (NYLIAC: 4.90%)

Candriam Bonds Credit Opportunities (0.00%)

Candriam Bonds Emerging Debt Local Currencies (CIG: 0.02)

Candriam Bonds Emerging Markets (0.01%)

Candriam Bonds Emerging Markets Corporate (CIG: 0.01%)

Candriam Bonds Emerging Markets Total Return (CIG: 0.01%)

Candriam Bonds Euro (0.00%)

Candriam Bonds Euro Corporate (0.00%)

Candriam Bonds Euro Corporate Financials (0.00%)

Candriam Bonds Euro Diversified (0.00%)

Candriam Bonds Euro Government (0.00%)

Candriam Bonds Euro High Yield (CIG: 0.08%)

Candriam Bonds Euro Short Term (0.00%)

Candriam Bonds Euro Long Term (CIG: 0.01%)

Candriam Bonds Floating Rate Notes (0.00%)

Candriam Bonds Global Government (0.00%)

Candriam Bonds Global High Yield (0.00%)

Candriam Bonds Global Inflation Short Duration (0.00%)

Candriam Bonds Global Sovereign Quality (0.00%)

Candriam Bonds International (CIG: 0.02%)

Candriam Bonds Total Return (0.00%)

Candriam Bonds US Corporate (CIG: 0.01%)

Candriam Business Equities (Belgium) (0.00%)

Candriam Business Equities EMU (0.00%)

Candriam Business Equities Global Income (0.00%)

Candriam Diversified Futures (CIG: 0.01%)

Candriam Equities L (Luxembourg) (NYLIAC: 0.35%)

Candriam Equities L Australia (CIG: 0.01%)

Candriam Equities L Biotechnology (0.00%)

Candriam Equities L Emerging Markets (0.00%)

Candriam Equities L EMU (CIG: 0.02%)

Candriam Equities L ESG Market Neutral (NYLIAC: 95.83%; CIG: 0.03%)

Candriam Equities L Europe (CIG: 0.02%)

Candriam Equities L Europe Edge (CIG: 0.01%)

Candriam Equities L Europe Innovation (0.00%)

Candriam Equities L Europe Optimum Quality (CIG: 0.01%)

Candriam Equities L Global Demography (0.00%)

Candriam Equities L Global Income (CIG: 0.04%)

Candriam Equities L Life Care (0.00%)

------

Candriam Equities L Meta Globe (CIG: 0.01%)

Candriam Equities L Oncology Impact (0.00%)

Candriam Equities L Risk Arbitrage Opportunities (CIG: 0.03%)

Candriam Equities L Robotics & Innovation Technology (0.00%)

Candriam Equities L US Edge (CIG: 0.01%)

Candriam Equities L World Edge (NYLIAC: 99.95%; CIG: 0.05%)

Candriam Fund (Luxembourg) (0.00%)

Candriam Fund Sustainable Euro Corporate Bonds Fossil Free (0.00%)

Candriam Fund Sustainable European Equities Fossil Free (0.00%)

Candriam Impact One (Luxembourg) (NYLIAC: 30.62%)

Candriam Index Arbitrage (Luxembourg) (0.00%)

Candriam L (Luxembourg) (CIG: .08%)

Candriam L Balanced Asset Allocation (0.00%)

Candriam L Conservative Asset Allocation (0.00%)

Candriam L Dynamic Asset Allocation (CIG: 7.32%)

Candriam L Multi-Asset Income (0.00%)

Candriam L Multi-Asset Income & Growth (CIG: 0.01%)

Candriam L Multi-Asset Premia (CIG: 0.04%)

Candriam Long Short Credit (0.00%)

Candriam M (CIG: 8.95%)

Candriam M Global Trading (CIG: 0.06%)

Candriam M Impact Finance (CIG: 12.69%)

Candriam M Multi Strategies (CIG: 0.14%)

Candriam Money Market (Luxembourg) (CIG: 0.20%)

Candriam Money Market Euro (CIG: 0.00%)

Candriam Money Market Euro AAA (0.42%)

Candriam Money Market USD Sustainable (0.00%)

Candriam Multi-Strategies (France) (CANBEL 16.51%, CANFR: 25.32%, CANLUX: 58.14%, CIG: 0.01%)

Candriam Patrimoine Obli-Inter (France) (0.00%)

Candriam Risk Arbitrage (Luxembourg) (CIG: 20.71%)

Candriam Sustainable (Luxembourg) (NYLIAC: 0.10; CIG: 0.02%)

Candriam Sustainable Bond Emerging Markets (0.00%)

Candriam Sustainable Bond Euro (0.00)

Candriam Sustainable Bond Euro Corporate (0.00%)

Candriam Sustainable Bond Euro Short Term (0.00%)

Candriam Sustainable Bond Global (CIG: 0.02%)

Candriam Sustainable Bond Global Convertible (CIG: 0.03%)

Candriam Sustainable Bond Global High Yield (0.00%)

Candriam Sustainable Bond Impact (NYLIAC: 16.59%)

Candriam Sustainable Defensive Asset Allocation (CIG: 0.01%)

Candriam Sustainable Equity Children (CIG: 0.01%)

Candriam Sustainable Equity Circular Economy (0.00%)

Candriam Sustainable Equity Climate Action (0.00%)

Candriam Sustainable Equity Emerging Markets (0.00%)

Candriam Sustainable Equity Emerging Markets Ex-China (CIG: 0.01%)

Candriam Sustainable Equity EMU (0.00%)

Candriam Sustainable Equity Europe (0.00%)

Candriam Sustainable Equity Europe Small & Mid Caps (0.00%)

Candriam Sustainable Equity Future Mobility (CIG: 0.01%)

Candriam Sustainable Equity Japan (0.00%)

Candriam Sustainable Equity Quant Europe (0.00%)

Candriam Sustainable Equity US (0.00%)

Candriam Sustainable Equity Water (CIG: 100%)

Candriam Sustainable Equity World (0.00%)

Candriam Sustainable Money Market Euro (0.00%)

Candriam World Alternative (Luxembourg) (CIG: 25.42%)

Candriam World Alternative Alphamax (CIG: 25.47%)

Cleome Index (Luxembourg) (0.00%)

Cleome Index EMU Equities (0.00%)

Cleome Index Euro Corporate Bonds (0.00%)

Cleome Index Euro Government Bonds (0.00%)

Cleome Index Euro Long Term Bonds (0.13%)

Cleome Index Euro Short Term Bonds (CIG: 0.01%)

Cleome Index Europe Equities (0.00%)

Cleome Index USA Equities (0.00%)

Cleome Index World Equities (CIG: 0.01%)

NYLIM GF (Luxembourg) (NYLIMH: 38.30%; CIG: 0.02%)

NYLIM GF AUSBIL Global Essential Infrastructure (NYLIMH: 27.33% CIG: .01%)

NYLIM GF AUSBIL Global Small Cap (NYLIMH: 98.44%; CIG: .02%)

NYLIM GF US High Yield Corporate Bonds (NYLIMH: 32.33%; CIG: .03%)

Paricor (Belgium) (CIG: 0.07%)

Paricor Patrimonium (Belgium) (CIG: 0.07%)

IndexIQ (CIG: .36%)

IndexIQ Factors Sustainable Corporate Euro Bond (CIG: .52%)

------

IndexIQ Factors Sustainable Europe Equity (CIG: .43%)

IndexIQ Factors Sustainable Japan Equity (CIG: .21%)

CGH UK Acquisition Company Limited (UK)

Tristan Equity Partners (GP) Limited (UK)

Tristan Equity Partners LP (UK)

Tristan Equity Pool Partners (GP) Limited (UK)

Tristan Capital Partners Holdings Limited (England & Wales) (80%)

EPISO 3 Co-Investment (GP) Limited (Scotland)

EPISO 3 Co-Investment LP (Scotland)

TIPS One Co-Investment GP Sarl (Luxembourg)

TIPS Co-Investment SCSp (Luxembourg)

TCP Incentive Partners (GP) Sarl (Luxembourg)

TCP Incentive Partners SCSp (Luxembourg)

TCP Co-Investment (GP) Sarl (Luxembourg)

TCP Co-Investment SCSp (Luxembourg)

CCP III Co-Investment (GP) Limited (Scotland)

CCP III Co-Investment LP (United Kingdom)

CCP IV Co-Investment LP (Scotland)

EPISO 4 Co-investment LLP (United Kingdom)

EPISO 4 (GP) LLP (United Kingdom)

EPISO 4 Incentive Partners LLP (England & Wales) (4.7%) (18 Individual members and three corporate members)

CCP 5 Co-Investment LLP (England & Wales) (100%,)

Tristan (Holdings) Limited (UK) (individual owns 100% of the entity)

EPISO 3 Feeder (GP) Limited (Scotland) (40%)

EPISO 3 Feeder LP (Scotland)

Tristan Capital Limited (England & Wales) (100%)

Tristan Capital Partners LLP (England & Wales) (80%) (25 individual members)

CCP III (GP) LLP (England & Wales) (50%)

CCP III Incentive Partners (GP) Limited (Scotland)

CCP III Incentive Partners LP (Scotland)

Curzon Capital Partners III (GP) Limited (England & Wales)

CCP III (GP) LLP (England & Wales) (99%, 1% held by TCP LLP)

Curzon Capital Partners III LP (LUX)

Curzon Capital Partners III Sarl (LUX)

CCP III Netherlands Holding BV (NLD)

Nova Investments Sp. z.o.o. Sarl (POL)

CCP III Falcon Holding Sarl (LUX)

Stadtgalerie Written GmbH (Germany) (92.4%)

CCP III Dartford JV Sarl (Lux) (98.67%)

CCP III Dartford I Sarl (LUX)

Curzon Capital Partners IV GP Limited (United Kingdom)

CCP IV (GP) LLP (United Kingdom) (99%, 1% held by TCP LLP)

Curzon Capital Partners IV LP (United Kingdom)

Curzon Capital Partners IV S.a.r.l. (LUX)

CCP IV Bolt FinCo S.a.r.l. (LUX)

CCP IV IREF 1 Holding Sarl (LUX)

CCP IV IREF 1 (ITA)

CCP IV Bolt 1 Sarl (LUX)

Stratford City Offices Jersey Unit

Bolt Nominee 1 Limited (UK)

Bolt Nominee 2 Limited (UK)

CCP IV Bolt 2 Sarl (LUX)

CCP IV Erneside Holding Sarl (LUX)(99.99976%)

CCP IV France Investments Sarl (LUX)

OPPCI CCP IV France Investments (FRA)

SCI Escape Cordeliers (FRA)(1 share held by CCPIV France Investment Sarl)

The Forum, Solent, Management Company Limited (UK)

SBP Management Limited (UK)(27.83%)

CCP IV (GP) S.á.r.l. (LUX)

CCP IV Keirin Luxembourg S.á.r.l. (LUX)

CCP IV SCSp (LUX)(74%)

Keirin Holding S.á.r.l. (LUX)

CCP IV UK Holding S.á.r.l. (LUX)

Cardiff Gate RP Limited (LUX)

Rotherham Foundry RP Limited (LUX)

Warrington Riverside RP Limited (LUX)

Birmingham Ravenside RP Limited (LUX)

Walsall Bescot RP Limited (LUX)

RW Sofas Limited (LUX)

Bangor Springhill RP Limited (LUX)

EPISO 3 Incentive Partners (GP) Limited (Scotland)

EPISO 3 Incentive Partners LP (Scotland)

EPISO 3 (GP) LLP (United Kingdom) (64%)

------

European Property Investors Special Opportunities 3 LP (UK)

EPISO 3 L.P. (UK)

EPISO 3 Luxembourg Holding S.a.r.l. (LUX)

EPISO 3 Wave Holding S.a.r.l. (LUX)

EPISO 4 (GP) II Sarl (Luxembourg)

EPISO 4 Student Housing SCSp (Luxembourg)

EPISO 4 (GP) LLP (United Kingdom)

European Property Investors Special Opportunities 4 LP (UK)

EPISO 4 Caeser Holding Sarl (LUX)

Trophy Value Added Fund (Italy)(74.15%)

EPISO 4 Luxembourg Holding Sarl (LUX)

EP Office 1 Spzoo (POL)

EP Office 2 Spzoo (POL)

EP Retail Spzoo (POL)

EP Apartments Spzoo (POL)

EP Hotel Spzoo (POL)

EPISO 4 Seed Holding Sarl (LUX)(99.99976%)

EPISO 4 Seed Sarl (LUX)

EPISO 4 Flower Holding Sarl(99.99976%) (LUX)

EPISO 4 Flower Sarl (LUX)

EPISO 4 Twilight GP Limited (UK)

EPISO 4 Twilight LP (UK)

Twilight Ireland PRS Properties Eclipse DAC (IRL)

EPISO 4 West Holding Sarl (LUX)(97.5%)

EPISO 4 Antrim Sarl (LUX)

EPISO 4 Banbridge Sarl (LUX)

EPISO 4 France Investments Sarl (LUX)(90%)

OPPCI EPISO 4 France Investments (FRA) (1share held by SCI VDF)

SAS VDF (FRA)

SCI VDF (FRA)

EPISO 4 Switch Holding S.a.r.l. (LUX)

E4 Switch Norway AS (Norway) (80%)

EPISO 4 Pilgrim Holding S.a.r.l. (Luxembourg)

TP Property S.a.r.l. (LUX)

TB Property (Plymouth) Limited (England & Wales)

TB Property Developments (Plymouth) Limited (England & Wales)

EPISO 4 Lynx Holding S.a.r.l. (LUX) (97.6%)

EPISO 4 Lynx S.a.r.l. (LUX)

EPISO 4 Lynx Marketing S.a.r.l. (LUX)

CCP 5 Pool Partnership GP Limited (Jersey)

CCP 5 Pool Partnership SLP (Jersey)

CCP 5 GP LLP (United Kingdom) (80%)

Curzon Capital Partners 5 Long-Life LP (United Kingdom)

CCP 5 (GP) S.a.r.l. (Luxembourg)

Curzon Capital Partners 5 Long-Life SCA SICAV-SIF (United Kingdom)

CCP 5 Jersey Fragco 1 Limited (Jersey)

CCP 5 Jersey Fragco 2 Limited (Jersey)

CCP 5 Jersey Fragco 3 Limited (Jersey)

CCP 5 Jersey Fragco 4 Limited (Jersey)

CCP 5 Jersey Fragco 5 Limited (Jersey)

CCP 5 Jersey Fragco 6 Limited (Jersey)

CCP 5 Jersey Fragco 7 Limited (Jersey)

CCP 5 Jersey Fragco 8 Limited (Jersey)

CCP 5 Jersey Fragco 9 Limited (Jersey)

CCP 5 Jersey Fragco 10 Limited (Jersey)

CCP 5 Jersey Fragco 11 Limited (Jersey)

CCP 5 Long-Life Luxembourg S.á.r.l. (Luxembourg)

CCP 5 LL GP Sárl (Luxembourg)

Curzon Capital Partners 5 Long Life SCSp (Luxembourg)

EPISO 5 Incentive Partners GP Limited (Jersey)

EPISO 5 Incentive Partners SLP (Jersey)

EPISO 5 (GP) Sárl (Luxembourg)

European Property Investors Special Opportunities 5 LP (Luxembourg)

EPISO 5 Luxembourg Holding S.á.r.l. (Luxembourg)

EPISO 5 Portfolio GP S.á.r.l. (Luxembourg)

EPISO 5 Silver JV SCSp (Luxembourg)

Sterling Square Holdings S.á.r.l. (Luxembourg)

------

European Property Investors Special Opportunities 5 SCSp-SICAV-SIF (Luxembourg)

EPISO 5 Co-Investment SCSp (Luxembourg)

EPISO 6 UK Portfolio GP Limited (UK) ("EPISO6UK")

EPISO 6 (GP) S.á.r.l. (Luxembourg)

EPISO 6 Co-Investment SCSp (Luxembourg)

European Property Investors Special Opportunities 6 SCSp SICAV-SIF(Luxembourg)

EPISO 6 UK Investment Holdings Limited (Jersey) (64%) ("EPISO6")

EPISO 6 Pegasus Holding Limited (UK) (64%)

Pegasus Affordable Housing LLP (UK) (62%)

Pegasus Affordable Limited (UK) (62%)

Zen Housing Limited (UK) (62%)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EPISO 6 Waterfall Top Holdings Limited (England&Wales)

Waterfall HoldCo Limited (England&Wales)

Waterfall PropCo Limited (England&Wales)

EPISO 6 Phoenix JV LLP (UK) (EPISO6UK: 50%; EPISO6: 50%)

Phoenix Core Holdco Limited (UK)

Phoenix Core Propco Limited (UK) ("CorePropco")

Cody TP Management Company Limited (CorePropco-GP Guarantor 100%, DevCo- Guarantor)

EPISO 6 Luxembourg Holding S.á.r.l. (LUX)

Phoenix Development Holding S.á.r.l. (LUX) (99%, TP: 1%)

Phoenix DevCo S.ár.l. (LUX) ("DevCo")

EPISO 6 Spectre JV S.á.r.l. (LUX)

EPISO 6 Spectre 1 Holding S.á.r.l. (Luxembourg)

EPISO 6 Spectre 2 Holding S.á.r.l. (Luxembourg)

EPISO 6 Spectre 3 Holding S.á.r.l. (Luxembourg)

EPISO 6 Curado Holding S.á.r.l. (Luxembourg)

Claybrook, S.L. (Spain) (90%)

Barnfield Spain, S.L. (Spain)

EPISO 6 Macbeth Holding S.á.r.l. (Luxembourg)

Macbeth 4 SRL (Belgium)

Montague 1 Sárl (LUX)

EPISO 6 Moomin Holding Sárl (LUX)

EPISO 6 Siem Holding Sárl (LUX) (85%)

EPISO 6 Siem Sárl (LUX)

EPISO 6 Emerald Holdings S.á.r.l. (LUX) (96%)

BCRE Leipzig Wohnen Nord B.V.

BCRE Leipzig Wohnen Ost B.V.

BCRE Leipzig West Ost B.V.

TAG Leipzig-Immobilien GmbH

Hella Acquico GP S.á.r.l. (Luxembourg)

Hella Acquico GP SCSp (Luxembourg)

Hella Holding S.á.r.l. (96%) (Luxembourg)

H Main Holding S.á.r.l. (Luxembourg)

H Main 1 S.á.r.l. (Luxembourg)

H Main 2 S.á.r.l. (Luxembourg)

H Main 3 S.á.r.l. (Luxembourg)

H Main 4 S.á.r.l. (Luxembourg)

H Main 5 S.á.r.l. (Luxembourg)

H Main 6 S.á.r.l. (Luxembourg)

H Main 7 S.á.r.l. (Luxembourg)

EPISO 6 Panther Co-Investment SCSp (Jersey) (92.15%)

EPISO 6 Panther (Jersey) GP Limited (Jersey) (90%)

EPISO 6 Panther (Jersey) JV SLP (Jersey)

EPISO 6 Panther (Jersey) Holdco Limited (Jersey)

EPISO 6 Panther Property Limited (Jersey)

Raag St. Andrew Hotel Limited (UK)

Raag Hotels Limited (Jersey)

QMK Pub Westminster Limited (UK) RAAG OBS Limited (Jersey) QMK OBS Limited (IRL)

Raag Dublin Limited (Jersey)

QMK Dublin Limited (IRE)

Raag Kensington Holdings Limited (Jersey)

Raag Kensington Hotel Limited (Jersey)

QMK Kensington Limited (UK)

Raag Westminster Holdings Limited (Jersey)

Raag Westminster Hotel Limited (jersey)

QMK Westminster Limited (UK)

Raag Liverpool Street Holdings Limited (Jersey)

Raag Liverpool Street Hotel Limited (Jersey) QMK Liverpool Street Limited (UK)

Raag Kings Cross Holdings Limited (Jersey)

Raag Kings Cross Hotel Limited (Jersey)

------

QMK KX Limited (UK)

Raag Paddington Holdings Limited (Jersey)

Raag Paddington Hotel Limited (Jersey)

QMK Paddington Limited (UK)

Raag Canary Wharf Limited (Jersey)

QMK Canary Wharf Limited (UK)

Raag Shoreditch Limited (Jersey)

QMK Shoreditch Limited (UK)

Raaag Aberdeen (Jersey)

QMK Management Limited (UK)

Raag P2 Limited (Jersey)

TIPS One Incentive Partners GP Limited (Jersey)

TIPS One Incentive Partners SLP (Jersey)

TIPS One GP Sarl (Luxembourg)

Tristan Income Plus Strategy One SCSp (Luxembourg)

TIPS One Alpha Holdings Sarl (Luxembourg)

TIPS One Alpha PV I Sarl (Luxembourg)

TIPS One Co-Investment GP Sarl (Luxembourg)

TIPS One Co-Investment SCSp (Luxembourg)

CCP IV (GP) LLP (England & Wales) (50%)

Curzon Capital Partners IV (GP) Limited (England & Wales)

CCP 5 GP LLP (England & Wales)(33%)(2 individual members)

CCP 5 Pool Partnership GP Limited (Jersey)

CCP 5 Pool Partnership SLP (Jersey)

Tristan Capital Partners Asset Management Limited (England & Wales)

TCP SPAIN, SL (Spain) (64.5%)

TCP France (France)

TCP NL BV (Nehterlands)

TCP Poland Spolka z ograniczoną odpowiedzialnoscią (Poland)

TCP Co-Investment (GP) S.à.r.l. (Luxembourg)

TCP Co-Investment SCSp (Luxembourg)

German Property Performance Partners Investors Feeder Verwaltungs GmbH (Germany)

EPISO 4 (GP) S.à.r.l. (Luxembourg)

EPISO 4 SCSp (Luxembourg)

EPISO 4 (GP) II S.à.r.l. (Luxembourg)

EPISO 4 Student Housing SCSp (Luxembourg)

Ausbil Investment Management Limited (Australia) ("AUSBIL") (81.46%)

Ausbil Australia Pty. Ltd. (Australia)

Ausbil Asset Management Pty. Ltd. (Australia)

Ausbil Global Infrastructure Pty. Limited (Australia) (55%) (45% owned by 4 employees)

Ausbil Investment Management Limited Employee Share Trust (Australia) (Ausbil: 100%)

Ausbil Global SmallCap Fund (Australia) (NYLIAC: 26.14%)

Ausbil Long Short Focus Fund (Australia) (NYLIAC: 22.74%)

NYLIFE Distributors LLC (Delaware)

Flatiron RR LLC (Delaware)

Flatiron CLO 2013-1-Ltd. (Cayman Islands) (NYL: 0%) (NYLIC: 25% equity)

Flatiron CLO 2015-1 Ltd. (Cayman Islands) (NYL: 0%) (NYL Investors Approx. 59.155% Equity)

Flatiron CLO 17 Ltd. (Cayman Islands) (NYL: 0%) (NYLIC: 4.09% debt, NYL Investors 54% equity)

Flatiron CLO 18 Ltd. (Cayman Islands) (NYL: 0%) (NYL Investors 100% Equity)

Flatiron CLO 19 Ltd. (Cayman Islands) (NYL: 0%)

Flatiron CLO 20 Ltd. (Cayman Islands) (NYL: 0%) (NYL Investors 62% Equity)

Flatiron CLO 21 Ltd. (Cayman Islands) NYL: 0%)

Flatiron RR CLO 22 LLC (Cayman Islands) NYL: 0%)

Flatiron CLO 24 Ltd. (Cayman Islands) NYL: 0%)

Flatiron CLO 25 Ltd. (Cayman Islands) (NYL: 0%)

Flatiron CLO 26 Ltd. (Jersey) (NYL: 0%)

Flatiron CLO 23 LLC (Delaware)

Flatiron RR CLO 27 Ltd. (Cayman Islands) (NYL: 0%)

Flatiron CLO 28 Ltd. (Cayman Islands) (NYL: 0%)

Flatiron RR LLC, Manager Series (Delaware Series LLC) (Series A)

Flatiron RR LLC, Retention Series (Delaware Series LLC) (Series B)

Stratford CDO 2001-1 Ltd. (Cayman Islands)

NYLIFE LLC (Delaware)

Eagle Strategies LLC (Delaware)

New York Life Capital Corporation (Delaware)

New York Life Trust Company (New York)

NYLIFE Securities LLC (Delaware)

NYLINK Insurance Agency Incorporated (Delaware)

Silver Spring, LLC (Delaware)

Silver Spring Associates, L.P. (Pennsylvania)

SCP 2005-C21-002 LLC (Delaware)

SCP 2005-C21-003 LLC (Delaware)

SCP 2005-C21-006 LLC (Delaware)

SCP 2005-C21-007 LLC (Delaware)

------

SCP 2005-C21-008 LLC (Delaware)

SCP 2005-C21-009 LLC (Delaware)

SCP 2005-C21-017 LLC (Delaware)

SCP 2005-C21-018 LLC (Delaware)

SCP 2005-C21-021 LLC (Delaware)

SCP 2005-C21-025 LLC (Delaware)

SCP 2005-C21-031 LLC (Delaware)

SCP 2005-C21-036 LLC (Delaware)

SCP 2005-C21-041 LLC (Delaware)

SCP 2005-C21-043 LLC (Delaware)

SCP 2005-C21-044 LLC (Delaware)

SCP 2005-C21-048 LLC (Delaware)

SCP 2005-C21-061 LLC (Delaware)

SCP 2005-C21-063 LLC (Delaware)

SCP 2005-C21-067 LLC (Delaware)

SCP 2005-C21-069 LLC (Delaware)

SCP 2005-C21-070 LLC (Delaware)

NYMH-Ennis GP, LLC (Delaware)

NYMH-Ennis, L.P. (Texas)

NYMH-Freeport GP, LLC (Delaware)

NYMH-Freeport, L.P. (Texas)

NYMH-Houston GP, LLC (Delaware)

NYMH-Houston, L.P. (Texas)

NYMH-Plano GP, LLC (Delaware)

NYMH-Plano, L.P. (Texas)

NYMH-San Antonio GP, LLC (Delaware)

NYMH-San Antonio, L.P. (Texas)

NYMH-Stephenville GP, LLC (Delaware)

NYMH-Stephenville, L.P. (Texas)

NYMH-Taylor GP, LLC (Delaware)

NYMH-Taylor, L.P. (Texas)

NYMH-Attleboro MA, LLC (Delaware)

NYMH-Farmingdale, NY LLC (Delaware)

NYLMDC-King of Prussia GP, LLC (Delaware)

NYLMDC-King of Prussia Realty, LP (Delaware)

Country Place LP (Delaware)

Country Place JV LLC (Delaware)

REEP-MF Salisbury Square Tower One TAF LLC (Delaware) (NYLIC: 95.5%; NYLIAC: 0.5%)

REEP-DRP Salisbury Square Tower One TAB JV LLC (LLC: 80%)

Salisbury Square Tower One LLC (Delaware)

REEP-MF Salisbury Square Tower Two TAF LLC (Delaware) (inactive)

REEP-MF Salisbury Square TAF LLC (Delaware) (inactive)

REEP-IND MCP WEST NC LLC (Delaware)

Cumberland Properties LLC (Delaware)

NYLife Real Estate Holdings LLC (Delaware)

Huntsville NYL LLC (Delaware)

REEP-IND Forest Park NJ LLC (Delaware)

FP Building 4 LLC (Delaware)

FP Building 1-2-3 LLC (Delaware)

FP Building 17, LLC (Delaware)

FP Building 20, LLC (Delaware)

FP Mantua Grove LLC (Delaware)

FP Lot 1.01 LLC (Delaware)

REEP-IND NJ LLC (Delaware)

NJIND JV LLC (Delaware) (93%)

NJIND Hook Road LLC (Delaware)

NJIND Bay Avenue LLC (Delaware)

NJIND Bay Avenue Urban Renewal LLC (Delaware)

NJIND Corbin Street LLC (Delaware)

REEP-MF Cumberland TN LLC (Delaware)

Cumberland Apartments, LLC (Tennessee)

REEP-MF Marina Landing WA LLC (Delaware)

REEP-SP Marina Landing LLC (Delaware) (98%)

REEP-MF Woodridge IL LLC (Delaware)

REEP-RTL SASI GA LLC (Delaware)

REEP-RTL Bradford PA LLC (Delaware)

REEP-RTL CTC NY LLC (Delaware)

5005 LBJ Tower LLC (Delaware) (97%)

REEP-OFC/RTL MARKET ROSS TX LLC (Delaware)

MARKET ROSS TX JV LLC (Delaware) (98.7%)

MARKET ROSS TX GARAGE OWNER LLC (Delaware)

MARKET ROSS TX OFFICE OWNER LLC (Delaware)

MARKET ROSS TX RETAIL OWNER LLC (Delaware)

REEP-OFC Mallory TN LLC (Delaware)

------

3665 Mallory JV LLC (Delaware) (90.9%)

REEP-OFC WATER RIDGE NC LLC (Delaware)

REEP-OFC 2300 Empire LLC (Delaware)

REEP-MF Wynnewood PA LLC (Delaware)

Wynnewood JV LLC (Delaware) (100%)

REEP-MU Fayetteville NC LLC (100%) (Delaware)

501 Fayetteville JV LLC (85%) (Delaware)

501 Fayetteville Owner LLC (Delaware) (100%)

REEP-MU SOUTH GRAHAM NC LLC (Delaware)

401 SOUTH GRAHAM JV LLC (Delaware) (90%)

401 SOUTH GRAHAM OWNER LLC (Delaware)

REEP-IND COMMERCE CITY CO LLC (Delaware)

REEP-BRENNAN COMMERCE CITY JV LLC (Delaware)

REEP-OFC Mass Ave MA LLC (Delaware)

REEP-MF FARMINGTON IL LLC (Delaware)

REEP-MARQUETTE FARMINGTON JV LLC (Delaware) (90%)

REEP-MARQUETTE FARMINGTON OWNER LLC (Delaware)

REEP-MF BELLEVUE STATION WA LLC (Delaware)

REEP-LP BELLEVUE STATION JV LLC (Delaware) (86.15%)

REEP-HINE ENCLAVE POINT AZ LLC (Delaware)

REEP-HINES ENCLAVE POINT JV LLC (Delaware) (50%)

REEP-MF WILDHORSE RANCH TX LLC (Delaware

REEP-WP WILDHORSE RANCH JV LLC (Delaware)

REEP-IND ROMULUS MI LLC (Delaware)

REEP-NPD ROMULUS JV LLC (87.14%)

REEP-MF SOUTH MAIN TX LLC (Delaware) (100%)

REEP-AO SOUTH MAIN JV LLC (Delaware) (99.99%)

REEP-AO SOUTH MAIN OWNER LLC (Delaware) (100%)

2015 DIL PORTFOLIO HOLDINGS LLC (Delaware) (NYLIC: 100%)

PA 180 KOST RD LLC (Delaware)

Cortlandt Town Center LLC (Delaware)

REEP-WP ART TOWER JV LLC (Delaware)

REEP-1250 Forest LLC (Delaware)

REEP-HZ SPENCER LLC (Delaware)

REEP-IND 10 WEST AZ LLC (Delaware)

REEP-IND 4700 Nall TX LLC (Delaware)

REEP-IND Aegean MA LLC (Delaware)

REEP-IND Alpha TX LLC (Delaware)

REEP-IND MCP VIII NC LLC (Delaware)

REEP-IND CHINO CA LLC (Delaware)

REEP-IND FRANKLIN MA HOLDER LLC (Delaware)

REEP-IND FREEDOM MA LLC (Delaware)

REEP-IND Fridley MN LLC (Minnesota)

REEP-IND Kent LLC (Delaware)

REEP-IND LYMAN MA LLC (Delaware)

REEP- IND MCP II NC LLC (Delaware)

REEP- IND MCP IV NC LLC (Delaware)

REEP- IND MCP V NC LLC (Delaware)

REEP- IND MCP VII NC LLC (Delaware)

REEP-INC MCP III OWNER NC LLC (Delaware)

REEP-IND MCP West NC LLC (Delaware)

REEP-IND STANFORD COURT LLC (Delaware)

REEP-IND STANFORD COURT CA LLC (Delaware)

REEP-IND Valley View TX LLC (Delaware)

REEP-IND Valwood TX LLC (Delaware)

REEP-MF 960 East Paces Ferry GA LLC (Delaware)

REEP-MF 960 EPF Opco GA LLC (Delaware)REEP-MF Emblem DE LLC (Delaware)

REEP-MF Gateway TAF UT LLC (Delaware) (NYLIC: 99%, NYLIAC: 1%)

REEP-WP Gateway TAB JV LLC (Delaware) (LLC: 99%, NYLIAC: 1%)

REEP-MF Mount Vernon GA LLC (Delaware)

REEP-MF Mount Laurel NJ LLC (Delaware)

REEP-MF NORTH PARK CA LLC (Delaware)

REEP-AVERY OWNER LLC (Delaware)

REEP-MF One City Center NC LLC (Delaware)

REEP-MF Wallingford WA LLC (Delaware)

REEP-MF STEWART AZ OLDER LLC (Delaware)

REEP-MF STEWART AZ (Delaware)

REEP-OFC Aspect OR LLC (Delaware) (NYLIC: 37%, NYLIAC: 63%)

REEP-OFC Bellevue WA LLC (Delaware)

REEP-OFC Financial Center FL LLC (Delaware)

REEP-OFC WATER RIDGE NC HOLDCO LLC (Delaware)

REEP-OFC ONE WATER RIDGE NC LLC (Delaware)

REEP-OFC TWO WATER RIDGE NC LLC (Delaware)

REEP-OFC FOUR WATER RIDGE NC LLC (Delaware)

------

REEP-OFC FIVE WATER RIDGE NC LLC (Delaware)

REEP-OFC SIX WATER RIDGE NC LLC (Delaware)

REEP-OFC SEVEN WATER RIDGE NC LLC (Delaware)

REEP-OFC EIGHT WATER RIDGE NC LLC (Delaware)

REEP-OFC NINE WATER RIDGE NC LLC (Delaware)

REEP-OFC TEN WATER RIDGE NC LLC (Delaware)

REEP-OFC ELEVEN WATER RIDGE NC LLC (Delaware)

REEP-MF FOUNTAIN PLACE MN LLC (Delaware)

REEP-MF FOUNTAIN PLACE LLC (Delaware)

REEP-MF Park-Line FL LLC (Delaware)

REEP-OFC 2300 Empire CA LLC (Delaware)

REEP-IND 10 WEST II AZ LLC (Delaware)

REEP-RTL Flemington NJ LLC (Delaware)

REEP-RTL Mill Creek NJ LLC (Delaware)

REEP-RTL NPM GA LLC (Delaware)

REEP-OFC 515 Post Oak TX LLC (Delaware) (NYLIC: 65%, NYLIAC: 35%)

REEP-RTL DTC VA LLC (Delaware) (NYLIC: 39%, NYLIAC: 61%)

REEP-RTL DTC-S VA LLC (Delaware) (NYLIC: 37%, NYLIAC: 63%)

REEP-OFC 410 TOWNSEND CA LLC (Delaware)

REEP-OFC 410 TOWNSEND LLC (Delaware)

REEP-2023 PH 5 LLC (Delaware) name change to Madison-LPP Kernersville GP LLC

REEP-2023 PH 6 LLC (Delaware) name change to Madison-LPP Kernersville LP

REEP-2023 PH 7 LLC (Delaware)

REEP-2023 PH 8 LLC (Delaware) name change to Madison-SS Kernersville QRS, Inc

REEP-OFC 600 TOWNSEND CA LLC (Delaware)

REEP-OFC 600 TOWNEND LLC (Delaware)

REEP-OFC 1341 G DC LLC (Delaware) (NYLIC: 65%, NYLIAC: 35%)

REEP-OFC 1030 15NM DC LLC (Delaware) (NYLIC: 65%, NYLIAC: 35%)

REEP-OFC 1111 19NW DC LLC (Delaware) (NYLIC: 63.826087%, NYLIAC: 36.173913%)

REEP 220 NW Owner LLC (Delaware)

REEP-OFC 1341 G DC LLC (Delaware) (NYLIC: 65%; NYLIAC: 35%)

REEP-OFC 1030 15NW DC LLC (Delaware) (NYLIC: 65%; NYLIAC: 35%)

REEP-OFC 1111 19NW DC LLC (Delaware) (NYLIC: 63.826087%; NYLIAC: 36.173913%)

REEP-OFC 30 WM IL LLC (Delaware) (formed 1.2.2025)

REEP-SS Marshfield LLC (Delaware) (formed 1.10.2025)

REEP-LLP Marshfield JV LLC (Delaware) (formed 1.10.2025)

REEP-SS Vallejo LLC (Delaware) (formed 1.7.2025)

REEP-OFC 353 Sacramento LLC (Delaware)

REEP-Royal 353 Sacramento JV LLC (Delaware)

REKA 51M HOLDINGS, LLC (Delaware)

NJIND Raritan Center LLC (Delaware)

NJIND Talmadge Road LLC (Delaware)

NJIND Melrich Road LLC (Delaware)

FP Building 18, LLC (Delaware)

FP Building 19, LLC (Delaware)

Summitt Ridge Apartments, LLC (Delaware)

PTC Acquisitions, LLC (Delaware)

Martingale Road LLC (Delaware)

NYLIC HKP MEMBER LLC (Delaware) (NYLIC-MM: 67.974%, NYLIAC-IM: 32.026%)

NYLIC HKP VENTURE LLC (Delaware (51%)

NYLIC HKP REIT LLC (Delaware) (51%)

New York Life Funding (Cayman Islands<sup>6</sup>

New York Life Global Funding (Delaware)<sup>6</sup>

Government Energy Savings Trust 2003-A (GEST) (New York)<sup>7</sup>

UFI-NOR Federal Receivables Trust, Series 2009B (New York) <sup>7</sup>

NYLARC Holding Company Inc. (Arizona)6

New York Life Agents Reinsurance Company (Arizona)<sup>6</sup>

JREP Fund Holdings I, L.P. (12.5%) (Cayman Is.)

Jaguar Real Estate Partners L.P. (30.3%) (Cayman Is.)

REEP-NYL JAG ACQUISITION CO MEMBER LLC (Delaware)

NYLIFE Office Holdings Member LLC (Delaware) (51%)

NYLIFE Office Holdings LLC (Delaware) (51%)

NYLIFE Office Holdings REIT LLC (Delaware)

REEP-OFC DRAKES LANDING CA LLC (Delaware)

REEP-OFC CORPORATE POINTE CA LLC (Delaware)

REEP-OFC VON KARMAN CA LLC (Delaware)

REEP-OFC ONE BOWDOIN SQUARE MA LLC (Delaware)

REEP-OFC 525 N Tryon NC LLC (Delaware)

525 Charlotte Office LLC (Delaware) (100%)

REEP-IMPIC OFC PROMINENCE ATLANTA LLC (Delaware)

REEP-IMPIC OFC 24th CAMELBACK AZ LLC (Delaware)

NYLIFE Office Holdings Acquisitions REIT LLC (Delaware)

REEP OFC Westory DC LLC (Delaware)

Skyhigh SPV Note Issuer 2020 Parent Trust (Delaware)<sup>7</sup>

------

Skyhigh SPV Note Issuer 2020 LLC (Delaware)<sup>7</sup>

Sol Invictus Note Issuer 2021-1 LLC (Delaware)

Veritas Doctrina Note Issuer SPV LLC (Delaware)

Fairview Capital Partners, LLC (Delaware) (49%)

AC 2023 NMTC Investor, LLC (Louisiana) (NYLIC: 79.20%, NYLIAC: 19.80%)

USB NMTC FUND 20223-6, LLC (Delaware)

NYLIC RLP II, LLC (Delaware)

6 Control is through a reliance relationship between NYLIC and this entity, not ownership of voting interests.

7 Control is through financial interest or investment management contract, not ownership of voting interests.

------

ITEM 30. INDEMNIFICATION

The New York Life Investments Group of Funds, which includes New York Life Investments Funds Trust, New York Life Investments VP Funds Trust and New York Life Investments Funds, maintains a joint directors and officers/errors and omissions ("D&O/E&O") liability insurance policy and joint independent directors liability ("IDL") insurance policy. The D&O/E&O liability insurance policy covers all of the directors and officers of the New York Life Investments Group of Funds and the IDL insurance policy covers the independent directors only. Subject to the terms, conditions and retentions of the policies, insured persons are covered for claims made against them while acting in their official capacities with the New York Life Investments Group of Funds.

Article VII of New York Life Investments VP Funds Trust's ("Registrant's") Declaration of Trust states as follows:

Section 3. Indemnification.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) For purposes of this Section 3 and Section 5 of this Article VII and any related provisions of the By-laws, "Agent" means any Person who is, was or becomes an employee or other agent of the Trust who is not a Covered Person; "Proceeding" means any threatened, pending or completed claim, action, suit or proceeding, whether civil, criminal, administrative or investigative (including appeals); and "liabilities" and "expenses" include, without limitation, attorneys' fees, costs, judgments, amounts paid in settlement, fines, penalties and all other liabilities whatsoever.

Laws:

(b) Subject to the exceptions and limitations contained in this Section, as well as any procedural requirements set forth in the By-Laws

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) every person who is, has been, or becomes a Trustee or officer of the Trust (hereinafter referred to as a "Covered Person") shall be indemnified by the Trust to the fullest extent permitted by law against any and all liabilities and expenses reasonably incurred or paid by him in connection with the defense of any Proceeding in which he becomes involved as a party or otherwise by virtue of his being or having been such a Trustee or officer, and against amounts paid or incurred by him in the settlement thereof;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) every Person who is, has been, or becomes an Agent of the Trust may, upon due approval of the Trustees (including a majority of the Trustees who are not Interested Persons of the Trust), be indemnified by the Trust, to the fullest extent permitted by law, against any and all liabilities and expenses reasonably incurred or paid by him in connection with the defense of any Proceeding in which he becomes involved as a party or otherwise by virtue of his being or having been an Agent, and against amounts paid or incurred by him in the settlement thereof;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) every Person who is serving or has served at the request of the Trust as a director, officer, partner, trustee, employee, agent or fiduciary of another domestic or foreign corporation, partnership, joint venture, trust, other enterprise or employee benefit plan ("Other Position") and who was or is a party or is threatened to be made a party to any Proceeding by reason of alleged acts or omissions while acting within the scope of his or her service in such Other Position, may, upon due approval of the Trustees (including a majority of the Trustees who are not Interested Persons of the Trust), be indemnified by the Trust, to the fullest extent permitted by law, against any and all liabilities and expenses reasonably incurred or paid by him in connection with the defense of any Proceeding in which he becomes involved as a party or otherwise by virtue of his being or having held such Other Position, and against amounts paid or incurred by him in the settlement thereof;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Without limitation of the foregoing and subject to the exceptions and limitations set forth in this Section, as well as any procedural requirements set forth in the By-Laws, the Trust shall indemnify each Covered Person who was or is a party or is threatened to be made a party to any Proceedings, by reason of alleged acts or omissions within the scope of his or her service as a Covered Person, against judgments, fines, penalties, settlements and reasonable expenses (including attorneys' fees) actually incurred by him in connection with such proceeding to the maximum extent consistent with state law and the 1940 Act.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) No indemnification shall be provided hereunder to any Person who shall have been adjudicated by a court or body before which the proceeding was brought (i) to be liable to the Trust or its Shareholders by reason of willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the conduct of his office (collectively, "Disabling Conduct") or (ii) not to have acted in good faith in the reasonable belief that his action was in the best interest of the Trust.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) With respect to any Proceeding disposed of (whether by settlement, pursuant to a consent decree or otherwise) without an adjudication by the court or other body before which the Proceeding was brought, no indemnification shall be provided to a Trustee, officer, Agent or other Person unless there has been a dismissal of the Proceeding by the court or other body before which it was brought for insufficiency of evidence of any Disabling Conduct with which such Trustee, officer, Agent or other Person has been charged or a determination that such Trustee, officer, Agent or other Person did not engage in Disabling Conduct:

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) by the court or other body before which the Proceeding was brought;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) by at least a majority of those Trustees who are neither Interested Persons of the Trust nor are parties to the Proceeding based upon a review of readily available facts (as opposed to a full trial-type inquiry); or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) by written opinion of independent legal counsel based upon a review of readily available facts (as opposed to a full trial- type inquiry).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) The Trust's financial obligations arising from the indemnification provided herein or in the By-Laws (i) may be insured by policies maintained by the Trust; (ii) shall be severable; (iii) shall not be exclusive of or affect any other rights to which any Person may now or hereafter be entitled; and (iv) shall continue as to a Person who has ceased to be subject to indemnification as provided in this Section as to acts or omissions that occurred while the Person was indemnified as provided herein and shall inure to the benefit of the heirs, executors and administrators of such Person. Nothing contained herein shall affect any rights to indemnification to which Trust personnel, other than Covered Persons, may be entitled, and other persons may be entitled by contract or otherwise under law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) Expenses of a Person entitled to indemnification hereunder in connection with the defense of any Proceeding of the character described in paragraphs (a) and (b) above may be advanced by the Trust or Series from time to time prior to final disposition thereof upon receipt of an undertaking by or on behalf of such Person that such amount will be paid over by him to the Trust or Series if it is ultimately determined that he is not entitled to indemnification under this Section 3; provided, however, that either (i) such Person shall have provided appropriate security for such undertaking, (ii) the Trust is insured against losses arising out of any such advance payments, or (iii) either a majority of the Trustees who are neither Interested Persons of the Trust nor parties to the matter, or independent legal counsel in a written opinion, shall have determined, based upon a review of readily available facts (as opposed to a trial-type inquiry or full investigation), that there is reason to believe that such Person will be found entitled to indemnification under Section 3.

Section 5. Insurance.

The Trustees shall be entitled and empowered to the fullest extent permitted by law to purchase with Trust assets insurance for liability and for all expenses reasonably incurred or paid or expected to be paid by a Person entitled to indemnification from the Trust in connection with any proceeding in which he or she may become involved by virtue of his or her capacity or former capacity entitling him or her to indemnification hereunder.

In addition, each Trustee has entered into a written agreement with the Registrant pursuant to which the Registrant is contractually obligated to indemnify the Trustees to the fullest extent permitted by law and by the Declaration of Trust and By-Laws of the Registrant.

Insofar as indemnification for liability arising under the Securities Act of 1933 may be permitted to trustees, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a trustee, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such trustee, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.

ITEM 31. BUSINESS OR OTHER CONNECTIONS OF INVESTMENT ADVISOR

New York Life Investment Management LLC ("New York Life Investments") acts as the investment adviser for each series of the following open- end registered management investment companies: New York Life Investments Funds Trust, New York Life Investments VP Funds Trust and New York Life Investments Funds.

The list of officers and directors of New York Life Investments, together with information as to their other business, profession, vocation or employment of a substantial nature during the past two years, is incorporated by reference to Schedules A and D of Form ADV filed by New York Life Investments (SEC File No: 801-57396).

American Century Investment Management, Inc. – File No. 801-8174

Brown Advisory LLC – File No. 80-38826<br>Candriam – File No. 801-80510

CBRE Investment Management Listed Real Assets LLC- File No. 801-49083<br>Dimensional Fund Advisors LP – File No. 801-16283<br>Epoch Investment Partners, Inc. – File No.

------

801-63118<br>FIAM LLC – File No. 801-63658<br>Janus Henderson Investors US LLC – File No. 801-13991<br>MacKay Shields LLC – File No. 801-5594<br>Massachusetts Financial Services Company – File No. 801-17352<br>Newton Investment Management North America – File No. 801-120501<br>NYL Investors LLC – File No. 801-78759<br>Pacific Investment Management Company, LLC – File No. 801-48187<br>PineStone Asset Management Inc. – File No. 801-122764<br>Schroder Investment Management North America Inc. – File No. 801-15834<br>Segall Bryant & Hamill, LLC – File No. 801-47232<br>Wellington Management Company LLC – File No. 801-15908<br>Winslow Capital Management LLC – File No. 801-41316

ITEM 32. PRINCIPAL UNDERWRITERS

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Inapplicable

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Inapplicable

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Inapplicable

ITEM 33. LOCATION OF ACCOUNTS AND RECORDS.

Certain accounts, books and other documents required to be maintained by Section 31(a) of the Investment Company Act of 1940, as amended, and the Rules promulgated thereunder are maintained at the offices of New York Life Insurance Company, 51 Madison Avenue, New York, NY 10010, the Registrant, the Manager, the Subadvisors and NYLIFE Distributors LLC. The Registrant, the Manager and NYLIFE Distributors LLC's address is 30 Hudson Street, Jersey City, New Jersey 07302. The Subadvisors addresses are: American Century Investment Management, Inc., 4500 Main Street, Kansas City, MO 64111; Brown Advisory LLC, 901 South Bond Street, Suite 400, Baltimore, Maryland 21231; Candriam,19-21 route d'Arlon L-8009 Strassen, Luexembourg; CBRE Investment Management Listed Real Assets LLC, 555 Lancaster Avenue, Suite 120; Radnor, PA 19087; Dimensional Fund Advisors LP, 6300 Bee Cave Road, Building One, Austin, Texas 78746; Epoch Investment Partners, Inc., 1 Vanderbilt Avenue, New York, NY 10017; FIAM LLC, 900 Salem Street, Smithfield, RI 02917; Janus Henderson Investors US LLC, 151 Detroit Street, Denver, CO 80206-4805; MacKay Shields LLC, 1345 Avenue of the Americas, New York, NY 10105; Massachusetts Financial Services Company, 111 Huntington Avenue, Boston, Massachusetts 02199; Newton Investment Management North America, BNY Mellon Center, 201 Washington Street, Boston, MA 02108; NYL Investors LLC, 51 Madison Avenue, New York, NY 10010; Pacific Investment Management Company LLC, 650 Newport Center Drive, Newport Beach, CA 92660; PineStone Asset Management Inc.,1981 McGill College Avenue, Suite 1600 Montreal, Québec H3A 2Y1; Schroder Investment Management North America Inc., 7 Bryant Park, New York, New York 10018; Segall Bryant & Hamill, LLC, 540 West Madison Street, Suite 1900, Chicago, IL 60661; Wellington Management Company LLC, 280 Congress Street, Boston, MA 02210; and Winslow Capital Management LLC, 4400 IDS Center, 80 South Eighth Street, Minneapolis, MN 55402.

Records relating to the Registrant's custodian are maintained by JPMorgan Chase Bank, N.A., 383 Madison Avenue, New York, New York 10179.

Records relating to the Transfer Agent of the NYLI VP Convertible Portfolio – Service 2 Class shares and NYLI VP Floating Rate Portfolio– Initial and Service Class shares are maintained by DST Asset Manager Solutions, Inc., 2000 Crown Colony Drive, Quincy, MA 02169.

ITEM 34. MANAGEMENT SERVICES.

Inapplicable.

ITEM 35. UNDERTAKINGS.

Inapplicable.

------

#### SIGNATURES
Pursuant to the requirements of the Securities Act of 1933 and the Investment Company Act of 1940, the Registrant certifies that it meets all of the requirements for effectiveness of this Registration Statement under Rule 485(b) and that it has duly caused this Post-Effective Amendment No. 159 to its Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New York in the State of New York, on the 19<sup>th</sup> day of September, 2025.

---

| | |
|:---|:---|
| **NEW YORK LIFE INVESTMENTS VP FUNDS TRUST** | **NEW YORK LIFE INVESTMENTS VP FUNDS TRUST** |
| By: | <u>/s/ Kirk C. Lehneis</u> |
|  | Kirk C. Lehneis |
|  | President and Principal Executive Officer |

---

Pursuant to the requirements of the Securities Act of 1933, this Post-Effective Amendment No. 159 to the Registration Statement has been signed by the following persons in the capacities indicated below on the date above.

---

| | |
|:---|:---|
| <u>SIGNATURE</u> | <u>TITLE</u> |
| <u>/s/ Kirk C. Lehneis</u> | President and Principal Executive Officer |
| Kirk C. Lehneis |  |
| <u>/s/ Naïm Abou-Jaoudé\*</u> | Trustee |
| Naïm Abou-Jaoudé |  |
| <u>/s/ Susan B. Kerley\*</u> | Trustee  |
| Susan B. Kerley |  |
| <u>/s/ David H. Chow\*</u> | Trustee |
| David H. Chow |  |
| <u>/s/ Karen Hammond\*</u> | Trustee |
| Karen Hammond |  |
| <u>/s/ Alan R. Latshaw\*</u> | Trustee |
| Alan R. Latshaw |  |
| <u>/s/ Jacques P. Perold\*</u> | Trustee and Chair of the Board |
| Jacques P. Perold |  |
| <u>/s/ Richard S. Trutanic\*</u> | Trustee |
| Richard S. Trutanic |  |
| <u>/s/ Jack R. Benintende</u> | Treasurer and Principal Financial and Accounting Officer |
| Jack R. Benintende |  |
| By:  |  |
| <u>/s/ J. Kevin Gao</u> | Secretary |
| J. Kevin Gao |  |
| As Attorney-in-Fact |  |
| \* Pursuant to Powers of Attorney previously filed. |  |

---

------

#### Exhibit Index
(h)(7)(cc) Amendment dated July 1, 2025, to the Transfer Agency Agreement

(p)(1) Code of Ethics of New York Life Investments dated December 2024

(p)(3) Code of Ethics of Epoch Investment Partners, Inc. dated October 2024

(p)(9) Code of Ethics of Candriam dated October 2024

------

## Ex-99.H

#### AMENDMENT TO <br> AMENDED AND RESTATED <br> TRANSFER AGENCY AND SERVICE AGREEMENT
This Amendment to the Amended and Restated Transfer Agency and Service Agreement ("Amendment") is effective as of the 1<sup>st</sup> day of July, 2025, by and among New York Life Investments Funds, a Massachusetts business trust, and New York Life Investments VP Funds Trust and New York Life Investments Funds Trust, each a Delaware statutory trust (each, a "Fund" and collectively, the "Funds"), and NYLIM Service Company LLC ("NSC"), a Delaware limited liability company, having its principal office and place of business at 30 Hudson Street, Jersey City, New Jersey 07302.

**WHEREAS,** the Funds and NSC are parties to an Amended and Restated Transfer Agency and Service Agreement, dated October 1, 2008, as amended ("Agreement"); and

**WHEREAS**, pursuant to Article 2.01 and Article 11 of the Agreement, the parties hereby wish to amend the Agreement to

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. update the Transfer Agency Fee Schedule to reflect the cost-of-living adjustment to the transfer agency fees effective July 1, 2025, as NSC notified the New York Life Investments Group of Funds' Board of Trustees at meetings held on June 4-5, 2025.

**NOW, THEREFORE,** in consideration of the mutual covenants contained in the Agreement and other good and valuable consideration, the receipt of which is hereby acknowledged, the parties agree as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Schedule A of the Agreement is hereby deleted in its entirety and replaced with the Schedule A attached hereto.

------

**IN WITNESS HEREOF**, the parties hereto have caused this Amendment to be executed by their duly authorized officers.

**NEW YORK LIFE INVESTMENTS FUNDS**<br>By: <u>/s/ Kirk C. Lehneis</u><br>Name: Kirk C. Lehneis<br>Title: President and Principal Executive Officer<br>

**NEW YORK LIFE INVESTMENTS FUNDS TRUST**<br>By: <u>/s/ Kirk C. Lehneis</u><br>Name: Kirk C. Lehneis<br>Title: President and Principal Executive Officer<br>

**NEW YORK LIFE INVESTMENTS VP FUNDS TRUST<br>**<br> By: <u>/s/ Kirk C. Lehneis</u><br>Name: Kirk C. Lehneis<br>Title: President and Principal Executive Officer<br>

**NYLIM SERVICE COMPANY LLC <br>**<br> By: <u>/s/ Jack R. Benintende</u><br>Name: Jack R. Benintende<br>Title: President<br>

------

#### SCHEDULE A
Effective Date: July 1, 2025<br>(unless otherwise indicated)<br>

---

| | |
|:---|:---|
| **<u>New York Life Investments Funds</u>**<br>NYLI Candriam Emerging Markets Debt Fund<br>NYLI Income Builder Fund<br>NYLI MacKay Convertible Fund<br>NYLI MacKay High Yield Corporate Bond Fund<br>NYLI MacKay Strategic Bond Fund<br>NYLI MacKay Tax Free Bond Fund<br>NYLI MacKay U.S. Infrastructure Bond Fund <br>NYLI Money Market Fund<br>NYLI Winslow Large Cap Growth Fund<br>NYLI WMC Enduring Capital Fund<br>NYLI WMC Value Fund<br>**<u>New York Life Investments VP Funds Trust</u>**<br>all currently available VP Portfolios<br>| &nbsp;&nbsp;**<u>New York Life Investments Funds Trust</u>**<br>NYLI Balanced Fund<br>NYLI Candriam Emerging Markets Equity Fund<br>NYLI CBRE Global Infrastructure Fund<br>NYLI CBRE Real Estate Fund<br>NYLI Conservative Allocation Fund <br>NYLI Conservative ETF Allocation Fund <br>NYLI Cushing MLP Premier Fund <br>NYLI Epoch Capital Growth Fund<br>NYLI Epoch Global Equity Yield Fund<br>NYLI Epoch International Choice Fund<br>NYLI Epoch U.S. Equity Yield Fund <br>NYLI Equity Allocation Fund<br>NYLI Equity ETF Allocation Fund <br>NYLI Fiera SMID Growth Fund<br>NYLI Floating Rate Fund<br>NYLI Growth Allocation Fund<br>NYLI Growth ETF Allocation Fund<br>NYLI MacKay Arizona Muni Fund<br>NYLI MacKay California Muni Fund<br>NYLI MacKay Colorado Muni Fund<br>NYLI MacKay High Yield Muni Bond Fund<br>NYLI MacKay New York Muni Fund<br>NYLI MacKay Oregon Muni Fund<br>NYLI MacKay Short Duration High Income Fund<br>NYLI MacKay Short Term Muni Fund <br>NYLI MacKay Strategic Muni Allocation Fund<br>NYLI MacKay Total Return Bond Fund<br>NYLI MacKay Utah Muni Fund<br>NYLI Moderate Allocation Fund<br>NYLI Moderate ETF Allocation Fund <br>NYLI PineStone Global Equity Fund<br>NYLI PineStone International Equity Fund<br>NYLI PineStone U.S. Equity Fund<br>NYLI S&P 500 Index Fund<br>NYLI Short Term Bond Fund<br>NYLI U.S. Government Liquidity Fund<br>NYLI WMC Growth Fund<br>NYLI WMC International Research Equity Fund<br>NYLI WMC Small Companies Fund<br>|

---

------

#### TRANSFER AGENCY FEE SCHEDULE
**As Amended effective July 1, 2025**<br>(unless otherwise indicated)

#### 1) Maintenance and Transaction Charges – Billable Monthly\* <br>
\* For each share class other than Class P, Class R6 and SIMPLE Class shares, the Funds listed below will be billed at the greater of A or B.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A) Per Account Annual Fee:

The following Funds will be billed at a rate of 1/12 of the annual fee for each Fund account serviced during the month. "Accounts serviced" is defined as all open accounts at month end and accounts that close during the month, including underlying Shareholder accounts which may be held in omnibus positions and serviced by other administrators.

#### NEW YORK LIFE INVESTMENTS FUNDS <br>

---

| | |
|:---|:---|
| &nbsp;&nbsp;**EQUITY FUNDS** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**ACCOUNT RATES** |
| &nbsp;&nbsp;NYLI Winslow Large Cap Growth Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$26.64 |
| &nbsp;&nbsp;NYLI WMC Enduring Capital Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$26.64 |
| *NYLI WMC Value Fund* | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$26.64 |
| &nbsp;&nbsp;**FIXED INCOME & BLENDED FUNDS** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**ACCOUNT RATES** |
| &nbsp;&nbsp;NYLI Candriam Emerging Markets Debt Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$32.00 |
| &nbsp;&nbsp;NYLI Income Builder Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$32.00 |
| &nbsp;&nbsp;NYLI MacKay Convertible Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$32.00 |
| &nbsp;&nbsp;NYLI MacKay High Yield Corporate Bond Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$32.00 |
| &nbsp;&nbsp;NYLI MacKay Strategic Bond Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$32.00 |
| &nbsp;&nbsp;NYLI MacKay Tax Free Bond Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$32.00 |
| &nbsp;&nbsp;NYLI MacKay U.S. Infrastructure Bond Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$32.00 |
| &nbsp;&nbsp;**MONEY MARKET FUND** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**ACCOUNT RATES** |
| &nbsp;&nbsp;NYLI Money Market Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$31.13 |

---

#### NEW YORK LIFE INVESTMENTS FUNDS TRUST <br>

---

| | |
|:---|:---|
| &nbsp;&nbsp;**EQUITY FUNDS** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**ACCOUNT RATES** |
| &nbsp;&nbsp;NYLI Candriam Emerging Markets Equity Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$26.64 |
| &nbsp;&nbsp;NYLI CBRE Global Infrastructure Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$26.64 |
| &nbsp;&nbsp;NYLI CBRE Real Estate Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$26.64 |
| &nbsp;&nbsp;NYLI Conservative Allocation Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$26.64 |
| &nbsp;&nbsp;NYLI Cushing MLP Premier Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$26.64 |
| &nbsp;&nbsp;NYLI Epoch Capital Growth Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$26.64 |
| &nbsp;&nbsp;NYLI Epoch Global Equity Yield Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$26.64 |
| &nbsp;&nbsp;NYLI Epoch International Choice Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$26.64 |
| &nbsp;&nbsp;NYLI Epoch U.S. Equity Yield Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$26.64 |
| &nbsp;&nbsp;NYLI Equity Allocation Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$26.64 |
| &nbsp;&nbsp;NYLI Fiera SMID Growth Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$26.64 |
| &nbsp;&nbsp;NYLI Growth Allocation Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$26.64 |
| &nbsp;&nbsp;NYLI S&P 500 Index Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$26.64 |

---

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;**EQUITY FUNDS** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**ACCOUNT RATES** |
| &nbsp;&nbsp;NYLI Moderate Allocation Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$26.64 |
| &nbsp;&nbsp;NYLI PineStone Global Equity Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$26.64 |
| &nbsp;&nbsp;NYLI PineStone International Equity Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$26.64 |
| &nbsp;&nbsp;NYLI PineStone U.S. Equity Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$26.64 |
| &nbsp;&nbsp;NYLI WMC Growth Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$26.64 |
| &nbsp;&nbsp;NYLI WMC International Research Equity Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$26.64 |
| &nbsp;&nbsp;NYLI WMC Small Companies Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$26.64 |
| &nbsp;&nbsp;**FIXED INCOME & BLENDED FUNDS** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**ACCOUNT RATES** |
| &nbsp;&nbsp;NYLI Balanced Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$32.00 |
| &nbsp;&nbsp;NYLI Floating Rate Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$32.00 |
| &nbsp;&nbsp;NYLI MacKay Arizona Muni Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$32.00 |
| &nbsp;&nbsp;NYLI MacKay California Muni Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$32.00 |
| &nbsp;&nbsp;NYLI MacKay Colorado Muni Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$32.00 |
| &nbsp;&nbsp;NYLI MacKay High Yield Muni Bond Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$32.00 |
| &nbsp;&nbsp;NYLI MacKay New York Muni Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$32.00 |
| &nbsp;&nbsp;NYLI MacKay Oregon Muni Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$32.00 |
| &nbsp;&nbsp;NYLI MacKay Short Duration High Income Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$32.00 |
| &nbsp;&nbsp;NYLI MacKay Short Term Muni Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$32.00 |
| &nbsp;&nbsp;NYLI MacKay Strategic Muni Allocation Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$32.00 |
| &nbsp;&nbsp;NYLI MacKay Total Return Bond Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$32.00 |
| &nbsp;&nbsp;NYLI MacKay Utah Muni Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$32.00 |
| &nbsp;&nbsp;NYLI Short Term Bond Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$32.00 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;B) Fund Minimum (CUSIP/Class/Fund):<br>

The Funds listed above will be billed at $458.84 per month per CUSIP (*i.e.,* 1/12 of the annual Fund Minimum charge of $5,506.08) for each Fund serviced during the month that is not being charged at the per account rate. Those Funds that do not have a minimum account volume are charged at the Fund Minimum level until such account volumes are achieved. Seed accounts are excluded from Fund Minimums.

The fees and charges set forth above shall increase annually over the fees and charges during the prior 12 months in an amount equal to the annual percentage of change in the Northeastern Consumer Price Index as last reported by the U.S. Bureau of Labor Statistics.<br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;C) Expense Allocation Methodology

<br>**<u>All Funds (except New York Life Investments ETF Asset Allocation Funds</u>**<sup>1</sup>**<u>)</u>**<br>For purposes of allocating the transfer agency expenses for each Fund under this Agreement: (i) Class A, Class A2, Class I, Class R1, Class R2, Class R3 and Class Z shares will be grouped together as one group; (ii) Investor Class, Class C and Class C2 shares will be grouped together as a separate group; and (iii) SIMPLE Class, Class P and Class R6 shares will not be grouped together with any other share class.

<sup>1</sup> The New York Life Investments ETF Asset Allocation Funds consist of NYLI Conservative ETF Allocation Fund, NYLI Equity ETF Allocation Fund, NYLI Growth ETF Allocation Fund, and NYLI Moderate ETF Allocation Fund.

------

<br>For each Fund, the transfer agency expenses will be calculated and allocated between the share classes in each group in the following manner:<br>multiplying the total number of accounts in each group of share classes by the per account fee to determine the total transfer agency fees allocable to each group, and<br>allocating the total fees per group among the share classes in the group based on the relative assets of the share classes.<br>**<u>Class P and Class R6 Shares</u>**<br>For Class P and Class R6 shares, a Fund will be charged a transfer agency fee of 0.004% of the average daily net assets attributable to Class P and Class R6 shares of the Fund.<br>**<u>New York Life Investments ETF Asset Allocation Funds</u>**<br>Each share class of the New York Life Investments ETF Asset Allocation Funds will be charged a transfer agency fee as follows:<br>

---

| | |
|:---|:---|
| &nbsp;&nbsp;**NEW YORK LIFE INVESTMENTS ETF ASSET ALLOCATION FUNDS** | &nbsp;&nbsp;&nbsp;&nbsp;**ACCOUNT RATES** |
| &nbsp;&nbsp;Shareholder accounts with total value of less than $12,000 | &nbsp;&nbsp;0.20% on assets |
| &nbsp;&nbsp;Shareholder accounts with total value of $12,000 or more to the extent the size of a shareholder account is available | &nbsp;&nbsp;$26.64 |

---

#### SIMPLE Class Shares
SIMPLE Class shares of a Fund will be charged a transfer agency fee as follows:

---

| | |
|:---|:---|
| &nbsp;&nbsp;**SIMPLE CLASS SHARES** | &nbsp;&nbsp;&nbsp;&nbsp;**ACCOUNT RATES** |
| &nbsp;&nbsp;Shareholder accounts with total value of less than $12,000 | &nbsp;&nbsp;0.20% on assets |
| &nbsp;&nbsp;Shareholder accounts with total value of $12,000 or more to the extent the size of a shareholder account is available | &nbsp;&nbsp;Each Fund's respective Account Rate as set forth in Section 1). A above |

---

#### 2) Other Items
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A) <u>New</u> <u>Funds</u><br>New Funds that contain "seed money" only will not be charged the Fund Minimum.<br><u>Fund Billing</u> <u>Restrictions/Caps</u><u><br></u><br> In order to facilitate the introduction of New Fund and Products and keep transfer agency expenses at a minimum, certain billing restrictions and/or Caps apply to New Funds (except the New York Life Investments ETF Asset Allocation Funds). New Funds (Class A, A2, C, C2, I, R1, R2, and R3) are charged a maximum transfer agency expense of 25 basis points for one year. After one year, the Fund expenses are reviewed and, at

------

Management discretion, will either continue to be charged the 25 basis points maximum or commencement of the per account rate or Fund Minimum charge will begin.

------

**IN WITNESS WHEREOF**, each of the Funds listed below and NYLIM Service Company LLC have agreed upon this Transfer Agency Fee Schedule and have caused this Transfer Agency Fee Schedule to be executed in their names and on their behalf by and through their duly authorized officers as of the day and year first written above.<br>

**NEW YORK LIFE INVESTMENTS FUNDS**<br>By: <u>/s/ Kirk C. Lehneis</u><br>Name: Kirk C. Lehneis<br>Title: President and Principal Executive Officer<br>

**NEW YORK LIFE INVESTMENTS FUNDS TRUST**<br>By: <u>/s/ Kirk C. Lehneis</u><br>Name: Kirk C. Lehneis<br>Title: President and Principal Executive Officer<br>

**NEW YORK LIFE INVESTMENTS VP FUNDS TRUST<br>**<br> By: <u>/s/ Kirk C. Lehneis</u><br>Name: Kirk C. Lehneis<br>Title: President and Principal Executive Officer<br>

**NYLIM SERVICE COMPANY LLC <br>**<br> By: <u>/s/ Jack R. Benintende</u><br>Name: Jack R. Benintende<br>Title: President<br>

------

## Ex-99.P

![](img_f8d6bddc32d24f4.jpg)

![](img_a8fdb3a8baa74f4.jpg)

## New York Life Investments
![](img_a8fdb3a8baa74f4.jpg)

## Code of Ethics
![](img_a8fdb3a8baa74f4.jpg)

## December 2024
![](img_a8fdb3a8baa74f4.jpg)

------

![](img_110b0127ed644f4.jpg)

**SECTION 1 GENERAL FIDUCIARY PRINCIPLES**![](img_110b0127ed644f4.jpg)

---

| | |
|:---|:---|
| &nbsp;&nbsp;As fiduciaries to our clients' assets, New York Life Investments<sup>1</sup> and its employees have a duty to act in good faith and in the best interest of its clients. To this end, this Code of Ethics ("Code") sets forth practices and standards to assist employees avoid potential conflicts that may arise from their personal trading. In conducting personal trading, Employees have the following responsibilities, for example:<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Place the interest of clients before your own personal trading. Employees may not engage in insider trading, front-running or scalping;<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Conduct personal trading in a manner as to avoid any actual or potential conflict of interest or abuse of an individual's position of trust and responsibility;<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Avoid taking inappropriate advantage of your position at the Company when conducting personal trading; and<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Act with integrity and in accordance with both the letter and spirit of applicable laws. Employees may not do anything indirectly that, if done directly, would violate the Code. For example, never use a derivative, or any other instrument or technique, to circumvent Code restrictions. Such actions would be the equivalent of direct Code violations. | ![](img_946efaec0de64f4.jpg) |

---

<sup>1</sup> Apogem Capital LLC, Flatiron RR LLC Manager Series, MacKay Shields LLC, MacKay Shields UK LLP, NYL Investments Europe Investment Management Limited, NYLIFE Distributors LLC, New York Life Investment Management LLC, New York Life Investment Management (UK) Limited, NYLIM Service Company LLC, and the following New York Life Insurance Company subsidiaries: New York Life Trust Company and NYL Investors LLC. Each registered investment adviser referred to above may be referred to individually as an "Investment Adviser."

------

This Code does not attempt to identify all possible circumstances. When in doubt, exercise good judgment and ask for help when you need it.

------

![](img_110b0127ed644f4.jpg)

**SECTION 2 PERSONAL INVESTING ACTIVITIES PROCEDURES**

![](img_110b0127ed644f4.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;2.1 <u>Applicable to all</u> <u>Employees</u>

![](img_da91daf323ce4f4.jpg)

#### The following requirements governing personal trading are applicable to all Employees:
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Active personal trading (e.g., day trading) is discouraged. While there is currently no limitation on the number of trades that an Employee may execute or trade requests that an Employee may submit, personal trading limitations may be placed on any Employee if: (i) it is believed to be in the best interest of the Company or its clients, (ii) such trading interferes with an Employee's professional duties, or (iii) there are excessive violations of the Code.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· No personal trades may be effected through Company's traders and trading systems.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Employees may not purchase and sell (or exchange), or sell and purchase (or exchange), shares of the same NYLI Mutual Fund within 30 days. The 30-day holding period is measured from the time of the most recent purchase of shares of the relevant NYLI Mutual Fund by the Employee. This applies to all NYLI Funds, including shares owned through a 401(K) plan or similar account, or through a variable insurance product. It does not apply to purchases that are effected as part of an automatic dividend reinvestment plan, an automatic investment plan, a payroll deduction plan or program, or transactions in money market funds.

------

&nbsp;&nbsp;&nbsp;&nbsp;2.2 <u>Additional Requirements</u> <u>for</u> <u>Access</u> <u>Persons</u> <u>and Investment</u> <u>Personnel</u>

![](img_39071d34a5814f4.jpg)

**Access Persons, Investment Personnel and Index Personnel** are subject to the following additional requirements:

&nbsp;&nbsp;&nbsp;&nbsp;2.2.1 <u>Preclearance</u> <u>of</u> <u>Covered</u> <u>Securities</u>

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· **Access Persons must preclear all transactions in Covered Securities (see Appendix B for a list of Covered Securities).** Each Access Person must submit their requests through the Employee Trade Pre-Clearance System ("ComplySci") available on the intranet (nylife.complysci.com) between the hours of 9:00 a.m. and 4:00 p.m. EST. Automated feedback will be provided to the Employee as to whether the request is approved or denied. In the event that the system is unavailable, Access Persons must contact Investments Compliance ("Compliance"). Compliance will provide approval or denial via email.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· **Access Persons must preclear all transactions in Covered Securities (see Appendix B for a list of Covered Securities).** Each Access Person must submit their requests through the Employee Trade Pre-Clearance System ("ComplySci") available on the intranet (nylife.complysci.com) between the hours of 9:00 a.m. and 4:00 p.m. EST. Automated feedback will be provided to the Employee as to whether the request is approved or denied. In the event that the system is unavailable, Access Persons must contact Investments Compliance ("Compliance"). Compliance will provide approval or denial via email. | ![](img_3d2b1d73681d4f4.jpg) |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Access Persons must preclear all transactions in **NYLI ETFs and Single Stock ETFs.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· **Pre-clearance approval is only good during U.S. market hours (9:30 a.m. to 4:00 p.m. EST)**. If you do not trade during the market session for which you were granted approval, the approval expires. If your transaction is not executed during that market session, a new request must be submitted.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· All stop orders and good to cancel orders are prohibited.

&nbsp;&nbsp;&nbsp;&nbsp;2.2.2 <u>Holding</u> <u>Period/Short</u> <u>Swing</u> <u>Rule</u>

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· **Access Persons may not purchase and sell (or exchange) or sell and purchase (or exchange) the same (or equivalent) Covered Security within sixty (60) calendar days.** The holding period is measured from the time of the most recent purchase of shares of the relevant Covered Security by the Employee (Last In First Out method). Exceptions may be made by Compliance to accommodate special circumstances.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· **Transactions in NYLI ETFs are subject to a seven-day Holding Period.** <br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Access Persons who receive a grant of options through an Employee Stock Option Plan, or who chooses to exercise those options in a Cashless Exercise, will be allowed an exception from the sixty-day holding period, but only after obtaining approval by email from Compliance. | ![](img_3c597fd81f5e4f4.jpg) |

---

&nbsp;&nbsp;&nbsp;&nbsp;2.2.3 <u>Trading</u> <u>/Black-Out</u> <u>Periods</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Access Persons may not purchase or sell a Covered Security on a day when there is a transaction for a Client of their respective Investment Adviser. Access Persons deemed Investment Personnel and Index Personnel are further restricted during black-out periods.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Investment Personnel and Index Personnel may not purchase or sell a Covered Security if any purchase or sale of such securities has been made for an Investment Adviser Client account in the prior <u>seven</u> calendar days or can reasonably be anticipated for a Company Client account in the next <u>seven</u> calendar days.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Exceptions may be granted to the black-out period related to Investment Personnel and Index Personnel on days when there is no Buy or Sell order for a Client of the Company and your personal trading involves one of the following: | ![](img_9aede669ba274f4.jpg) |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) 2000 shares or less in securities in the Russell 1000 Index; or

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) 500 shares or less in securities **NOT** in the Russell 1000 Index

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Blackout exceptions will not apply to Index Personnel or the NYLIM Multi-Asset Solutions team during a black-out period resulting from an Index Rebalance.

&nbsp;&nbsp;&nbsp;&nbsp;2.2.4 <u>Preclearance Exceptions</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Requirements pertaining to preclearance, hold and blackout periods (Sections 2.2.1 through 2.2.3) do not apply to the following transactions:

####  Certain securities and transaction types set forth in Section 2.2.1 through 2.2.3. See Appendix B for a list of exempt securities and transactions.
 In Discretionary Managed Accounts provided the Employee provides Compliance with a copy of the fully executed investment management agreement, which provides for the investment advisor's complete discretion and control over the account. The Employee (and his/her investment advisor) are required to certify that he/she will not have any direct or indirect influence or control over the account. Employees that have Discretionary Managed Accounts managed by an immediate family member are subject to preclearance requirements. Access Persons are prohibited from investing in and/or holding Private Placements and IPOs in Third-Party Discretionary Managed Accounts.

 That are non-volitional in nature: e.g., stock splits, stock dividends, exchanges and conversions, mandatory tenders, pro rata distributions to all holders of a class of securities, gifts, inheritances, margin/maintenance calls (where the securities to be sold are not directed by the covered person), and sales pursuant to regulated tender offers.

**Even though pre-clearance requirements may not apply in certain situations, Employees are reminded of their fiduciary duty, and must place the interest of clients before your own personal trading, and conduct personal trading in a manner that avoids any actual or potential conflict of interest.**

&nbsp;&nbsp;&nbsp;&nbsp;2.3 <u>Initial</u> <u>Public</u> <u>Offerings, Limited Offerings</u> <u>(e.g.,</u> <u>Private</u> <u>Placements, Private Equity and Hedge Funds and/or Alternative Investments) and Initial Coin Offerings</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Access Person or Employees who are Registered Representatives of NYLIFE Distributors may not directly or indirectly acquire Beneficial Ownership in any securities in an Initial Public Offering of securities, a Limited Offering (e.g., private placement, private equity hedge fund and/or alternative investments) or a virtual currency token offered in an initial or digital coin offering (also called ICOs or token sales) except with the express written prior approval of Compliance. Employees must submit a preclearance request through ComplySci. If ComplySci is unavailable,

------

employees must contact Compliance.

&nbsp;&nbsp;&nbsp;&nbsp;2.4 <u>Options Trading</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· <u>Transactions by Access Persons</u> 

 Access Persons may trade options on individual securities but must ensure that expiration dates meet or exceed the 60-day holding period and short swing rule.

 Access Persons are also prohibited from trading in uncovered options on individual securities (i.e., trading in a position where the seller of an option contract does not own any, or enough, of the underlying security). Should an Access Person decide to exercise any option prior to expiration, a separate preclearance request would also need to be entered prior to exercise. As discussed above, options on individual ETFs (excluding single-stock ETFs and NYLI ETFs) are excluded from the pre-clearance, 60-day holding period and short swing rule requirements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· <u>Transactions by Investment Personnel</u> 

 Investment Personnel may not trade in options with respect to individual securities. Transactions in index options effected on a broad-based index are permitted.

 Transactions by Access Persons and Investment Personnel in index options effected on a broad-based index, options on individual ETFs (excluding single-stock ETFs and NYLI ETFs) and options on commodities are permitted, and, these types of options do not require pre-clearance, nor are they subject to the 60-day holding period and short swing rule.

------

&nbsp;&nbsp;&nbsp;&nbsp;2.5 <u>NYLI Funds and NYLI ETFs Independent Trustees</u>

The following requirements apply only to the Independent Trustees of the NYLI Funds and NYLI ETFs.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· <u>Pre Clearance</u>

 An Independent Trustee need only obtain prior approval from the Adviser CCO or Senior Compliance Officer before directly or indirectly acquiring or disposing of beneficial ownership in a Covered Security if he/she knew or, in the ordinary course of fulfilling his/her duties as a Trustee should have known<sup>2</sup>, (i) that during the 15-day period immediately before or after a transaction in that security, a NYLI Fund or ETF, or any series thereof, purchased or sold that security, or (ii) an Adviser or subadvisers considered purchasing or selling that security on behalf of the NYLI Fund or ETF.

 With respect to the NYLI ETF Independent Trustees, the preclearance requirement to obtain prior approval from the CCO does not apply to purchases and sales of any non-NYLI ETF.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· <u>Initial Certification</u>

 Each newly appointed Independent Trustee is required to provide an initial certification stating that he/she has received a copy of the Code and that he/she understands the relevant requirements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· <u>Annual Certification</u>

 Each Independent Trustee is also required to certify on an annual basis that he/she has received, read, understood and complied with this Code.

&nbsp;&nbsp;&nbsp;&nbsp;2.6 <u>Section</u> <u>16</u> <u>Requirements (NYLI Closed End Funds and NYLI Interval Funds)</u>

<sup>2</sup> The "should have known" standard implies no duty of inquiry, does not presume there should have been any deduction or extrapolation from discussions or memoranda dealing with tactics to be employed meeting a Funds' investment objectives, or that any knowledge is to be imputed because of prior knowledge of the Fund's portfolio holdings, market considerations, or the Fund's investment policies, objectives and restrictions.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Certain Employees, including NYLI Independent Trustees, are considered "Fund Insiders" pursuant to Section 16 of the Exchange Act with respect to closed-end funds (including interval funds). Pre-clearance by Fund Insiders is required prior to transacting in closed-end fund shares, including closed-end fund shares purchased or sold in Discretionary Managed Accounts.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· In addition, transactions in closed-end fund shares by Fund Insiders require additional reporting to the U.S. Securities and Exchange Commission and are subject to holding periods. Please refer to the NYLI Funds' Policies and Procedures for Compliance with Section 16 of the Securities Act of 1934 or contact Compliance for more information.

---

| | |
|:---|:---|
| &nbsp;&nbsp;![](img_110b0127ed644f4.jpg)<br>**SECTION 3 RECORDKEEPING AND REPORTING REQUIREMENTS**<br>![](img_110b0127ed644f4.jpg) | ![](img_2abf461204cc4f4.jpg) |

---

3.1 <u>Initial Securities</u> <u>Holdings and Account</u> <u>Reports</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Access Persons must, no later than 10 days after becoming an employee, submit an initial holdings and account report and certification electronically through ComplySci. The holdings information presented in this report must be current as of 45 days prior to employment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Access Persons must also disclose all broker, dealer or bank accounts in which any Securities (including Covered Securities) are held. Non-Access Persons are only required to disclose where Affiliated or Reportable Fund shares are held. Additionally, each new Employee shall file an "Acknowledgement of Receipt of the Code of Ethics and Related Policies" via ComplySci.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· In addition, NYLIFE Distributors Registered Representatives **are also required to notify Compliance of any crypto currency accounts**. Upon opening any new brokerage and/or crypto currency accounts, Registered Representatives must notify Compliance of the new account in accordance with NYLIFE Distributors procedures.

------

3.2 <u>Quarterly</u> <u>Reporting</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Access Persons must, no later than 30 calendar days following quarter end, certify to all transactions in any Covered Security and Affiliated Funds or, alternatively, must confirm that there were no such transactions in the applicable quarter. This does not apply to transactions in Discretionary Managed Accounts as described in Section 2.2.4. Employees must complete this requirement electronically through ComplySci.

3.3 <u>Annual Reporting</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· No later than January 30th each year: (i) all Employees must file an annual certification indicating that the Employee has complied with the Code; and (ii) Access Persons must also file an annual holdings report or submit updated, complete brokerage statements and certify to their brokerage accounts as of year-end. Employees must complete these requirements electronically through ComplySci.

3.4 <u>Opening</u> <u>of</u> <u>Brokerage</u> <u>Accounts</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Access Persons shall promptly notify Compliance of any new account opened with a broker, dealer or bank including Discretionary Managed Accounts. Access Persons must provide Compliance with sufficient information so that Compliance can arrange for duplicate confirmations and accounts statements to be provided to Compliance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Access Persons may only open brokerage accounts with a firm that provides Compliance with an electronic feed of trade confirmations and statements. Contact Compliance for the complete list of firms. Exceptions are limited and require the approval of Compliance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Non-Access Persons are only required to notify Compliance of any new accounts opened with a broker, dealer or bank in which Affiliated Fund shares or Reportable Fund shares are held.

![](img_110b0127ed644f4.jpg)

**SECTION 4 ADMINISTRATION**

![](img_110b0127ed644f4.jpg)

4.1 <u>Sanctions</u> <u>and Review</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Upon discovering a violation of the Code, the Company shall take whatever remedial steps it deems necessary and available to correct an actual or apparent conflict (e.g., trade reversal etc.). Following those corrective efforts, Compliance may impose sanctions if, based upon all of the facts and circumstances considered, such action is

------

deemed appropriate.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· The magnitude of these penalties varies with the severity of the violation, although repeat offenders will likely be subjected to harsher sanctions. These sanctions may include, among others, the reversal of trades, disgorgement of profits, suspension of trading privileges or, in more serious cases, inclusion in annual performance evaluations, suspension or termination of employment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· It is important to note that violations of the Code may occur without employee fault (e.g., despite preclearance). In those cases, punitive action may not be warranted, although remedial steps may still be necessary.

4.2 <u>Acknowledgment</u> <u>and Training</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Each Employee must certify initially and annually thereafter that he or she has read and understood, is subject to and has complied with the Code and its related polices. Each Employee must attend a Code of Ethics training session conducted by Compliance within a reasonable time of becoming an Employee.

4.3 <u>Exceptions</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· The CCO or LCO, as applicable, in consultation with Compliance, may grant an exception to the Code in circumstances on a case-by-case basis if it is determined that the proposed conduct involves no opportunity for abuse and does not conflict with interests. Exceptions shall be structured to be as narrow as is reasonably practicable with appropriate safeguards designed to prevent abuse of the exception. Exceptions are expected to be rare. Notwithstanding the foregoing, however, no exception to a provision of the Code shall be granted where such exception would result in a violation of Rule 17j-1 or Rule 204A-1.

------

**Appendix A DEFINITIONS**

![](img_110b0127ed644f4.jpg)

**Affiliated Fund** - The NYLI Funds and NYLI Exchange Traded Funds ("NYLI ETFs")

**Beneficial Ownership** - interpreted in the same manner as it would be under Rule 16a-1(a)(2) under the Securities Exchange Act of 1934, as amended (the "Exchange Act") in determining whether a person is the beneficial owner of a security for purposes of the Exchange Act and the rules and regulations thereunder. A beneficial owner is any person who, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has or shares a direct or indirect pecuniary interest in the securities. A pecuniary interest in securities means the opportunity, directly or indirectly, to profit or share in any profit derived from a transaction in those securities. A person is presumed to have an indirect pecuniary interest in securities held by members of a person's Immediate Family who either reside with, or are financially dependent upon, or whose investments <u>are</u> <u>controlled</u> <u>by,</u> <u>that</u> <u>person</u>. A person also has a beneficial interest in securities held: (i) in a trust which he or she is a trustee, has a beneficial interest or is the settlor with a power to revoke; (ii) by another person and he or she has a contract or an understanding with such person that the securities held in that person's name are for his or her benefit; (iii) in the form of a right to acquisition of such security through the exercise of warrants, options, rights, or conversion rights; (iv) by a partnership of which he or she is a member; (v) by a corporation that he or she uses as a personal trading medium; or (vi) by a holding company that he or she controls.

**Chief Compliance Officer ("CCO")** – CCO, as applicable, of each New York Life Investments entity.

**Covered Security** - means any security as defined in Section 202(a)(18) of the Advisers Act. **Please see Appendix B for a list of Covered Securities, Exempt Securities, Prohibited Activities and Holding Periods. If you have a question regarding whether a security is considered a "Covered Security," please contact Compliance.** 

**Discretionary Managed Account** – an account managed on a discretionary basis by a person (or Robo-Adviser) other than an Employee over which the Employee has no direct or indirect influence or control over the selection or disposition of securities and no advance knowledge of transactions therein.

**Immediate Family** - any of the following individuals: child, stepchild, grandchild, parent, stepparent, grandparent, spouse, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, sister-in-law, including adoptive relationships who reside in the same household. **The term also includes (i) any related or unrelated individual who resides with, and (ii) whose investments are controlled by, or whose financial support is materially contributed to by, the employee, such as a "significant other."**

**NYLI Independent Board Member - a trustee of a registered fund who is not an "interested person" of the NYLI Funds or NYLI ETFs, as defined in Section 2(a)(19)(B) of the 1940 Act.**

------

**Index Rebalance** - a time period when a NYLI ETF or other accounts for which New York Life Investment Management LLC ("NYLIM") acts as advisor and/or sub-advisor receives its rebalance or reconstitution information with respect to an underlying index for which (i) NYLIM or (ii) an unaffiliated entity serves as the index provider.

**Index Personnel** – employees who maintain affiliated indexes and are responsible for rebalancing, validating and delivering index component securities and weightings of each affiliated index to the trading team.

**Local Compliance Officer ("LCO")** – CCO or designee of an applicable NYL Investments entity.

#### NYLI ETFs – each exchange traded fund series of the New York Life Investments ETF Trust and New York Life Investments Active ETF Trust.
**NYLI Funds** – each open-end fund and closed-end fund series of the New York Life Investments Funds.

**Non-Access Person –** employees that do not fall into the definition of Access Person.

**Private Placement** - an offering that is exempt from registration under the Securities Act of 1933 under Sections 4(a)(2) or 4(a)(6), or Rules 504, 505 or 506 thereunder.

**Reportable Fund** – an investment company, whether or not affiliated, advised or subadvised by the Company.

**Restricted List** – a listing of securities maintained by Compliance in which trading by Access Persons is generally prohibited.

**Registered Representative** - an Employee who is registered as such with a member firm of the Financial Industry Regulatory Authority ("FINRA").

**Supervised Person** – partners, officers, directors (or other persons occupying a similar status or performing similar functions) and employees, as well as any other persons who provide advice on behalf of an adviser and are subject to the adviser's supervision and control.

------

#### COMPLYSCI System availability

#### 9:00 a.m. to 4:00 p.m. Eastern Standard Time APPENDIX B

---

| |
|:---|
| **<u>Securities and Transaction Types Not Requiring Preclearance or Subject to a Holding Period and Requiring Disclosure</u>** |
| &nbsp;&nbsp;&nbsp;&nbsp;· Open-end mutual funds **(not including NYLI Funds which are subject to a 30-day hold)** |
| &nbsp;&nbsp;&nbsp;&nbsp;· Direct obligations of the U.S. government |
| &nbsp;&nbsp;&nbsp;&nbsp;· Direct obligations of the U.K. government |
| &nbsp;&nbsp;&nbsp;&nbsp;· Government-sponsored enterprises fixed income securities (e.g., FNMA, FHLMC) |
| &nbsp;&nbsp;&nbsp;&nbsp;· Variable Rate Demand Notes (VRDN's) and variable rate demand obligations (VRDO's) |
| &nbsp;&nbsp;&nbsp;&nbsp;· Money Market Funds **(does not require disclosure)** |
| &nbsp;&nbsp;&nbsp;&nbsp;· Bankers' acceptances, Bank CDs, commercial paper **(does not require disclosure)** |
| &nbsp;&nbsp;&nbsp;&nbsp;· Securities futures and options on direct obligations of the US government or Non-U.S. governments and associated derivatives |
| &nbsp;&nbsp;&nbsp;&nbsp;· Options, forwards, and futures on commodities and foreign exchange, and associated derivatives |
| &nbsp;&nbsp;&nbsp;&nbsp;· ETFs **(not including NYLI ETFs or single stock ETFs)** |
| &nbsp;&nbsp;&nbsp;&nbsp;· Unit Investment Trusts |
| &nbsp;&nbsp;&nbsp;&nbsp;· Options on ETFs not issued though NYLIM or that are not single stock ETFs |
| &nbsp;&nbsp;&nbsp;&nbsp;· Municipal Bonds (**except for employees of MacKay Shields**) |
| &nbsp;&nbsp;&nbsp;&nbsp;· Municipal auction rate securities ("ARS") with short-term coupon resets (e.g., 7 days) and closed-end municipal auction rate "Preferred" shares (**except for employees of MacKay Shields**) |
| &nbsp;&nbsp;&nbsp;&nbsp;· Transfers of cash or securities, including gifts of stock given or received |
| &nbsp;&nbsp;&nbsp;&nbsp;· Sales of previously approved private investments |

---

------

---

| |
|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;· Commodities, futures, currencies or precious metals (except for single stock futures and initial coin offerings. |
| &nbsp;&nbsp;&nbsp;&nbsp;· Transactions in approved discretionary managed accounts |
| &nbsp;&nbsp;&nbsp;&nbsp;· Crypto Index Funds and Single Asset products invested in cryptocurrencies, which are traded on a public exchange |
| &nbsp;&nbsp;&nbsp;&nbsp;· Automatic Investment Plans such as Dividend Reinvestment Plans, Employee Stock Purchase Plans or similar accounts |
| &nbsp;&nbsp;&nbsp;&nbsp;· Securities that are not "Covered Securities" |
| &nbsp;&nbsp;&nbsp;&nbsp;· Stock options issued by a corporation as part of a compensation package (e.g., board memberships) do not require pre-clearance. However, a subsequent sale of the stock obtained by means of the exercise must receive prior clearance |
| &nbsp;&nbsp;&nbsp;&nbsp;· High quality short-term debt instruments, including repurchase agreements |
| &nbsp;&nbsp;&nbsp;&nbsp;· Interests in qualified state college tuition programs (529 Plans) and 529 ABLE accounts **(does not require disclosure)** |
| &nbsp;&nbsp;&nbsp;&nbsp;· Cryptocurrencies or digital currencies, such as Bitcoin, Ethereum, Litecoin and Dogecoin, which are a virtual or digital representations of value. However, a virtual currency token offered in an initial or digital coin offering will be deemed a Covered Security for purposes of the Code and subject to preclearance requirements |
| &nbsp;&nbsp;&nbsp;&nbsp;· That are non-volitional in nature: e.g., stock splits, stock dividends, exchanges and conversions, mandatory tenders, pro rata distributions to all holders of a class of securities, gifts, inheritances, margin/maintenance calls (where the securities to be sold are not directed by the covered person), and sales pursuant to regulated tender offers |
| &nbsp;&nbsp;&nbsp;&nbsp;· Involving stock options issued by a corporation as part of a compensation package (e.g., board memberships) do not require pre-clearance. However, a subsequent sale of the stock obtained by means of the exercise must receive prior clearance |
| &nbsp;&nbsp;&nbsp;&nbsp;· Interval Funds |
| **<u>Accounts Not Requiring Disclosure</u>**  |
| &nbsp;&nbsp;&nbsp;&nbsp;· Non-NYL 401K accounts **(unless they hold NYLI Funds or ETFs, common stock or stock options)**. (However, if an Access Person's immediate family member has a NYL 401k account or has a 401k account which can hold the types of securities mentioned above, the Access Person must report the account.) |

---

------

---

| |
|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;· Annuities **(Unless they hold NYLI Funds)** |
| &nbsp;&nbsp;&nbsp;&nbsp;· Accounts that cannot hold or trade covered securities regardless of intent (i.e., commodities, currencies). If the account is a brokerage account regardless of intent, it must be disclosed. |
| &nbsp;&nbsp;&nbsp;&nbsp;· Banking or savings accounts |
| &nbsp;&nbsp;&nbsp;&nbsp;· Mutual fund accounts held directly with the fund family to hold and trade that family of mutual funds only (i.e., account held with American Funds to hold and trade American Funds only). |
| **<u>Preclearance and Reporting of Securities Transactions Required</u>** |
| &nbsp;&nbsp;&nbsp;&nbsp;· Corporate Bonds |
| &nbsp;&nbsp;&nbsp;&nbsp;· Stock (common and preferred) or other equity securities, including any security convertible into equity securities |
| &nbsp;&nbsp;&nbsp;&nbsp;· Closed-end funds (including Business Development Companies (BDCs)) |
| &nbsp;&nbsp;&nbsp;&nbsp;· NYLI ETFs and Single Stock ETFs |
| &nbsp;&nbsp;&nbsp;&nbsp;· Options on securities (but not their non-volitional exercise or expiration), excluding ETFs not requiring preclearance. Options on NYLI ETFs and Single Stock ETFs do require preclearance and are subject to the holding periods of the underlying instrument as mentioned below. Transactions in index options effected on a broad-based index do not require preclearance |
| &nbsp;&nbsp;&nbsp;&nbsp;· Warrants |
| &nbsp;&nbsp;&nbsp;&nbsp;· Rights |
| &nbsp;&nbsp;&nbsp;&nbsp;· Limited Offerings (e.g., private placements, hedge funds and/or alternative investments). (Access Persons are prohibited from investing in and/or holding limited offerings in Third-Party Discretionary Managed Accounts) |
| &nbsp;&nbsp;&nbsp;&nbsp;· Initial Public Offerings (IPOs)(Registered Representative are prohibited from investing in IPOs. Access Persons are prohibited from investing in and/or holding IPOs in Third-Party Discretionary Managed Accounts) |
| **<u>Prohibited Investments and Activities</u>** |
| &nbsp;&nbsp;&nbsp;&nbsp;· Initial public offerings (IPOs) by Registered Representatives |
| &nbsp;&nbsp;&nbsp;&nbsp;· Selling of naked call or naked puts |

---

------

---

| |
|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;· Options trading in covered securities by Investment Personnel. However, transactions by Access Persons (including Investment Personnel) in index options effected on a broad-based index, options on individual ETFs (excluding single-stock ETFs and NYLI ETFs) and options on commodities are permitted, and, these types of options do not require pre-clearance, nor are they subject to the 60-day holding period and short swing rule |
| &nbsp;&nbsp;&nbsp;&nbsp;· Good until Canceled or Stop Loss Orders |
| &nbsp;&nbsp;&nbsp;&nbsp;· Securities on the Restricted List |
| **<u>Security Holding Periods</u>** |
| &nbsp;&nbsp;&nbsp;&nbsp;· Covered securities (and Options on such securities) requiring preclearance - 60-calendar days (last in, first out) |
| &nbsp;&nbsp;&nbsp;&nbsp;· NYLI Funds - 30-calendar days (last in, first out) |
| &nbsp;&nbsp;&nbsp;&nbsp;· NYLI ETFs - 7-calendar days (last in, first out) |

---

------

## Ex-99.P

Epoch Investment Partners, Inc.

Code of Ethics and Business Conduct

OCTOBER 2024

------

*TD Epoch Code of Ethics and Business Conduct – October 2024* 

**<u>**Table of Contents**</u>** 

---

| | | | |
|:---|:---|:---|:---|
| ***[1. Statement of General Principles](#td_code37729_1_1_5)*** | **** | ***4*** | **** |
| ***[2. Definition of Terms Used](#td_code37729_2_1_5)*** | **** | ***5*** | **** |
| ***[3. Compliance with Laws, Rules and Regulations](#td_code37729_3_1_5)*** | **** | ***6*** | **** |
| &nbsp;&nbsp;&nbsp;&nbsp; ***[Retaliation Prohibited](#td_code37729_4_1_5)*** | **** | ***7*** | **** |
| ***[4. Compliance with Disclosure Controls and Dealing with External Auditors](#td_code37729_5_1_5)*** | **** | ***7*** | **** |
| ***[5. Conflicts of Interest](#td_code37729_6_1_5)*** | **** | ***8*** | **** |
| ***[6. Disclosure and Reporting of Conflicts of Interest](#td_code37729_7_1_5)*** | **** | ***9*** | **** |
| ***[7. Insider Trading](#td_code37729_8_1_5)*** | **** | ***10*** | **** |
| &nbsp;&nbsp;&nbsp;&nbsp; **[What is confidential information about TD Epoch?](#td_code37729_9_1_5)** | **** | ***10*** | **** |
| &nbsp;&nbsp;&nbsp;&nbsp; **[What is non-public information?](#td_code37729_10_1_5)** | **** | ***10*** | **** |
| &nbsp;&nbsp;&nbsp;&nbsp; **[What is material information?](#td_code37729_11_1_5)** | **** | ***11*** | **** |
| &nbsp;&nbsp;&nbsp;&nbsp; **[How might I receive information about TD Epoch that is non-public and confidential?](#td_code37729_12_1_5)** | **** | ***11*** | **** |
| &nbsp;&nbsp;&nbsp;&nbsp; **[How might I receive information that is non-public and material?](#td_code37729_13_1_5)** | **** | ***12*** | **** |
| &nbsp;&nbsp;&nbsp;&nbsp; **[How do I protect information that is non-public and confidential about TD Epoch?](#td_code37729_14_1_5)** | **** | ***12*** | **** |
| &nbsp;&nbsp;&nbsp;&nbsp; **[How do I protect information that is non-public and material?](#td_code37729_15_1_5)** | **** | ***12*** | **** |
| &nbsp;&nbsp;&nbsp;&nbsp; **[Usage of Expert Networks and Political Intelligence Firms for Research](#td_code37729_16_1_5)** | **** | ***13*** | **** |
| &nbsp;&nbsp;&nbsp;&nbsp; **[Discussions with Other Buy Side Investors](#td_code37729_17_1_5)** | **** | ***13*** | **** |
| ***[8. Corporate Opportunities](#td_code37729_18_1_5)*** | **** | ***14*** | **** |
| ***[9. Prohibition on Illegal Payments](#td_code37729_19_1_5)*** | **** | ***14*** | **** |
| ***[10. Competition and Fair Dealing](#td_code37729_20_1_5)*** | **** | ***14*** | **** |
| ***[11. Preferential Treatment and Gifts & Entertainment](#td_code37729_21_1_5)*** | **** | ***14*** | **** |
| ***[12. Corporate Books and Records](#td_code37729_22_1_5)*** | **** | ***15*** | **** |
| ***[13. Document Retention](#td_code37729_23_1_5)*** | **** | ***15*** | **** |
| ***[14. Non-Disclosure of Information](#td_code37729_24_1_5)*** | **** | ***16*** | **** |
| ***[15. Guarding of Corporate Assets](#td_code37729_25_1_5)*** | **** | ***16*** | **** |
| ***[16. Implementation of the Code](#td_code37729_26_1_5)*** | **** | ***16*** | **** |
| &nbsp;&nbsp;&nbsp;&nbsp; **[Code of Ethics Contact Person](#td_code37729_27_1_5)** | **** | ***16*** | **** |
| &nbsp;&nbsp;&nbsp;&nbsp; **[Reporting Violations](#td_code37729_28_1_5)** | **** | ***17*** | **** |
| &nbsp;&nbsp;&nbsp;&nbsp; **[Investigations of Violations](#td_code37729_29_1_5)** | **** | ***17*** | **** |
| &nbsp;&nbsp;&nbsp;&nbsp; **[Amendments to the Code](#td_code37729_30_1_5)** | **** | ***17*** | **** |
| ***[17. Enforcement](#td_code37729_31_1_5)*** | **** | ***17*** | **** |
| ***[18. Condition of Employment or Service](#td_code37729_32_1_5)*** | **** | ***17*** | **** |
|  ***[Exhibit A – Personal Trading Procedures](#td_code37729_33_1_5)*** | **** | ***19*** | **** |

---

------

*TD Epoch Code of Ethics and Business Conduct – October 2024* 

---

| | | | |
|:---|:---|:---|:---|
| ***[1. Requirements Applicable to Personal Trading Activity](#td_code37729_34_1_5)*** | **** | ***19*** | **** |
| &nbsp;&nbsp;&nbsp;&nbsp; **[Definitions of Terms Used](#td_code37729_35_1_5)** | **** | ***19*** | **** |
| &nbsp;&nbsp;&nbsp;&nbsp; **[Prohibited Activities and Transactions](#td_code37729_36_1_5)** | **** | ***21*** | **** |
| &nbsp;&nbsp;&nbsp;&nbsp; **[Same Direction Transactions](#td_code37729_37_1_5)** | **** | ***22*** | **** |
| &nbsp;&nbsp;&nbsp;&nbsp; **[Opposite Direction Transactions](#td_code37729_38_1_5)** | **** | ***22*** | **** |
| &nbsp;&nbsp;&nbsp;&nbsp; **[Holding Period](#td_code37729_39_1_5)** | **** | ***22*** | **** |
| &nbsp;&nbsp;&nbsp;&nbsp; **[Limitation on the Number of Pre-Clearance Requests](#td_code37729_40_1_5)** | **** | ***23*** | **** |
| &nbsp;&nbsp;&nbsp;&nbsp; **[Pre-Clearance of Reportable Securities Transactions in Employee-Related Accounts](#td_code37729_41_1_5)** | **** | ***23*** | **** |
| &nbsp;&nbsp;&nbsp;&nbsp; ***[Reporting Requirements Applicable to Employee-Related Accounts](#td_code37729_42_1_5)*** | **** | ***25*** | **** |
|  ***[Exhibit B - Initial Certification](#td_code37729_43_1_5)*** | **** | ***27*** | **** |

---

------

*TD Epoch Code of Ethics and Business Conduct – October 2024* 

**1.** **Statement of General Principles** 

This Code of Ethics and Business Conduct ("Code") applies to you, as an officer, director, or employee of Epoch Investment Partners, Inc.<sup>1</sup> ("TD Epoch", "Epoch" or the "Company"), as well as your Family Members (as defined below) and in appropriate circumstances, the Code may be provided and applied to TD Epoch's agents and representatives, including but not limited to, consultants and temporary employees who may periodically work onsite at TD Epoch's offices (collectively defined as "You" below). TD Epoch will evaluate such individuals on a case-by-case basis to determine if they should be considered access persons for purposes of this Code depending on their specific role and access to client information.

TD Epoch is committed to the principle of honest and ethical conduct in all aspects of its business. We both expect and require You to be familiar with this Code and to adhere to those principles and procedures set forth in the Code that apply to You. The Company's specific procedures contained in memoranda, policies, e-mail, or other guidance, which we may from time to time distribute to our officers, directors and employees, are separate requirements and are in addition to and not in derogation of this Code.

TD Epoch's business should be carried on with loyalty to the interest of its Clients (as defined below). In furtherance of the foregoing, You shall not:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Employ any device, scheme or artifice to defraud TD Epoch or a Client; or,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Engage in any act, practice or course of conduct that operates or would operate as a fraud or deceit upon TD
Epoch or a Client.

As a fiduciary, TD Epoch is committed to a high standard of business conduct which encompasses conducting business in accordance with both the spirit and letter of applicable laws and regulations as well as in accordance with ethical business practices. While this Code does not cover every issue that may arise, the Code sets out basic principles to guide You and is intended to provide a clear statement of the fundamental principles that govern TD Epoch's business to promote, among other things:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between
personal and professional relationships;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Mitigation of conflicts of interest, including disclosure to an appropriate person or persons identified in
the Code of any material transaction or relationship that reasonably could be expected to give rise to such a conflict;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Full, fair, accurate, timely, and understandable disclosure in reports and documents that TD Epoch files with
various regulatory authorities or prepares and distributes to various affiliates of The Toronto-Dominion Bank ("TD");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Compliance with applicable governmental laws, rules and regulations, not only of the United States, but also
of foreign jurisdictions in which we or any of our direct or indirect subsidiaries operate;

<sup>1</sup> This Code also applies to employees of Epoch Investment Partners UK, Ltd ("Epoch UK") as well as employees of TD Southeast Asia who support Epoch. Epoch UK employees must also adhere to the FCA Principles in the UK Supplement. The UK Supplement sets out certain UK specific policies and procedures which the employees of Epoch UK must observe to fulfill Epoch UK's own administrative requirements and to achieve compliance with the requirements of the Financial Services & Markets Act 2000 and the FCA Rules of the Financial Conduct Authority, by which Epoch UK is authorized and regulated. Unless otherwise directed, you must also comply with the policies and procedures contained within the Epoch Investment Partners Compliance Policies & Procedures Manual.

------

*TD Epoch Code of Ethics and Business Conduct – October 2024* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● The prompt reporting of Code violations to an appropriate person or persons identified in the Code; and,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Accountability for adherence to the Code.

Furthermore, to build a stronger company and maintain our culture of integrity - a culture of lawful and ethical conduct, we ask that You utilize the channels identified herein to ask questions or raise good faith concerns about observed or perceived violations of the Code. We are at our best when each of us helps identify and correct concerns in our workplace so that we may strengthen the business for all and enhance our reputation as an ethical and compliant company.

If an applicable law conflicts with a policy set forth in this Code, You must comply with the law; however, if a local custom or policy conflicts with this Code, You must comply with the Code. If You have any questions about these conflicts, You should ask your supervisor or the Code of Ethics Contact Person how to handle the situation.

If You violate the standards in this Code, You will be subject to disciplinary action. If You are in a situation that You believe may violate or lead to a violation of this Code, You should follow the guidelines described in Section 3 of this Code and notify your supervisor or the Code of Ethics Contact Person as soon as practical.

From time to time, the Company may waive some provisions of this Code. Any waiver of the Code for executive officers or directors of the Company requires the approval of the Chief Compliance Officer who may consult with the Directors (as defined below) or the Operating Committee (as defined below).

**2.** **Definition of Terms Used** 

"Business Associate" means any supplier of services or materials, Client, customer, consultant, professional advisor, lessor of space or goods, tenant, licensor, licensee or partner of TD Epoch.

"Client" means any entity which receives investment advisory services from TD Epoch for a fee.

"Code of Ethics Contact Person" means the Chief Compliance Officer or such person or persons as may be designated from time to time.

"Conflict Resolution Group" means the TD Epoch's President, Chief Compliance Officer and business line Chief Financial Officer.

"Directors" means the directors of Epoch Investment Partners, Inc.

"Family Members" means Immediate Family Members and any company, partnership, limited liability company, trust or other entity that is directly or indirectly controlled by You or by any Immediate Family Member.

"Immediate Family Member" includes the spouse (or life partner) and children of You and any relative (by blood or marriage) of You residing in the same household.

------

*TD Epoch Code of Ethics and Business Conduct – October 2024* 

"Investor" means an investor in a Private Fund or UCITS managed by TD Epoch.

"PTCC" means Compliance Science Personal Trading Control Center.

"Operating Committee" means the TD Epoch's Operating Committee which meets frequently and is responsible for implementing the Company's strategy, making operational decisions and overseeing the day-to-day running of the Company.

"You" means each director, officer, and employee of TD Epoch, temporary employees and consultants who reside in TD Epoch offices.

**3.** **Compliance with Laws, Rules and Regulations** 

Obeying the law, both in letter and in spirit, is the foundation on which TD Epoch's ethical standards are built. You must respect and obey the laws of the cities, states, and countries in which TD Epoch and its direct and indirect subsidiaries operate. It is our personal responsibility to adhere to the standards and restrictions imposed by those laws, rules and regulations. Although not all employees are expected to know the details of these laws, it is important that You know enough to determine when to seek advice from your supervisors or other appropriate personnel.

Where You reasonably believe that TD Epoch, or a director, officer or employee of TD Epoch, is not compliant with any law, regulation or section of this Code, we ask that You utilize our established channels identified herein to report such violations so that they may be properly addressed. As an initial matter, please bring the matter up directly with your immediate supervisor and the Code of Ethics Contact Person (or if the matter involves your supervisor, then directly with the Code of Ethics Contact Person), and if the matter is not ultimately resolved by either a reasonable explanation or action taken to rectify any non-compliance, we encourage You to bring the matter directly to the attention of the Operating Committee. With respect to financial matters in particular, and not just confined to those of our employees performing accounting functions, where You believe that TD Epoch has or is about to engage in any financial irregularity or impropriety, You are encouraged to bring the matter to the attention of the Operating Committee. This may be done anonymously and without fear of reprisal of any sort. Any complaint directed to the Operating Committee may be sent by mail as follows:

The Operating Committee

Attention: David A Barnett

Epoch Investment Partners, Inc.

One Vanderbilt Avenue

New York, New York 10017

In addition, TD Epoch officers or employees can also report violations to an independent third party, EthicsPoint:

EthicsPoint

<u>www.ethicspoint.com</u>

1-866-293-2365

------

*TD Epoch Code of Ethics and Business Conduct – October 2024* 

Nothing contained in this Code prohibits employees from exercising their legal rights to communicate with or report violations of law to government entities or regulatory authorities (e.g., the SEC). For avoidance of doubt, You do not need prior authorization from Your supervisor, the Operating Committee, the CCO, nor any other person or entity affiliated with TD Epoch to make any such reports or disclosures and do not need to notify TD Epoch that they have made such reports or disclosures. Additionally, nothing in this Manual prohibits You from recovering an award pursuant to a whistleblower program of a government agency or entity.

***Retaliation Prohibited***

TD Epoch will not tolerate retaliation of any kind (also known as victimization in some jurisdictions) because an employee in good faith raises a concern or reports a violation or suspected violation of our Code or of an TD Epoch policy or practice.

Retaliation is any conduct that would reasonably dissuade an employee from raising or reporting good faith concerns through our internal reporting channels or with any governmental body, or from participating in or cooperating with any investigation of such concerns. It includes conduct that would reasonably dissuade an employee from filing, testifying or participating in a legal proceeding relating to a violation of law, or from providing information to or otherwise assisting a government or law enforcement agency pursuing a violation of law.

If you feel You have been subjected to retaliation, we encourage you to immediately raise your concerns through the provided channels so that TD Epoch may promptly and properly address such concerns.

**4.** **Compliance with Disclosure Controls and Dealing with External Auditors** 

The honest and accurate recording and reporting of financial information is of critical importance to TD Epoch. This is not only essential for our officers and directors to make informed business decisions, but is essential to TD Epoch's ability to file accurate financial reports with regulatory bodies and TD and to enable TD Epoch to comply with various laws relating to the maintenance of books and records and financial reporting.

TD Epoch has implemented internal accounting controls that must be strictly adhered to by You as an officer, director or employee or any other person subject to the Code. You are prohibited from knowingly circumventing or failing to implement the internal accounting controls of TD Epoch as now existing or as may be modified, revised, amended or supplemented in the future. If You become aware of actual or suspected breaches or violations of TD Epoch's internal accounting controls or any fraudulent or questionable transactions or occurrences, whether actual or suspected, we ask that You immediately utilize our established channels to report such concerns to enable us to take proper corrective action. Potentially fraudulent or questionable transactions or occurrences include, without limitation, embezzlement, forgery, alteration of checks and other documents, theft, misappropriation or conversion of assets for personal use, falsification of

------

*TD Epoch Code of Ethics and Business Conduct – October 2024* 

records, and the reporting of the financial condition of TD Epoch contrary to generally accepted accounting principles.

TD Epoch has implemented a system of disclosure controls and procedures to assure that all important information regarding the business and prospects of Epoch is brought to the attention of TD Epoch's Chief Executive Officer. You are required to adhere to this system of disclosure controls and procedures, and You should promptly report any significant event or occurrence (whether positive or negative) that affects TD Epoch or its Business Associates to enable us to respond appropriately. General economic conditions need not be reported.

Open, honest and fair dealings with our external and internal auditors are essential to the financial reporting process. You are required to be candid in discussing matters concerning internal controls and business disclosures with TD Epoch's officers, directors, and external auditors. Factual information is important. Opinions and observations are strongly encouraged. You are prohibited from making any false or misleading statement to any external auditor of TD Epoch in connection with an audit or examination of TD Epoch's financial statements or the preparation or filing of any document or report. Similarly, You are prohibited from engaging in any conduct to fraudulently influence, coerce, manipulate or mislead any accountant engaged in the audit or review of any of TD Epoch's financial statements.

**5.** **Conflicts of Interest** 

Section 206(2) of the Advisers Act prohibits investment advisers from engaging in any transaction, practice, or course of business which operates as a fraud or deceit upon any client or prospective client whereas Section 206(4) of the Advisers Act prohibits investment advisers from engaging in any act, practice, or course of business which is fraudulent, deceptive, or manipulative. Rule 206(4)-8(a) under the Advisers Act effectively extends this prohibition so as to apply to pooled investment vehicle investors or prospective investors. A failure to identify, disclose and/or manage a conflict of interest could constitute a violation of any of these provisions.

TD Epoch's policy is to disclose, mitigate, and/or eliminate all identified conflicts of interest in the best interests of its Clients and Investors. In the event that a conflict of interest arises between Clients and/or Investors, TD Epoch's policy is to seek to resolve such conflict as fairly as possible in relation to all parties.

You must avoid any activity or personal interest that creates, or appears to create, a conflict between your interests and the interests of TD Epoch or a Client or Investor. A conflict of interest occurs when your private interest interferes or appears to interfere with the interests of the Company or a Client or Investor. For example, a conflict of interest would arise where You or a Family Member receives improper personal benefits as a result of your position in the Company. Conflicts of interest include, by way of example:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Soliciting or accepting gifts, entertainment, or other benefits from an organization that does, or seeks to
do, business with TD Epoch in violation of TD Epoch's policies;

------

*TD Epoch Code of Ethics and Business Conduct – October 2024* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Owning a meaningful financial interest in, being employed by or acting as a consultant to or board member of
an organization that competes with TD Epoch;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Owning a meaningful financial interest in, being employed by or acting as a consultant to or board member of
an organization that does, or seeks to do, business with TD Epoch;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Borrowing money from a Business Associate unless that Business Associate is regularly engaged in the business
of lending money or such other property, and the loan and the terms thereof are in the ordinary course of the Business Associate's business; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Making a material decision on a matter on behalf of TD Epoch or a Client where your financial, reputational,
or other self-interests may reasonably call the appropriateness of the decision into question.

**6.** **Disclosure and Reporting of Conflicts of Interest** 

TD Epoch requires You to fully disclose any potential or actual conflicts of interest as soon as it is known by speaking with the Code of Ethics Contact Person who may discuss and/or seek the approval of the conflict with the Conflict Resolution Group and the Operating Committee depending on the nature and severity of the conflict. Additionally, TD Epoch requires You to complete a Compliance Questionnaire upon joining the firm and at least annually thereafter. Many of the questions contained in the Compliance Questionnaire are intended to identify actual or potential conduct that could constitute a conflict of interest.

Neither You nor a Family Member shall personally benefit, directly or indirectly, or derive any other personal gain from any business transaction or activity of TD Epoch, except when the transaction or activity has been fully disclosed to and approved in writing by the Conflict Resolution Group. For the avoidance of doubt, the receipt of business gifts or entertainment pursuant to TD Epoch's Business Entertainment and Gift Policy does not require written Conflict Resolution Group approval.

Neither You nor a Family Member shall have any meaningful personal business or financial interest in any Business Associate or competitor of TD Epoch, without prior written consent from the Conflict Resolution Group. For the avoidance of doubt, holding 5% or less of the outstanding equity interests of a Business Associate or competitor whose equity interests are publicly traded shall not be deemed "meaningful."

Neither You nor a Family Member shall hold any position with (including as a member of the board of directors or other governing body) or perform services for a Business Associate or a competitor of TD Epoch, without prior written consent from the Conflict Resolution Group.

Neither You nor a Family Member shall provide any services to other business enterprises which reasonably could be deemed to adversely affect the proper performance of your work for TD Epoch or which might jeopardize the interests of TD Epoch or a Client, including serving as a director, officer, consultant or advisor of another business, without prior consent in writing by the Conflict Resolution Group. In addition, You must

------

*TD Epoch Code of Ethics and Business Conduct – October 2024* 

list all outside business interests on the new employee certification and on the annual Code of Ethics and Business Conduct acknowledgement and certification.

Neither You nor a Family Member shall direct, or seek to direct, any business of TD Epoch to any business enterprise in which you or a Family Member has a meaningful ownership position or serves in a leadership capacity, without prior written consent from the Conflict Resolution Group. For the avoidance of doubt, holding 5% or less of the outstanding equity interests of a Business Associate or competitor whose equity interests are publicly traded shall not be deemed "meaningful."

**7.** **Insider Trading** 

You are not permitted to use or share information that is both non-public and confidential about TD Epoch for trading purposes or for any other purpose except the conduct of TD Epoch's business. You are not permitted to use or share information that is both non-public and material about other public companies for trading purposes or for any purpose. To use such information for personal financial benefit or to "tip" others who might make an investment decision on the basis of this information is not only unethical but also illegal. You are strictly prohibited from using any illegal means, such as hacking, to obtain any non-public or material information. TD Epoch has separately prepared and distributed to You a copy of TD Epoch's Personal Trading Procedures relating to personal securities trades by You and Family Members, which is attached hereto as "<u>Exhibit A</u>."

***What is confidential information about TD Epoch?***

Confidential information regarding TD Epoch includes any information regarding TD Epoch's business activities, any information regarding TD Epoch's directors, officers and employees, and any information regarding TD Epoch's clients for which disclosure, by an individual authorized to make such disclosure, has not been previously made. By way of example, the following information is considered confidential:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Information You obtain concerning present or future securities transactions undertaken for TD Epoch's
clients;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Information You obtain relating to past, present, or future business activities of TD Epoch; or,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Information You obtain relating to a director's, officer's, or employee's medical, financial,
employment, legal or personal affairs.

For the avoidance of doubt, all information regarding TD Epoch's revenue, assets under management, fee structures, number and types of clients, and business plans is confidential unless such information has been previously disclosed by an individual authorized to make such disclosure.

***What is non-public information?***

Information is non-public until it has been made available to investors. The distribution of non-public information must occur through commonly recognized channels for the classification to change, such as through the inclusion in reports filed with the U.S. Securities and Exchange Commission, press releases issued by the issuer of the securities,

------

*TD Epoch Code of Ethics and Business Conduct – October 2024* 

or reference to such information in publications of general circulation such as The Wall Street Journal or The New York Times. In addition, there must be adequate time for the public to receive and digest the information. Non-public information does not change to public information solely by selective dissemination. The confirmation by an insider of unconfirmed rumors, even if the information in question was reported as rumors in a public form, may be non-public information. Examples of the ways in which You might receive non-public information or be transmitted include in person, in writing, by telephone, during a presentation, by email, IM, or Bloomberg messaging, by texting, through social media sites, by drone, through online black or grey markets, and artificial intelligence engines. You must be aware that even where there is no expectation of confidentiality, a person may become an insider upon receiving Material Nonpublic Information. You should consult with the CCO or designee if there is any question as to whether material information is non-public.

***What is material information?***

Information is material where there is a substantial likelihood that a reasonable investor could consider the information important in deciding whether to buy or sell the securities in question, or where the information, if disclosed, could be viewed by a reasonable investor as having significantly altered the total mix of information available. Where the nonpublic information relates to a possible or contingent event, materiality depends upon a balancing of both the probability that the event will occur and the anticipated magnitude of the event in light of the totality of the activities of the issuer involved.

Common examples of material information include information concerning a company's sales, earnings, dividends, significant acquisitions or mergers, business opportunities, discovery or research developments, bankruptcy or insolvency, debt service or liquidity problems, change in capital structure, major litigation or events that could lead to litigation, and criminal, civil and government investigations and indictments. So-called market information, such as information concerning an impending securities transaction may also, depending upon the circumstances, be material. Material information need not relate to a company's business. For example, information about the contents of an upcoming newspaper column may affect the price of a security, and therefore be considered material. Advance notice of forthcoming secondary market transactions could also be material. Additionally, material information pertaining to one issuer may affect the stock prices of other companies (such as competitors or major service providers). These examples are by no means exclusive. Because materiality determinations are often challenged with the benefit of hindsight, if You have any doubt whether certain information is material, such doubt should be resolved against trading or communicating such information.

***How might I receive information about TD Epoch that is non-public and confidential?***

You can expect to receive various forms of information about TD Epoch in the normal course of your role as a director, officer, or employee that is both non-public and confidential; however, You are prohibited from seeking to obtain such information if the information is not directly related to your duties or responsibilities. For example, if your duties or responsibilities do not require You to know about present or future securities

------

*TD Epoch Code of Ethics and Business Conduct – October 2024* 

transactions undertaken for TD Epoch's clients, You are prohibited from seeking to obtain such information.

***How might I receive information that is non-public and material?***

You may encounter information that is both non-public and material in variety of ways, including, without limitation:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● During discussions or interviews, either private or group, with a public company's management;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● During discussions or interviews with a public company's vendors, suppliers, or competitors;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● During discussions or interviews with members of the press;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● During discussions with credit analysts, traders, attorneys, accountants, consultants, research providers,
investment bankers or other professionals;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● By receiving information packages from issuers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● During discussions with certain sensitive Clients or Investors such as executive-level officers or directors
of a public company; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● By being a board member of a public company.

You are prohibited from soliciting or accepting information about a public company where You know, or should know, that such information is both non-public and material.

***How do I protect information that is non-public and confidential about TD Epoch?***

When not in use, You must keep all documents or files containing confidential information in locked desk drawers or file cabinets. Under no circumstances, should confidential information be left on desks, counter tops, or floors where the information is visible to others. You must not review or work on any documents that contain confidential information about TD Epoch in any setting that would permit others to see the information, such as in airplanes, public spaces, or even open areas in TD Epoch's offices.

***How do I protect information that is non-public and material?***

If You believe that You are in possession of non-public and material information, You are instructed to immediately contact the Code of Ethics Contact Person. You are prohibited from sharing this information with any other officer, director, or employee at TD Epoch unless You receive permission from the Code of Ethics Contact Person and follow the information barrier procedures implemented by the Code of Ethics Contact Person. For the avoidance of doubt, You are prohibited from sharing this information with anyone other than the Code of Ethics Contact Person until the Code of Ethics Contact Person implements information barrier procedures. In addition, the Code of Ethics Contact Person may add the company to the TD Epoch restricted list which is maintained by the Compliance Department.

For the avoidance of doubt, You are prohibited from trading the securities of any company about which You may possess Material Nonpublic Information, or derivatives related to the issuer in question. Additionally, You may not conduct research, trading, or other investment activities regarding a security for which You may have Material

------

*TD Epoch Code of Ethics and Business Conduct – October 2024* 

Nonpublic Information until the CCO or Code of Ethics Contact Person dictates an appropriate course of action.

When not in use, You must keep all documents or files containing non-public and material information in locked desk drawers or file cabinets. Under no circumstances, should such information be left on desks, counter tops, or floors where others can see the documents. You must not review or work on any documents that contain non-public and material information in any setting that would permit others to see the documents, such as in airplanes, public spaces, or even open areas in TD Epoch's offices.

***Usage of Expert Networks and Political Intelligence Firms for Research***

Prior to engaging with a new expert network/consultants or political intelligence firm, employees must request pre-approval from the CCO and CIO. Such relationships may only be approved after sufficient due diligence by the CCO including a review of the relevant company's policies prohibiting experts from disclosing material non-public information.

***Discussions with Other Buy Side Investors***

Employees may consider it beneficial to communicate with other investment advisers, buy side investors, and/or employees thereof ("Buy Side Investors"), either because they have knowledge of a specific investment, theme, or thesis, or because it is condition of participating in an idea dinner or idea sharing website. In connection with these interactions, an Employee may subsequently determine that it is in TD Epoch's (and our clients') interests to disclose certain information on TD Epoch's investments and research to the other Buy Side Investor.

While these interactions and disclosures are permissible, You should not disclose:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Information that could be considered MNPI or that TD Epoch has otherwise agreed with a third party to keep
confidential;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Specific information relating to TD Epoch's trading of securities, including the timing and/or sizing of
trades;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Information that could be detrimental to TD Epoch's (or the clients') business interests, such as
disclosure of information on a short position where there is limited capacity for borrow; or,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Information on TD Epoch's intentions for future proxy votes.

You are also subject to the following prohibitions when interacting with other Buy Side Investors:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● You may not provide proprietary models or other research without the prior approval of the CCO;

------

*TD Epoch Code of Ethics and Business Conduct – October 2024* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● You may not provide research obtained from a third-party research provider to any Buy Side Investor; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● You must not participate in/provide ideas via an idea dinner without the prior approval of the CCO.

If you have any questions about whether any information is permissible to be disclosed in an interaction with a Buy Side Investor, you should consult with the CCO.

**8.** **Corporate Opportunities** 

You owe a duty to the Company to advance the Company's business interests wherever possible. You and Family Members are prohibited from personally profiting, directly or indirectly, due to your position with TD Epoch, to the detriment (or at the expense) of TD Epoch or any Business Associate. You are prohibited from taking for yourself opportunities that are discovered through the use of Company property or information or through your position with TD Epoch, without the consent of TD Epoch's Code of Ethics Contact Person.

**9.** **Prohibition on Illegal Payments** 

You and your Family Members are prohibited from, directly or indirectly, making any illegal payment, offering to make any illegal payment, promising to make any illegal payment, or taking any other unlawful action with respect to any government official, including officials of foreign governments. By way of example, You are prohibited from paying, offering, or promising anything of value to a foreign official, foreign political party, foreign party official, or candidate for foreign office with the intent to influence any act or decision of a foreign official, to induce the official to do or omit to do any act in violation of the official's lawful duty, or to obtain any improper advantage.

**10.** **Competition and Fair Dealing** 

TD Epoch seeks to outperform competitors fairly and honestly through superior performance, and never through unethical or illegal business practices. Stealing proprietary information, possessing trade secret information that was obtained without the owner's consent, inducing such disclosures by past or present employees of other companies, or engaging in any unlawful competitive practices is prohibited. You should respect the rights of and deal fairly with TD Epoch's clients, suppliers, competitors, and employees. You are prohibited from taking unfair advantage of any person through manipulation, concealment, abuse of privileged information, misrepresentation of material facts, or any other intentional, unfair-dealing practice.

**11.** **Preferential Treatment and Gifts & Entertainment** 

The purpose of business entertainment and gifts in a commercial setting is to create goodwill and sound working relationships, not to gain unfair advantage. You shall not offer or provide a business gift or entertainment unless it (1) is not a cash gift or cash equivalent, (2) is consistent with customary business practices, (3) is not excessive in value, (4) cannot

------

*TD Epoch Code of Ethics and Business Conduct – October 2024* 

be construed as a bribe or payoff, and (5) does not violate any applicable laws or regulations. If You are uncertain whether a business gift or entertainment is inappropriate, You should seek guidance from your supervisor or the Code of Ethics Contact Person. Additional policies with respect to the giving and receipt of gifts are contained in TD Epoch's Compliance Policies and Procedures Manual.

**12.** **Corporate Books and Records** 

You must ensure that all of TD Epoch's documents that You are responsible for in the normal course of your duties are completed accurately, truthfully, in a timely manner and properly authorized.

All of TD Epoch's books, records, accounts, and financial statements must be maintained in reasonable detail, appropriately reflect the Company's transactions, conform to applicable legal requirements, must be recorded in compliance with all applicable laws and accounting practices and in accordance with the United States' generally accepted accounting principles designated by TD Epoch, and be accurately maintained in accordance with the Company's system of internal controls. The making of false or misleading entries, records or documentation is strictly prohibited.

Ensuring accurate and complete business and financial records is everyone's responsibility, not just the obligation of accounting and finance personnel. Accurate recordkeeping and reporting reflects on TD Epoch's reputation and credibility, and ensures that our Company satisfies its legal and regulatory obligations. Always record and classify transactions properly, never falsify any document, and never distort the true nature of any transaction or other company information. You may never create a false or misleading report under TD Epoch's name. In addition, no payments or established accounts shall be used for any purpose other than as described by their supporting documentation. Unrecorded or "off the books" funds or assets should not be maintained unless permitted by applicable law or regulation.

You may not take any action to defraud, influence, coerce, manipulate or mislead any other officer, director or employee of TD Epoch or any external auditor or legal counsel for TD Epoch for the purpose of rendering the books, records or financial statements of TD Epoch incorrect or misleading.

Errors, or possible errors or misstatements in TD Epoch's books and records should be brought to the attention of the Code of Ethics Contact Person promptly upon discovery thereof. The Code of Ethics Contact Person shall promptly inform the Chief Financial Officer of any such error or misstatement.

You are expected to cooperate fully with TD Epoch's internal auditors and external auditors. You shall not impede or interfere with the financial statement audit process.

**13.** **Document Retention** 

The Company seeks to comply fully with all laws and regulations relating to the retention and preservation of records. You shall comply fully with the Company's policies or procedures regarding the retention and preservation of records. Under no circumstances

------

*TD Epoch Code of Ethics and Business Conduct – October 2024* 

may Company records be destroyed selectively or maintained outside Company premises or designated storage facilities. Specific document retention policies are contained in the Compliance Policies and Procedures Manual.

Where there is actual or potential litigation or reasonable likelihood of an external investigation, TD Epoch may determine that it is necessary to preserve information relating to the matter, such as emails and other documents that might otherwise be deleted in the ordinary course of business. If You become aware of any actual or potential litigation, subpoena, or other legal proceeding involving TD Epoch, you should notify the Chief Compliance Officer immediately, so that the Company may determine what additional document preservation may be necessary. You are expected to comply with any document retention or preservation instructions that you receive from the Compliance Department.

**14.** **Non-Disclosure of Information** 

Neither You nor your Family Members shall discuss, or inform others about, any actual or contemplated business transaction by a Business Associate or the Company except in the performance of your employment duties or in an official capacity and then only for the benefit of the Business Associate or the Company, as appropriate. In no event should you discuss, or inform others about, any actual or contemplated business transaction by a Business Associate or the Company in violation of applicable law.

**15.** **Guarding of Corporate Assets** 

You have a duty to safeguard Company assets, including its physical premises and equipment, records, customer information and Company trademarks, trade secrets and other intellectual property. Company assets shall be used for Company business only. Without specific authorization, neither you nor a Family Member may take, loan, sell, damage or dispose of Company property or use, or allow others to use, Company property for any non-Company purposes.

**16.** **Implementation of the Code** 

While each of us is individually responsible for compliance with the Code, You do have access to a number of resources to assist You in understanding your legal and ethical obligations as an employee of the Company. The Company has the following resources, people and processes in place to answer questions and guide You through difficult decisions.

***Code of Ethics Contact Person***

The Chief Compliance Officer is the designated Code of Ethics Contact Person for purposes of this Code and shall report directly to the Chief Executive Officer all material matters arising under this Code. At his discretion, the Chief Executive Officer will report matters arising under this Code to the Directors, or to the Company's Operating Committee, as may be determined to be appropriate. The Code of Ethics Contact Person is responsible for overseeing, interpreting, and monitoring compliance with the Code. Any questions relating to how this Code should be interpreted or applied should be addressed

------

*TD Epoch Code of Ethics and Business Conduct – October 2024* 

to the Code of Ethics Contact Person. If You are unsure of whether a situation violates this Code, You should discuss the situation with your supervisor or the Code of Ethics Contact Person.

***Reporting Violations***

With regards to reporting violations, please see Section 3. Compliance with Laws, Rules and Regulations.

***Investigations of Violations***

Reported violations will be promptly and thoroughly investigated and, to the extent possible, treated confidentially. TD Epoch complies with the law in conducting investigations and TD Epoch expects that employees will cooperate with lawful investigations and provide truthful information to facilitate an effective investigation.

***Amendments to the Code***

The Code is updated and maintained on a regular basis. You are required to acknowledge and comply with the Code and all amendments. At a minimum, all employees are required to complete an annual certification through PTCC during TD Epoch's annual recertification period.

**17.** **Enforcement** 

You can expect that TD Epoch will take appropriate action with respect to any employee, officer, or director who violates, or whose Family Member violates, any provision of this Code. Any alleged violation of the Code shall be reported promptly to the CEO for his consideration and such action as the CEO in its sole judgment, shall deem warranted.

**18.** **Condition of Employment or Service<sup>2</sup>** 

Compliance with this Code is a condition of your employment. Employee conduct not in accordance with this Code shall constitute grounds for disciplinary action, including, without limitation, termination of employment.

This Code is <u>not</u> an employment contract nor is it intended to be an all-inclusive policy statement on the part of the Company. TD Epoch reserves the right to provide the final interpretation of the policies contained in this Code as well as the specific procedures contained in memorandums, policies, e-mail or other guidance, which we may from time to time distribute to You. TD Epoch reserves the right to revise these policies or procedures as deemed necessary or appropriate.

By signing below or completing the certification on PTCC, I acknowledge that I have read TD Epoch's Code of Ethics and Business Conduct (a copy of which has been

<sup>2</sup> Full time employees, or persons deemed access persons, are generally required to complete an initial certification of the Code in a substantially similar format online.

------

*TD Epoch Code of Ethics and Business Conduct – October 2024* 

supplied to me and which I will retain for future reference) and agree to comply in all respects with the terms and provisions hereof. I also acknowledge that this Code of Ethics and Business Conduct may be modified or supplemented from time to time and I agree to comply with those modifications and supplements as well.

---

| | |
|:---|:---|
| <br> Print Name | <br> Signature |
| <br> Date |  |

---

------

*TD Epoch Code of Ethics and Business Conduct – October 2024* 

**Exhibit A – Personal Trading Procedures** 

**1.** **Requirements Applicable to Personal Trading Activity** 

TD Epoch has adopted the following procedures concerning the pre-clearance and periodic reporting of transactions and accounts for all Access Persons (as defined below). TD Directors (as defined below), shall not be required to adhere to such pre-clearance or reporting requirements since TD Directors do not have access to non-public information regarding client purchases or sales, have no access to portfolio holdings and are not involved in securities recommendations to clients. The Chief Compliance Officer shall, on an annual basis, meet with the TD Directors in person and discuss and confirm that each of them will abide by these policies.

***Definitions of Terms Used***

"Access Persons" for purposes of personal trade reporting and pre-clearance includes all TD Epoch employees, including certain temporary employees and consultants who reside on TD Epoch premises.

"Approving Official" for a personal trade pre-clearance request is the Code of Ethics Contact Person, or in his or her absence the Compliance Officer or other personnel as may be appointed from time-to-time. At no time may an individual who may otherwise serve as an Approving Official also be the Approving Official for a pre-clearance request for their own personal trade or for the personal trade of their Family Members.

"Beneficial ownership" of a Security (as defined below) is to be determined in the same manner as it is for purposes of Section 16 of the Securities Exchange Act of 1934. This means that a person should generally consider themselves the beneficial owner of any securities in which he has a direct or indirect pecuniary interest. In addition, a person should consider themselves the beneficial owner of securities held by his or her spouse, his or her dependent children, a relative who shares his or her home, or other persons by reason of any contract, arrangement, understanding or relationship that provides them with sole or shared voting or investment power.

"Client Account" means any account which receives investment advisory services from TD Epoch for a fee.

"Code of Ethics Contact Person" shall mean the Chief Compliance Officer or such person or persons as may be from time to time designated.

"Employee-Related Account" is any personal account or any other account in which You or a Family Member has a direct or indirect pecuniary interest and over which You or a Family Member exercises any control or influence and can transact in Reportable Securities or Securities. For example, an "Employee-Related Account" includes any account of your Immediate Family Members, but excludes any such account over which neither You nor your Immediate Family Members exercises control or influence (i.e., an account over which some other third person or entity exercises exclusive discretionary authority). Employee-Related Accounts include but are not

------

*TD Epoch Code of Ethics and Business Conduct – October 2024* 

limited to brokerage accounts, Treasury Direct accounts, 401(k) plans, IRAs, or other retirement plans, among other accounts.

"Family Members" means Immediate Family Members and any company, partnership, limited liability company, trust or other entity that is directly or indirectly controlled by You or by any Immediate Family Member of You.

"Immediate Family Member" includes the spouse (or life partner) and children of You and any relative (by blood, marriage or adoption) of You residing in the same household as You. Immediate Family Members include children, stepchildren, grandchildren, parents, stepparents, grandparents, spouse, siblings, mother-in-law, father-in-law, sons-in-law, daughters-in-law, brothers-in-law, or sisters-in-law, and any such adoptive relationships.

"Investment Person" or "Investment Personnel" means all officers, directors or employees who occupy the position of portfolio manager (or who serve on an investment committee that carries out the portfolio management function) with respect to any Client Accounts and all officers, directors or employees who provide or supply information and/or advice to any portfolio manager (or committee), or who execute or help execute any portfolio managers (or committees) decisions, and all officers, directors or employees who, in connection with their regular functions, obtain contemporaneous or advance information regarding the purchase or sale of a Security by or for any Client Accounts.

"New Idea Research Monitor List" means the list of securities maintained by Investment Personnel that may lead to investments for Client Accounts.

"Operating Committee" means the Operating Committee of TD Epoch which meets periodically and is responsible for implementation of TD Epoch's business strategy.

"Private Placement" is also known as a "Limited Offering." An offering that is exempt from registration pursuant to sections 4(a)(2) or 4(6) of the Securities Act, or pursuant to Rules 504 or 506 of Regulation D. Private placements include interests in private funds (e.g., hedge funds, private equity funds, venture capital funds, real estate funds, etc.), interests in LLCs, including real estate for investment purposes, and interests in private companies, among other things.

"Purchase or sale of a Security" includes, among other things, the writing of an option to purchase or sell a Security.

"Reportable Security" shall have the same meaning as that set forth in Section 2(a)(36) of the 1940 Act, except that it shall not include securities issued by the Government of the United States or an agency thereof, bankers acceptances, bank certificates of deposit, commercial paper and high-quality short-term debt instruments, including repurchase agreements, shares issued by money market funds, registered, open-end mutual funds other than those open-end mutual funds advised by TD Epoch, and interests in 529 college savings plans. For the sole purpose of this policy, the term "Reportable Security" shall also include all exchange-traded funds ("ETFs"), exchange-traded notes, closed-end funds, and index or ETF derivatives. Common examples of

------

*TD Epoch Code of Ethics and Business Conduct – October 2024* 

"Reportable Securities" include equities, corporate bonds, municipal bonds, options, warrants, and Private Placements. Commodities are not Reportable Securities.

"Security<sup>3</sup>" is defined by the SEC broadly to include stocks, bonds, certificates of deposit, options, interests in Private Placements, futures contracts on other securities, participations in profit-sharing agreements, and interests in oil, gas, or other mineral royalties or leases, among other things. "Security" is also defined to include any instrument commonly known as a security.

A "Security held or to be acquired by a Client Account" means any Security which, within the most recent fifteen days: (i) is or has been held by a Client's Account; or (ii) is being or has been considered by TD Epoch for purchase within a Client's Account.

A Security is "being purchased or sold by a Client Account" from the time when a purchase or sale order has been communicated to the person who places the buy and sell orders for Client Accounts until the time when such order has been fully completed or terminated.

"TD Director" refers to those directors who are non-employee directors of TD Epoch.

"You" means all Access Persons.

***Prohibited Activities and Transactions***

You and your Family Members, with respect to a Security held or to be acquired by a Client Account and with respect to a Security being purchased or sold by a Client Account, are prohibited from:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Short selling securities issued by TD or other TD Restricted Securities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Entering into any contract or series of contracts that create a short sale of TD or other TD Restricted
Securities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Trading in put or call options or other derivatives on securities issued by TD or other TD Restricted
Securities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Trading in units or shares in TD mutual funds or pooled funds in any manner that is not consistent with the
best interests of other unit holders.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Certain Access Persons may from time to time be subject to blackout periods restricting the ability to
purchase or sell securities issued by TD or other TD Restricted Securities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Acquiring securities as part of an initial public offering by an issuer.

<sup>3</sup> "Security" may also include certain assets that are issued and transferred using distributed ledger or blockchain technology, including, but not limited to, virtual currencies, cryptocurrencies, digital "coins" or "tokens" ("Digital Assets"). A Digital Asset is likely to be considered a Security if it is offered and sold as an investment contract. On April 3, 2019, the SEC published a framework for investment contract analysis of Digital Assets: https://www.sec.gov/files/dlt-framework.pdf. Generally, virtual currency or cryptocurrency coins or tokens that are being offered, or previously were offered, as part of certain types of initial coin offerings ("ICOs"). For the avoidance of doubt, virtual currency or cryptocurrency coins or tokens that were created outside the context of an ICO are not to be considered Securities. Any questions about whether an instrument is a security for purposes of the Federal Securities Laws should be directed to the CCO or the Code of Ethics Contact Person.

------

*TD Epoch Code of Ethics and Business Conduct – October 2024* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Trading in securities that are on the TD Epoch restricted list or TD Epoch's New Idea Research Monitor
List without approval of the Code of Ethics Contact Person.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Trading in securities of market comparable or related companies to a company in which you are in possession of
MNPI of.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Employing any device, scheme or artifice to defraud a Client.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Making any untrue statement of a material fact or omitting to state a material fact necessary in order to make
the statements made, in light of the circumstances under which they are made, not misleading.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Engaging in any act, practice or course of business which would operate as a fraud or deceit upon a Client.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Engaging in any manipulative practice with respect to a Client.

***Same Direction Transactions***

Subject to the pre-clearance procedures below, neither you nor your Family Members may purchase or sell, directly or indirectly, any Reportable Security during the time<sup>4</sup> that the same (or a related) Reportable Security is being purchased or sold by a Client Account where You or your Family Member's trade is on the same side (purchase or sale) as the trade for the Client Account.

***Opposite Direction Transactions***

Subject to the pre-clearance procedures below, neither You nor your Family Members may purchase or sell, directly or indirectly, any Security within 7 calendar days after the time that the same (or a related) Security is being purchased or sold by a Client Account where your trade or your Family Member's trade is on the opposite side (purchase or sale) as the trade in the Client Account. The determination of whether a Client Account has transacted within 7 calendar days shall be made at the time the Access Person requests pre-clearance. In limited circumstances, where subsequent to execution of your or your Family Member's trade, TD Epoch receives an additional Client or new assets which would necessitate the purchase or sale of the same security such a personal trade will not be considered a violation of this prohibition. Furthermore, subject to the discretion of the Code of Ethics Contact person, certain de minimis transactions may be approved and not be considered a violation of this section of the Code. For purposes of this section de minimis is defined to include purchases or sales of up to 1,000 shares of a Security if the issuer has a market capitalization of over $1 billion.

***Holding Period***

Neither You nor your Family Member shall sell a Security or cover a short sale within 30 days of acquiring that Security or short sale, other than broad based ETFs or ETF derivative for which a 7 day holding period applies, except in the case of involuntary transactions, such as in connection with a reorganization or other extraordinary transactions requiring the surrender or exchange of securities, or upon the prior written consent of an Approving Official for good cause shown. You or your Family Member must adhere to the stated holding period irrespective of taxable lots.

<sup>4</sup> Applies to personal trades within a permitted daily trading window in securities where Epoch has active open orders.

------

*TD Epoch Code of Ethics and Business Conduct – October 2024* 

***Limitation on the Number of Pre-Clearance Requests***

You and your Family Members are limited to a maximum of fifteen (15) pre-clearance requests per quarter. Exceptions to this restriction will be considered in hardship situations and at the discretion of the Chief Compliance Officer.

***Pre-Clearance of Reportable Securities Transactions in Employee-Related Accounts***

Neither You nor your Family Member may place an order for the purchase or sale of any Reportable Security (including a Private Placement) for an Employee-Related Account until the transaction has been approved by an Approving Official in accordance with the following procedures.

When either You or your Family Member wishes to complete a transaction in an Employee-Related Account, You must submit electronically a pre-clearance request through PTCC between the hours of 10:00 a.m. and 3:30 p.m. EST. Your pre-clearance request will be routed electronically to the TD Epoch trading desk who will review the electronic request and determine whether TD Epoch is active in the Security in which you have requested approval. Once approved by the trading desk, the pre-clearance request will be sent electronically to the Code of Ethics Contact Person and other designated Approving Officials. Approval or denial of that request is then made by the Code of Ethics Contact person or in their absence an Approving Official. Once the Code of Ethics Contact person or an Approving Official has approved or denied the trade request, You will receive electronic notification from PTCC. In limited circumstances, an Approving Official or a designee may waive the requirement that a Pre-Clearance Request Form be electronically submitted on or before the date of the proposed transaction, provided that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● You communicate orally or via e-mail the required information and make
the required representations to the Approving Official or a designee on or before the date of the proposed transactions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● The Approving Official or a designee makes a written record of the same; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● You submit a pre-clearance request through PTCC by the end of the same
trading day as your verbal or email pre-clearance request.

By submitting an electronic pre-clearance request through PTCC, You represent that to the best of your knowledge and belief, and after due inquiry, neither You nor your Family Member is in possession of any material, nonpublic information concerning the Security proposed to be bought or sold, and the proposed transaction is not otherwise prohibited by the Code or these procedures.

An Approving Official will base their decision to approve or disapprove a Pre-Clearance Request on the following factors:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● The general policies set forth in the Code and these procedures;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● The requirements under federal and state laws, rules, and regulations as they may apply to the proposed
transaction;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● The timing of the proposed transaction in relation to transactions or contemplated transactions for any Client
Accounts; and

------

*TD Epoch Code of Ethics and Business Conduct – October 2024* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● The nature of the securities and the parties involved in the proposed transaction.

Any approval of a proposed transaction is effective for the proposed transaction date only and is subject to the conditions, if any, specified by the Approving Official. A breach of any of the above procedures may, depending upon the circumstances, subject you to sanctions, up to and including termination of employment.

Investment Personnel, before acting on personal investment opportunities, must share all personal trading ideas with the Portfolio Manager, in each respective strategy, so the Portfolio Manager can determine whether the investment opportunity may be appropriate for Client accounts. The Compliance Department monitors all employees' trading and provides periodic reports to all Portfolio Managers regarding the volume and nature of Investment Personnel transactions.

For the avoidance of confusion, the pre-clearance requirements shall not apply to the following transactions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Purchases and sales of any Security by TD Directors<sup>5</sup>;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Purchases and sales of shares of open-end mutual funds not managed by
TD Epoch;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Purchases that are part of an automatic purchase plan, such as an automatic dividend reinvestment plan or a
plan to purchase a fixed number of shares or face value per month (e.g. purchases of an TD Epoch sub-advised mutual fund as part of an on-going payroll contribution
(401(k) Plan) do not require pre- mutual fund in the 401(k) plan requires pre-clearance as does any rebalancing You make which results in the purchase or sale of shares
of an TD Epoch sub-advised fund within the 401(k) plan);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Purchases and sales of fixed income securities issued, guaranteed or sponsored by a government member of the
Organization of Economic Co-Operation and Development ("OECD'');

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Purchases and sales that are involuntary (e.g., stock splits, tender offers, and share buy-backs);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Acquisitions of securities through inheritance;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Purchases and sales in any account over which neither You nor your Family Member has direct or indirect
influence or control over the investment or trading of the account (e.g., an account managed on a discretionary basis by an outside portfolio manager, including a "Blind Trust"). Such accounts must be brought to the attention of the CCO.
You may be asked to provide documentation to determine whether the account is eligible for the exception and the Employee may be required to provide account statements on a periodic basis to identify transactions that may be inconsistent with the
provisions of this Code.; and,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Purchases and sales of certain broad-based ETFs described in PTCC, as amended from time-to-time.

Furthermore, subject to the discretion of the Code of Ethics Contact person, a supplementary review of Investment Personnel transactions may be conducted.

<sup>5</sup> "TD Director" refers to those directors who are non-employee directors of Epoch

------

*TD Epoch Code of Ethics and Business Conduct – October 2024* 

***Reporting Requirements Applicable to Employee-Related Accounts***

Neither You nor your Family Members are permitted to maintain Employee-Related Accounts, at a domestic or foreign broker-dealer, investment adviser, bank, or other financial institution without the approval of the Code of Ethics Contact Person. All Employee-Related Accounts must be maintained at broker-dealers or financial institutions that provide TD Epoch with duplicate copies of all confirmations and periodic statements for such accounts. In addition, many broker-dealers supply account information in real time to the Code of Ethics Contact Person. Within 10 days of beginning your employment with TD Epoch, you must log into the PTCC system and disclose all Employee-Related Accounts and the Reportable Securities held in those accounts. The information must be no more than 45 days old prior to becoming a director, officer, or employee of TD Epoch. Initial reports must disclose the existence of all accounts that hold any Securities, even if none of those Securities fall within the definition of a "Reportable Security."

In addition to electronic feeds with PTCC, you are required to send to the broker-dealer or financial institution carrying each Employee-Related Account a letter authorizing and requesting that it forward duplicate confirmations of all trades and duplicate periodic statements, as well as any other information or documents as an Approving Official may request, directly to TD Epoch. A form letter drafted for this purpose may be obtained from the Code of Ethics Contact Person.

You are required to obtain pre-approval, through PTCC when You or a Family Member wish to open a new Employee-Related Account.

You shall certify your securities transactions and your Family Member's Reportable Securities transactions during each quarter within ten (10) days of quarter-end and Reportable Security holdings and Employee-Related Accounts as of December 31st of each year within ten (10) days of year-end via PTCC. With respect to an employee's TD Epoch 401(k) plan account, employees are not required to report transactions in their quarterly transaction certification or update holdings in their TD Epoch 401(k) annually. TD Epoch maintains the 401(k) accounts in PTCC on behalf of all employees. Additionally, employees are not required to submit quarterly reports for any transactions effected pursuant to an Automatic Investment Plan or any reports with respect to Securities held in accounts over which the employee had no direct or indirect influence or control, such as an account managed by an investment adviser on a discretionary basis. Any investment plans or accounts that may be eligible for either of these exceptions should be brought to the attention of the Code of Ethics Contact Person who will, on a case-by-case basis, determine whether the plan or account qualifies for an exception.

All new employees receive a username and password in order to access PTCC and are required to enter all accounts and securities in the system, including 401(k) or other retirement accounts from prior employers within 10 days of the commencement of their employment.

Access to information submitted pursuant to these procedures will be restricted to those persons who are assigned by TD Epoch to perform the review functions, and all such materials will be kept confidential, subject to the rights of inspection by the Board of

------

*TD Epoch Code of Ethics and Business Conduct – October 2024* 

Directors of TD Epoch, TD Epoch's Operating Committee or their designee, and governmental bodies authorized by law to obtain such access.

TD Epoch's *Personal Trading Procedures* are designed to mitigate any potential material conflicts of interest associated with Employees personal trading activities. Accordingly, the Code of Ethics Contact Person will closely monitor Employees' investment patterns to detect potentially abusive behavior.

------

*TD Epoch Code of Ethics and Business Conduct – October 2024* 

**Exhibit B - Initial Certification<sup>6</sup>** 

I certify that:

● I have read and understand the Epoch Investment Partners, Inc. ("TD Epoch") Personal Trading
Procedures, as outlined in the Code of Ethics and Business Conduct, and recognize that I am subject to its requirements.

● I have disclosed or reported all personal Reportable Securities holdings information on Compliance Science
Personal Trading Control Center in which I or a Family Member has a Beneficial Interest, including all Employee-Related Accounts as defined in the Personal Trading Procedures, as of the date I became a director, officer, or employee of TD Epoch. I
have also reported the name(s) of each person or institution managing any account (or portion thereof) for which I or my Immediate Family Members have no direct or indirect influence or control over the investment or trading of the account.

● I understand that TD Epoch will monitor securities transactions and holdings in order to ensure compliance
with the Code and the Personal Trading Procedures. I also understand that personal trading information will be made available to any regulatory or self-regulatory organization to the extent required by applicable law or regulation.

● For the purpose of monitoring securities transactions and holdings information under the TD Epoch Personal
Trading Procedures, I confirm that I will instruct all financial institutions to provide copies of trade confirmation and periodic statements, subject to these procedures. This covers my current Employee-Related Accounts and accounts that will be
opened in the future during my employment with TD Epoch.

● I understand that any circumvention or violation of the TD Epoch Personal Trading Procedures will lead to
disciplinary and/or legal actions, including up to and including termination of employment.

● I understand that I have to pre-clear any additions and report
deletions or changes with respect to my Employee-Related Accounts.

---

| | |
|:---|:---|
| <br> Print Name | <br> Signature |
| <br> Date |  |

---

<sup>6</sup> Full time employees are generally required to complete an initial certification of the Code in a substantially similar format online..

## Ex-99.P

![LOGO](img_52a01f436f044f6.jpg)

October 2024 CANDRIAMO A NEW YORK LIFE INVESTMENTS COMPANY Code of Ethics Candriam

------

![LOGO](img_0a855dfab92e4f6.jpg)

Code of Ethics Status: FINAL Document Type: Policy Version: V 3 Issuing Date: 07/06/2015 General Information Process Owner: Compl Responsible (Policy owner) Business Unit Contact / Backup Department Head of Conduct & Compliance Advisory Compliance Other Contributor(s) Department(s) Senior Compliance Officer [Complince \| Data classification Criticality level Confidential Medium Approval Authorities Responsible Date of last approval Board of Management 21/10/2024 Versions Version Revision Date A r Changes 1 11/03/2021 Compliance \| Update of the Policy 2 31/08/2023 Conduct & - Reformat: SupermanCo Compliance Advisory - Update of the Policy with: e Precisions towards the countries included for sovereign bond (Points 4 & 5, appendixes). e Obligation of certification after a period of absence (point 8) 3 16/09/2024 Conduct & 1.1.: The word Delegate is defined to avoid any Compliance misunderstanding. Advisory 6.2.: The transaction reporting process is shifting from a posttrade approval model, where transactions are submitted for validation one day after execution, to a pre-trade approval model, which requires prior validation before any transaction is carried out. Table of contents. October 2024 —Only forintemal use -2- .

------

![LOGO](img_61ba77628f804f6.jpg)

1. Introduction to the Code of Ethics 5 1.1. Definitions 5 1.2. Purpose 8 1.3. Scope 8 1.4. Policy owner and review of the Policy 8 1.5. General requirements, principles, and applicable regulatory framework 9 1.5.1. Fiduciary principles 10 1.5.2. Compliance with Law 11 1.5.3. Additional Prohibitions 11 1.5.4. Acknowledgement of receipt and Certification 11 1.6. Related policies and procedures 11 2. Roles and Responsibilities 12 2.1. The Board of Directors 12 2.2. The Board of Management 12 2.3. The Compliance Department 12 2.4. All employees 12 3. Prohibition on insider dealing and market manipulation 13 4. Authorized personal account transactions for non -covered persons 14 5. Authorized personal account transactions. for covered persons 14 6. General requirements regarding personal transactions-All staff members 15 6.1. Initial Holdings disclosure 15 6.2. Declaration of transactions 15 6.3. Holdings period requirement 16 6.4. Initial Public Offering and Limited Private Ofering (Private Placement) 16 6.5. Annual security account statement 16 6.6. Annual Certification 16 6.7. Restricted Security List 16 7. Additional requirements regarding personal transactions-covered persons 17 7.1. Quarterly Certification 17 7.2. Confirmation of personal transactions 17 8. Exceptions from reporting requirements 17 9. US Registered representatives 18 10. The Board of Directors 18 11. Miscellaneous 18 11. 1. Chief Legal & Compliance Officer 18 11.2. Review Procedures 18 11.3. lnterpretation 19 11.4. Reporting of Violations 19 11.5. Sanctions 19

------

![LOGO](img_b57998a6ad004f6.jpg)

11.6. Records 19 11.7. Confidentiality 19 11.8. Investment Clubs 20 12. U.S. Employee b enefit plans and Erisa 20 13. Data protection 20 14. Concluding provisions 20 15. Exhibit s 20 15.1. Exhibit 1- Covered accounts 20 15.2. Exhibit 2A- Covered persons only and their Relatives 22 15.3. Exhibit 28- Candriam Staff Members excluding Covered Persons 23 15.4. Exhibit 3- Covered Account over which the Covered Person has no direct or indirect influence or control ("Covered account managed by a Delegate without inter vention") 24

------

![LOGO](img_b7033bd425954f6.jpg)

1. Introduction to the Code of Ethics This Code of Ethics ("COE"), as amended from time to time, applies to all employees (includi? trainees, VIE and any person working under an open-ended or fixed-term employment contract with Candriam), officers, senior management, and directors (hereafter, the "Staff Members") of Candriam Luxembourg including its subsidiaries and branches (hereafter collectively referred to as "Candriam"). Employees personal securities transactions may raise potential conflicts of interest or be used to carry out market abuses and are therefore subject to special conditions. The following restrictions on transactions and actions to be taken are designed to provide a credible safeguard against abuses of trust and thus protect both Candriam and its Staff Members. Adherence to this Code is a fundamental and absolute condition of service with Candriam. Candriam will provide a copy of this Code and inform employees of any subsequent amendments promptly after its effective date. New employees are informed and trained about their obligations related to the COE shortly after joining the Company. Copies of this Code are always available on the Intranet forail Staff Members. Violations of the COE may result in the imposition of sanctions on employees, including suspension ordismissal from Candriam's employment. This Code shall be read in conjunction with the Code of Conduct, the Conflict-of-Interest Policy and the Market Abuse Policy. 1.1. Definitions Term Description Candriam, societe en commandite par actions, its branches and subsidiaries Candriam (hereafter collectively referred to as "Candriam") The Board of Directors shall mean the body who, under company law, monitors the management by the Senior Management. The Board of Directors shall have Board of the overall responsibility for the institution. It shall ensure execution of activities Directors and preserve business continuity by way of sound central administration and internal governance arrangements. Please refer to CSSF Circular 18/698 for further information. Board of Management shall be intended as the "Senior Management". Senior Management means the persons who effectively conduct the business of the IFM Board of within the meaning of Article 102(1)(c) of the 2010 Law and Article 7(1)(c) of the Management 2013 Law (hereinafter the "conducting officers") irrespective of the form or legal structure of the IFM. Please refer to CSSF Circular 18/698 for further information. The Luxembourg regulator of the financial sector(Commission de Surveillance du CSSF Secteur Financier) "Policy" shall include a system of detailed key measures/principles/guidelines to be implemented to achieve the strategy of the Company with regards to specific topics: Set of general guidelines that outline the organization's plan for tackling an Policy issue. Communication of the connection between the organization's vision and values and its day-to-day operations. Guidance for the day-to-day actions and strategies but allowing flexibility . Formal statement of a principle that should be followed by its intended audience. The Business Unit is either a department or a team within Candriam that represents a specific line of business, and it is part of the value chain of activities Business Unit of the company. A Business Unit often develops and implements its own processes independently Candriam employees, employees of Candriam group companies insourced by Employee Candriam and any temporary employees

------

![LOGO](img_7e8ac388a6654f6.jpg)

A program in which regular periodic purchases (or withdrawals) are made Automatic automatically in (or from) investment accounts in accordance with a predetermined investment plan schedule and allocation. An automatic investment plan includes a dividend reinvestment plan. It refers to exchange traded funds on commodities or that hold at least 30 underlying securities for which Candriam or its affiliates (including New York Life Candriam ETF entities) act as Management Company or investment adviser, Investment manager or placement agent. It refers to open-ended funds (UCITS, AIF, OIECs, U.S. registered investment companies and similar funds offered to the public), whether or not organized in the Candriam EU forwhich Candriam and its affiliates (including New York Life entities) act as Funds Management Company or investment adviser, investment delegate, Investment manager or placement agent COE It refers to the Code of Ethics Covered It refers to the type of accounts that have to be disclosed by Staff Members as Account defined under Exhibit 1 It refers to Staff Members subject to Candriam's supervision and who either. a) have access to non-public information regarding: - any purchase or sale of securities on behalf of a portfolio (including separately managed account, investment funds) advised or sub-advised by Candriam or - the holdings of any portfolio (including separately managed account, investment funds) which Candriam serves as an adviser or sub-adviser or any such investment company whose adviser or principal underwriter controls, is controlled by, or is under common control with Candriam; and/or b) are involved in making securities recommendations to clients and/or portfolio Covered Person (including separately managed account, investment funds), or who have access to such recommendations that are non-public. Covered persons also include: - persons discharging managerial responsibilities at Candriam, as well as persons closely associated with them (''!Relatives"). - portfoliomanagers and research staff, aswell as persons closely associated with them ('Relatives"). A group two or more people, each of whom contributes monies to an investment Investment Club pool and participates in the investment making decision process and shares in the investment returns. Transactions in any investments effected by: (a) the staff member for her/his own account (independently whether the transactions undertaken on such account by staff member himself are for her/his direct or indirect benefit or that of another person) or (b) the staff member for any other person who has given to the staff member, in her/is personal capacity, permission or authority to transact on their behalf. In summary to the above, transactions conducted by third parties are also deemed Personal personal transactions if a staff member has a beneficial interest in whole or in part transactions or makes investment decisions. Within the scope of this Code, the term "personal transactions" and "personal account dealing" have a broad interpretation. Besides securities in the usual sense, it also includes all transactions in respect of derivative instruments. This Code therefore applies to all types of transaction, not just those conducted, for example, on the stock exchang1e. The Code does not concern cryptocurrencies or digital currencies, such as Bitcoin or Ether, which are a virtual or digital representations of value. Non-Candriam It refers to exchange traded funds on commodities or that hold at least 30 ETF underlying securities for which Candriam, or its affiliates (including New York Life

------

![LOGO](img_00ffd4d026034f6.jpg)

entities) do not act as Management Company or investment adviser, Investment manager or placement agent It refers to open-ended funds (UCITS, AIF, OIECs, U.S. registered investment companies and similar funds offered to the public), whether or not organized in the Non-Candriam EU for which Candriam or its affiliates (including New York Life entities) do not act Funds as Management Company or investment adviser, investment delegate, Investment manager or placement agent Relatives It refers to Covered Person's spouse, children or relatives who reside in the same household. Refers to an individual or entity that has been authorized or assigned the Delegate responsibility to make investment decisions on behalf of another party, such as an investor, a board, or a company.

------

![LOGO](img_8c0638a868264f6.jpg)

1.2. Purpose Code of Ethics hereafter (the "Policy" or "COE") describes the framework established by Candriam in order to set out the principles and rules applicable to potential conflicts of interest. This COE is designed to ensure, among other things, that the personal securities transactions of Candriam's Staff Members are conducted in accordance with the following principles, and all other applicable policies and procedures (including Candriam's ERISA Plan Compliance Policy): (i) a duty at all times to place the best interests of Candriam's clients first and foremost . (ii) the requirement that all personal securities transactions be conducted in such a manner as to avoid any actual, potential or appearance of a conflict of interest or any abuse of a person's position of trust and responsibility. (iii) the requirement that Candriam Staff Members should not take inappropriate advantage of their positions with Candriam. 1.3. Scope The Policy applies to all Candriam employees, including any external contractor as the case may be. Each employee must ensure he/she understands his/her personal role and responsibilities resulting from the Policy. The Policy applies as well to any Candriam branch or subsidiary, when applicable, and its respective employees. 1.4. Policy owner and review of the Policy The Global Head of Compliance of Candriam is formally appointed as the owner of this Policy. Any amendments thereof must be duly approved by the Board of Management and the Board of Directors of Candriam. If you have any queries or comments regarding the information contained in this document, please contact the Policy Owner. As this Policy has been identified as a Medium as per the criteria defined in the Policy of Policies, Charters & Procedures, at the minimum, the Policy is reviewed/updated every two years- particularly in the case of any changes to applicable standards/regulatory rules. In accordance with Section 5.5.4 "Manual of procedures" of CSSF Circular 18/698, the Policy's description of the internal functioning, allocation of tasks and reporting lines are part of the procedures manual for employees of Candriam. For the implementation of the Policy, Candriam has put in place intemal rules in the Procedure Manual that must be used as guidelines by employeesfromdifferentfunctions and business units in the exercise of their day-to-day tasks.

------

![LOGO](img_96ca81b029ea4f6.jpg)

1.5. General requirements, principles, and applicable regulatory framework Candriam is subject to the ucns Law, the AIFM Law, as well as all relevant applicable laws, regulationand circulars enacted by the CSSF. This Policy was drafted and implemented to comply with applicable laws, regulations, and internalreferences: Issuer Reference Type I Description CSSF 18/698 Circular Authorisation and organisation of investment fund managers incorporated under Luxembourg law Compliance Code of Internal Set of principles, standards and moral & ethical Department Conduct Code expectations the Company's employees must adhere to Luxembourg Law of 23 Law Implements EU regulations on market abuse and December 2016 insider trading to ensure transparency and integrity in on market abuse financial markets. implementing Regulation (EU) No 596/2014 Luxembourg Law of 17 Law Governs undertakings for collective investment in December 2010 transferable securities (UCITS), implementing the (the "UCITS related EU Directive for fund management. Law") Luxembourg Law of 12 July Law Regulates alternative investment fund managers in 2013 on Luxembourg, aligning with the EU AIFM Directive to Alternative improve oversight and transparency in alternative Investment Fund investment funds. Managers (the "AIFM Law''). Luxembourg CSSF CSSF Transposes EU directives on organizational Regulation 10-4 Regulation requirements and risk management procedures for transposing UCITS management companies in Luxembourg. commission directive 2010/43/EU Belgium Law of 19 April Law Regulates alternative collective investment 2014 relating to undertakings and their managers, setting rules for alternative investment, governance, and transparency. collective investment undertakings and their managers: Article 26. Belgium Law of August 3, Law Governs collective investment undertakings, ensuring 2012, relating to compliance with the EU's UCilS Directive and undertakings for addressing debt investment undertakings. collective investment that meet the conditions of Directive 2009/65/EC

------

![LOGO](img_012237b6d6484f6.jpg)

Belgium Royal Decree of Royal Regulates the management companies of collective 12 November Decree investment undertakings in Belgium, ensuring 2012 relating to compliance with EU UCITS rules. management companies of undertakings for collective investment which comply with the conditions of Directive 2009/65/EC: Article 27. Belgium Law of 25 Law Governs access to the provision of investment October 2016 on services, including the status, regulation, and access to the oversight of portfolio management and investment activity of advisory firms. providing investment services: Article 25, §3. France Article L533-10 Code Governs rules for financial services, particularly of the Monetary concerning conflicts of interest, investor protection, and Financial and organizational requirements. Code. France Articles 321-42 AMF Outlines rules on the internal organization, conflict of to 45 of the AMF General interest management, and ethical requirements for General Regulation investment firms regulated by the French Financial Regulation. Markets Authority (AMF). France Article 63 of Delegated Provides additional rules for alternative investment Commission Regulation fund managers, focusing on transparency, risk Delegated management, and operational practices for AIFMs Regulation (EU) operating in France. No 231/2013 1.5.1. Fiduciary principles Candriam is subject to fiduciary requirements under the laws of jurisdictions in which it offers and provides services to clients. It is Candriam's policy that Staff Members subject to these requirements must conduct their personal account dealings in securities so as to avoid not only actual conflicts of interest with Candriam's clients, but also that they refrain from conduct which could give rise to the appearance of a conflict of interest that may compromise the trust our clients have placed in us. These Fiduciary principles are included in the applicable European and local laws of European Union members such as UCITS, MiFID and AIFM Directives. In addition, the Fiduciary Principles are defined in the US Investment Advisers Act of 1940. As a result, Candriam owes an undivided duty of loyalty to its clients, and Candriam expects its Staff Members to adhere to this duty. Additional requirements apply where Candriam is a fiduciary for separately managed accounts for U.S. employee benefit plan clients subject to the Employee Retirement Income Security Act of 1974, as amended ("ERISA" and "ERISA plan clients"). ERISA contains strict regulatory requirements including a fiduciary duty of prudence, which requires that a fiduciary demonstrate and document the procedural prudence of its decision making. ERISA also imposes a duty of loyalty, which requires that fiduciaries act for the exclusive benefit of the ERISA plan client's participants and beneficiaries.

------

![LOGO](img_4f66296f0a834f6.jpg)

This Code should be read together with Candriam's general ERISA Plan Compliance Policy. Candriam expects its Staff Members to adhere to these duties and the other duties imposed by ERISA 1.5.2. Compliance with Law Candriam strictly complies with the laws applicable to its business in the jurisdictions in which it offers or provides services to clients. Staff Members are required to do so as well to the extent any such laws are applicable. If a Staff Member is unsure of what laws are applicable, they can contact their Compliance function for clarification. 1.5.3. Additional Prohibitions In addition to the specific prohibitions on certain personal securities transactions as set forth herein, all Candriam Staff Members are prohibited from: (i) employing any device, scheme, or artifice to defraud any client or prospective client (including, with respect to Candriam's ERISA plan clients, acting for the exclusive benefit of the ERISA plan client). (ii) making to any client or prospective client any untrue statement of a material factor omitting to state to such prospect or client a material fact necessary in order to make the statements made, in light of the circumstances under which they are made, not misleading. (iii) engaging in any act, practice or course of business which operates or would operate as a fraud or deceit upon any client or prospective client. (iv) engaging in any manipulative practice with respect to any client or prospective client. (v) revealing to any third party (except in the normal course of his or her duties on behalf of a client) any non-public information regarding securities transactions by any client or the consideration by any client or the Firm of any securities transactions. (vi) causing any ERISA plan client to engage in any nonexempt prohibited transaction or any other transaction that would violate Candriam's applicable fiduciary duties under ERISA, as described under Candriam's ERISA Plan Compliance Policy. 1.5.4. Acknowledgement of receipt and Certification Each Staff Member s hall provide to the Compliance Department initially and not later than 10 calendar days after her/his arrival a signed Compliance Acknowledgement Letter in order to undertake her/himself to observe and comply with all policies and procedures as set out in the manual including the COE. Each Staff Member shall providetheCompliance with an Initial certification ofcompliance by any means accepted by Candriam including through any dedicated tool adopted by Candriam not later than 10 calendar days after the first compliance request. 1.6. Related policies and procedures The Policy is also to be read in conjunction with other policies and procedures: Conflicts of Interest Policy. Code of Conduct. Best Selection Policy. Relevant monitoring controls are performed appropriately according to the above-mentioned control processes ("first-level controls") and testing controls are carried out by the Compliance ("second -level controls").

------

![LOGO](img_4fe30836fafe4f6.jpg)

2. Roles and Responsibilities 2.1. The Board of Directors The Board of Directors is primarily responsible for supervision of the management of Candriam, responsible for the strategy I general policy, risk monitoring and shareholders relations and as part of this role, of examining and approving the key policies set forth by the Board of Management Candriam. 2.2. The Board of Management The Board of Management is responsible for establishing policies prescribing key measures, principles and guidelines to be implemented in order to plan, execute and control activities and achieve the objectives of the Company and the daily management of Candriam entities. The Board of Management examines and approve policies. The Board of Management via the Conducting Officers is also responsible for ensuring that all members of the staff are aware of the aspects of the Policy relevant to them. 2.3. The Compliance Department The Compliance Department is responsible of the control of the application and update of this Policy. 2.4. All employees All employees have a responsibility for carrying out aspects of the Policy that are relevant to them and any failure to adhere to this Policy can be considered as a breach of an employee's contract.

------

![LOGO](img_b464681dcfb14f6.jpg)

3. Prohibition on insider dealing and market manipulation Candriam Staff Members are required to adhere strictly to all applicable laws and regulations concerning insider dealing and disclosure of material inside information. Violations of these laws and regulations may result in disciplinary action by Candriam, as well as penalties under law. Insider information definitions in accordance with Article 7 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 can be summarized as the illegal use of confidential information from inside the company for personal gain. It is also described as: Use any non-public information. Offering a degree of certainty and specific enough to be able to infer an impact on the financial instruments. Directly or indirectly, information concerning one or more issuers of financial instruments; and Which, if it were made public, would be likely to have a significant effect on the price of those financial instruments or related derivative financial instruments such as commodity underlying. It also applies to auctioned products such as emissions. Market manipulation definitions according to Article 12 of Regulation (EU) No 596/2014 imply, inter alia, the following behaviour: a) The carrying out of transactions or issuing orders: Which give or are likely to give false or misleading signals as to the supply of, demand for, or price of financial instruments; or Which secure, or are likely to secure, by a person or persons acting in collaboration, the price of one or several financial instruments at an abnormal or artificial level, unless the person who entered into the transactions or issued the orders establishes that his/her reasons for so doi'Y:;j are legitimate and that those transactions or orders to trade conform to accepted market practices on the regulated market concerned. b) Carrying out transactions or issuing orders to trade which employ fictitious devices or any other form of deception or contrivance or c) Disseminating information, through the media (including the Internet, or by any other means), which gives or is likely to give false or misleading signals as to the supply of, demand for, or price of financial instruments, including the dissemination of rumors and false or misleading news, where the person who made the dissemination knew, or ought to have known, that the information was false or misleading. As a general rule, personal transactions undertaken by each Staff Member must not conflict with Candriam's duty of care to its clients and investors under the regulatory system nor contravene the market abuse rules or involve the misuse or improper disclosure of confidential information. Staff Members may not use confidential or proprietary information for personal investment purposes or for personal gain. The prohibition also extends to using another person to take such actions ordisclosirg information or opinions to another person, which might lead them to undertake such business. Any security purchased by an employee on a covered account in contravention of the COE must be sold immediately and no later than 2 business days after notification of the breach by the Compliance team. Employee will not be compensated for any financial disadvantage or loss arising in application of this Code. The following rules are designed to protect Staff Members and Candriam, from any allegation of improper conduct arising from personal transactions. Staff Members may not try to avoid the rules by undertaking their personal transactions through the names of other persons/third parties whether directly or indirectly connected to them. Therefore, if a Staff Member is not permitted to enter into a transaction for their own account, they must not procure any other person/third party to enter into such a personal transaction on their behalf.

------

![LOGO](img_ab30fe7167ae4f6.jpg)

4. Authorized personal account transactions for non- covered persons Each Staff Member, that is not a Covered Person, are not permitted to undertake personal transactions except that: The following transactions are permitted but must be reported to the Compliance Department as the case may be, in accordance with Section 8 and Exhibit 2: (i) Candriam Exchange Traded Funds ("ETF") that hold at least 30 underlying securities, and exchange traded funds on commodities. (ii) Candriam funds (UCilS,AIF, OEIC, U.S. registered investment companies and similar funds offered to the public, whether or not organized in the EU). (iii) Options and futures. (iv) Stocks or corporate bonds. (v) Sovereign bonds issues by an OECD Country or European Union Countries. The following transactions are permitted and must not be reported to the Compliance Department (i) Non-Candriam ExchangeTraded Funds{"ETF"} thatholdat least30 underlying securities,and exchange traded funds on commodities. (ii) Non-Candriam funds (UCilS, AIF, OEIC, U.S. registered investment companies and similar funds offered to the public, whether or not organized in the EU). (iii) Transactions that are non-volitional in nature1: e.g.,mandatory corporate actions (stock splits, stock dividends, exchanges and conversions, mandatory tenders, pro rata distributions to all holders of a class of securities), donation or inheritances of securities, and margin/maintenance calls (where the securities to be sold are not directed by the covered person). (iv) Transactions that are related to: a) Bankers' acceptances. b) Bank certificates of deposit. c) Commercial paper. EXHIBIT 2B summarizes these rules for Non-Covered persons. 5. Authorized personal account transactions for covered persons The following rules apply to Covered Persons and their Relatives. Covered Persons are not permitted to undertake personal transactions except that: the following transactions are permitted but must be reported to the Compliance Department as the case may be, in accordance with Section 8 and Exhibit 2: (i) Candriam Exchange Traded Funds ("ElF"} that hold at least 30 underlying securities, and exchange traded funds on commodities. (ii) Candriam funds (UCilS, AIF, OEIC, U.S. registered investment companies and similar 1 These transactions must however be reflected, as soon as possible and at the latest at each certification, in the quantities declared in position in the specific tool adopted by Candriam.

------

![LOGO](img_da1868405d064f6.jpg)

funds offered to the public, whether or not organized in the EU). (iii) Options and futures on commodities or securities indices that have at least 30 constituent underlying securities. (iv) Stocks orcorporate bonds issued by issuers which are considered as Large capitalization when the investment is made, which are considered to have a market capitalization exceeding 10 billion USD (on the secondary market or on the primary market when the overall issue is above 10 billion USD). (v) Sovereign bonds issues by an OE

------

![LOGO](img_d701e3331cc44f6.jpg)

2. Verification: The system runs automatic checks to ensure that the proposed transaction complies with Candriam's internal policies, regulatory rules, and that it does not exceed risk limits or security restrictions (prevention of market abuse). 3. Approval orrejection: After this review, the transaction is either approved orrejected based on the results of the checks. The user is informed of the decision (approval orrejection) and may, if approved, proceed with the transaction. 6.3. Holdings period requirement All Staff Members are prohibited from undertaking personal transactions for speculative purposes and must hold personal investments fora period longer than 30 calendar days. In practice, this obligationimpliesthat no sell can be done within 30 calendar days afterthe last buy of the same security/derivative contract (even if other buy transactions on the same instrument have been performed previously). Exceptions to this rule may be granted for compelling reasons. Furthermore, personal transactions must not demand too much of a Staff Member's timeor prevent them in any other way from fulfilling them contractual duties. All Staff Members are prohibited from selling securities short. Excessiveor inappropriate trading that interferes with job performance or compromisesthe duty that the Candriam owes to its clients will not be permitted. An unusually highlevel of personal trading is strongly discouraged. 6.4. Initial Public Offering and Limited Private Offering (Private Placement) Staff members may not acquire beneficial ownership of any security in an initial public offering,or a limited private offering (including investments in limited partnerships and hedge funds) not made to the general public or a virtual currency token offered in an initial ordigital coin offering (also called ICOs or token sales) except with the express written priorapprovalof the Conduct & Compliance Advisory Team . Requests for such permission are to be submitted by e-mail via conduct@candriam.com. 6.5. Annual security account statement Each year, no more than 30 calendar days afterthe end of each calendar year, all Staff Members must arrange to providea security account statement, of the holdings of their Covered Accounts from their banks/brokerto the Compliance Department. This can be done by any means accepted by Candriam including through any dedicated tool adopted by Candriam. The Compliance Department shall revie w these account statements to identify conflicts of interest or potential misconduct. 6.6. Annual Certification Each year, no more than 30 calendar days after the end of each calendar year, all Candriam Staff Members must provide the Compliance Department with a Certification of Compliance with this Code of Ethics by any means accepted by Candriam including through any dedicated tool adopted by Candriam. 6.7. Restricted Security List In addition, Staff Members may be subject to a Restricted Security List maintained by the Compliance Team that includes securities where Candriam has, oris in a position,to receive material non-public information about acompany as aresult of a special relationship between Candriam, a Covered Person

------

![LOGO](img_ea49a69d53744f6.jpg)

and the security's issuer. When applicable, concerned Staff Members are individually informed by Compliance of the existence of that restriction. Employees are not allowed to trade or invest in any securities listed on the Restricted Security List without the prior consent of the Compliance Team . If any concerned Staff Member already holds a security that is on the Restricted Security List and has not received consent from the Compliance Team, such Staff Member must continue to hold and may not execute any buy or sell orders for the relevant security until such security is removed from the Restricted Security List. 7. Additional requirements regarding personal transactions- covered persons This section only applies to Candriam Staff Members that are "Covered Persons" and their Relatives. 7.1. Quarterly Certification Each Covered Person, within 30 calendar days of the end of each calendar quarter (end March, June, September, and December), must confirm that he/she has complied with the Code of Ethicsand that he/she has either declared all reportable transactions or has no reportable transactions to declare, by any means accepted by Candriam including through any dedicated tool adopted by Candriam. 7.2. Confirmation of personal transactions All Covered Persons must provide a copy of the bank/broker-dealer confirmation of their personal transactions or arrange forthe bank/broker-dealer holding their Covered Accounts to send duplicate confirmation of their transaction to the Compliance Department no later than the business day after the transaction, or where the Staff Member enters into a transaction while absent from the office due, for example, to holiday or illness, without delay as soon as practicable thereafter and no later than the first day such Staff Member is back in the office. In this case, an explanatory comment must be included in the declaration when the timing of the required declaration is not respected . 8. Exceptions from reporting requirements There is no reporting requirement for all Staff Members with respect to personal transactions if: • Effected pursuant to an automatic investment plan (such as saving or pension plans but only with automatic investments). • Effected by a financial institution in any Covered Account over which the Staff Member has no direct or indirect influence or control (a "Personal account managed by a third party without intervention") to the condition that the investment discretion for such account has been delegated in writing toan independent fiduciary and such investment discretion is not shared with the Covered Person. • Effected by a Delegate in any Covered Account over which the Staff Member has no direct or indirect influence, control ("Covered account managed by a Delegate without intervention") to the condition that: o the Covered Person certifies in writing (using Exhibit 3)that they have not and will take any investment decision nor discuss any potential investment decisions with such Delegate, o and the Conduct & Compliance Advisory Team has determined that the account satisfies the foregoing requirements. There is also no requirements in terms of certifications and declarations forjustified absences (holidays, sick leave, maternity leave, etc.). The exemption is only valid during this period of time and until the return at work. From this date, the employee has to comply with all the obligations without delay as soon as practicable and no later than the first week of work.

------

![LOGO](img_e15742999ea24f6.jpg)

9. US Registered representatives Staff Members that are Registered Representatives in the United States are also subject to additional reporting requirements and must report securities holdirgs to their member firm(s). Please refer to the broker-dealer's policies and procedures for such disclosure requirements. 10. The Board of Directors Certain members of the Board of Directors of Candriam are either employed by Candriam affiliate New York Life Investment Management ("NYLIM") or another New York Life entity ("NYL Associated Directors") or are not employed by Candriam, New York Life, or any affiliate of Candriam or New York Life (an "Outside Director''). Candriam seeks to keep any NYL Associated Directors and Outside Directors informed of Candriam's investment activities through reports and other information provided in connection with Board meetings and other Board events. Since NYL Associated Directors and Outside Directors do not work in the investment business of Candriam, Candriam Policy is not to communicate routinely with them concerning specific trading information or advice on specific issues (i.e., no information is given regarding investments for which current activity is being considered for clients). In light of this code, such Director only needs to obtain prior approval for a personal trade in a security if he or she knew or, in the ordinary course of his or her activities should have known, that during a 15-day period immediately before or after a transaction in that security, either a Candriam client purchased or sold that security or Candriam considered purchasing or selling that security on behalf of a client. If this occurs, then the Director would be required to submit a transaction report forthe quarter in which the trade took place. That report may be submitted to Candriam under this code, orin the case of a NYL Associated Director, to NYLIM under its Code of Ethics. 11. Miscellaneous 11.1. Chief Legal & Compliance Officer The Chief Compliance Officer must request approvals from the Global Head of Compliance or submit reports with respect to their personal securities transactions or other activities restricted by the Code of Ethics by any means accepted by Candriam including through any dedicated tool adopted by Candriam. 11.2. Review Procedures A review of this Code will be made at least every two years by the Compliance function to ensure it remains accurate and fit for purpos

------

![LOGO](img_83f3a1e9abbf4f6.jpg)

11.3. lnterpretation Should any staff member have questions on how they interpret this Code or whether a proposed transaction, account, etc. should be reported, they are encouraged to contact the Conduct & Compliance Advisory Team for clarification. 11.4. Reporting of Violations All Staff Members, upon learning of any violation of these rules, are expected to report the violation promptly to the Compliance team in writing. The Compliance Team shall note on any such report the date of its receipt. Notwithstanding the foregoing, nothing in this Code of Ethics, or any other firm policy, guideline or agreement, prohibits or restricts you from initiating communications directly with, or responding to any inquiry from, any regulatory or supervisory authority regarding any good faith concerns about possible violations of law or regulation. 11.5. Sanctions If advised of a violation of this Code of Ethics by any Staff Member, the Chief Legal & Compliance Officer or the Global Head of Compliaoce may impose such sanctions as deemed appropriate and provided for by law. 11.6. Records Candriam will maintain and preserve the following records in the manner and to the extent set forth below, and these shall be available for examination by representatives of the SEC and other regulators as applicable, which may include the U.S. Department of Labor. (i) a copy of this Code andany other rules, policies, procedures and codes which are, or at any time within the pastfive years have been in effect, shall be held for the first two years in Candriam's office; (ii) a record of any violation of this Code and of any action/sanctions taken as a result of such violation shall be held for a period of not less than five years following the end of the fiscal year and for the first two years after the violation at Candriam's office; a copy of each report made, notice or acknowledgement received pursuant to this Pol icy shall be preserved in an easily accessible place for a period of not less than five years from the end of the fiscal year in which it is made and for the first two years in Candriam's office; (iii) a list of all persons who are required, or within the past five years have been required, to make reports pursuant to this Code shall be maintained in an easily accessible place, the first two years in Candriam's office; and (iv) record of any decision, and the reasons supporting the decision, to approve a transaction by an C

------

![LOGO](img_eb4bbb550aae4f6.jpg)

11.8. Investment Clubs Covered Persons are prohibited from joining an Investment Club ,which is defined as a group of people who pool their money to make investments and who collectively make investment decisions. Any questions as to whether an organization orpartnership qualifies as an Investment Club should be directed to the Compliance Team. 12. U.S. Employee benefit plans and Erisa This Code should be read together with Candriam's general ERISA Plan Compliance Policy.The ERISA Plan Compliance Policy which describes the comprehensive U.S. statutory scheme that governs the operation, administration, and investment of plans. ERISA's requirements include strict requirements relating to conflicts of interest and prohibited transactions. Any approval granted under this Code for an action that may relate to an ERISA plan client should take into account the requirements of ERISA. In addition, certain U.S. employee benefit plans are not subjectto ERISA, including governmental plans and church plans. These plans may instead be subject to other laws, such as state or local laws, which may be similar to or different from ERISA. The laws applicable to a U.S. governmental plan or church plans should be reviewed on a case-by-case basis. For example, the laws applicable to governmental plans, and even different governmental plans within the same city or state, can vary widely. Candriam will establish policies and procedures for instances when Candriam acts as an investment adviser or discretionary investment manager forplan clients not subject to ERISA. 13. Data protection These Covered Accounts relate not only to Staff Member's financial portfolios but also to thefinancial portfolios of their spouse, relatives and all persons referred to Exhibit 1. Given that such disclosures contain "personal data", Candriam must comply with specific rules governing privacy and data protection. Such personal data may be transferred to other Candriam/New York Life entities for Compliance purposes as well as to competent authorities in the European Union and the United States when duly required and or permitted by relevant laws or regulations. Staff Members and their Relatives are entitled to oppose on legitimate grounds to the collection and processing of personal data, request access personal data, rectify inaccuracies, requestthe deletion of personal data by contacting the Compliance Team. Given that Candriam does not have any contact with such Relatives, Candriam requests that Staff Members convey on its behalf the above information to them and relay to Candriam any request such Relative may have regarding the above data processing. Candriam will delete and purge such data within 5 years after the departure of Staff Member. 14. Concluding provisions The Policy comes into force with immediate effect and is subject to regular review and if indicated by the review, subsequent update. 15. Exhibits 15.1. Exhibit 1 -Covered accounts The Code of Ethics applies to all transactions in the following investment accounts:

------

![LOGO](img_bcb76d5760214f6.jpg)

Accounts held for your benefit by you or other persons (including nominees, custodians, brokers, pledgees, partnerships, personal holding companies, trustees or other fiduciaries). For covered persons, accounts held by (or for the benefit of) your spouse or any children or relatives who share your home. Accounts (otherthan Candriam client accounts) for which you have or share, directly or indirectly, through any contract, arrangement, understanding, relationship, or otherwise: Voting power (which includes power to vote, or to direct the voting of, a security). Investment power (which includes the power to dispose, or to direct the disposition� of a security. Accounts held by any other person to whose support you materially contribute or in which, by reason of any agreement or arrangement, you have or share benefits substantially equivalent to ownership, including, for example: Arrangements (which may be informal) under which you have agreed to share the profits from an investment. Accounts maintained or administered by you for a relative (such as children or parents) who do not share your home. Accounts you oversee which involve any other person not described above in which you may have an interest that could affect your best judgment.

------

![LOGO](img_7749259f3a494f6.jpg)

15.2. Exhibit 2A- Covered persons only and their Relatives 1 Rules for Covered Persons and their Relatives (Y=Yes/N=No, NA= Not Applicable) Declaration Holclng period Disclosure of Initial Annual security Confirmation of Financial Instruments Pre-clearance transactions (calendar days) holclngs accountsta?ent transaction All transactions prohlbHed except: Equities and CorpotateBonds issued by La-ge capE (Marketcap > 10 billion USO) at transaction date y y 30 days y y y Options and Futlres (Authorized Index ll'ld Commodities) y y 30 Days y y y Funds managed by or delegated to Can? E'1'F: y y 30 days y y y (inciLding Candriam ETF}(including authorizsd Non CandriamFunds(induding noo-Candriam ETF N N N N N N Sovereign bonds issued by an y y 30 days y y y OECD country or European Union Countries Priva , placement and IPOs y y 30 days NA NA y on large caps Money Mar 1tet instruments (such as "Bona de caisse", CD, CP) N N N N N N Specific c:.u.: Covered account managed by a third party wlllouinwvention N N N N N N AutomaticlnvestmentPian(saWigorpension plan N N N N N N Saving or Pension plan with intervention y y 30 days y y y MandatoryCorpora"' scions, donation, inheriiii"IOIBand marginfmaintenance calls N N 30 days N N N

------

![LOGO](img_30b3a617750a4f6.jpg)

15.3. Exhibit 28- Candriam Staff Members excluding Covered Persons I Rules for Non-Covered Persons (excluding relatives) (Y=Yes/N=No, NA= Non-Applicable) Declaration Holding period Disclosure of initial Annual security Confirmation of Financial Instruments pre-clearance transactions (calendar days) holdings account statement transaction Allowed for transactions: Equities and Corporate Bonds y y 30 days y y N Options and Futures y y 30 Days y y N Funds managed by or delegated to Candriarr y y 30 days y y N (including CandriamETF)(lnclud ingauthorized ETF Non Candriam Funds(induding no-Candriam ETF N N N N N N Sovereign bonds issued by an y y 30 days y y N DECO country or European Union Countries Private placement and IPOs y y 30 days NA NA N Money Market instruments N N N N N N (such as "Bons decaisse", CD, CP) Specific cases: Covered account managed by a third party ?intervention N N N N N N Automatic Investment Plan(saving or pension plan N N N N N N Saving or Pension plan with intervention y y y y y N Mandatory Corporate actions. donation, inherilalcesmargin/maintenance calls N N 30 days N N N

------

![LOGO](img_c37b31a43e1e4f6.jpg)

15A. Exhibit 3—Covered Account over which the Covered Person has !!Q direct or indirect influence or control ("Covered account managed by a Delegate without intervention") Employee identification Last name: Employee identification First name: Entity: Department: Position: For the account number :. at . .(Financial institution), I declare that as a person involved, I do not exercise any direct or indirect influence or control on this account and investment decisions for this account are made by . In accordance with the rules of the Code of Ethics (point 8), I choose not to report positions and transactions with regard to this account because the investment decisions are not taken by myself. Date: Signature: Please send this document to the Conduct & Compliance Advisory Team by e-mail to conduct@candriam.com.